<?xml version="1.0" encoding="iso-8859-1" ?>
<PASBIO>
    <framesest>
        <predicate lemma="translate">
            <roleset id="translate.01" name="molecular event of producing genetic product called protein&#x0A;" wordnet="10">
                <roles>
                    <role n="0" descr="resultant product &#x09;&#x09;&#x09;// protein //&#x0A;" />
                    <role n="1" descr="source &#x09;&#x09;&#x09;&#x09;&#x09;// mRNA, transcript // &#x0A;" />
                    <role n="2" descr="location as tissue, cell, vitro&#x0A;" />
                </roles>
                <example src="EGRAM" no="0">
                    <text>Alternative splicing of exon 4 results in a transcription that translated to a truncated C-terminal protein containing the first, second, and third transmembrane domains, while splicing of exons 3 and 4 would produce a protein with five membrane domains but without the third and fourth domains present in the ET-AR protein.</text>
                    <arg n="0">a truncated C-terminal protein containing the first, second, and third transmembrane domains</arg>
                    <arg n="1">a transcription</arg>
                </example>
                <example src="EGRAM" no="1">
                    <text>ISGF3 gamma has been shown to translated correctly into vitro from A1 clones (recombinant) bound to DNA with an indistinguishable specificity of ISGF3 gamma purified from HeLa cells.</text>
                    <arg n="0">ISGF3 gamma</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="EGRAM" no="2">
                    <text>ISGF3 gamma is able to be properly translated into vitro from clones bound to recombinant DNA with an indistinguishable specificity of ISGF3 gamma purified from HeLa cells.</text>
                    <arg n="0">ISGF3 gamma</arg>
                    <arg n="1">recombinant</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="EGRAM" no="3">
                    <text>ISGF3 gamma that can be translated into vitro of A1 clones (recombinant) bind the DNA with an indistinguishable specificity of ISGF3 gamma purified from HeLa cells.</text>
                    <arg n="0">ISGF3 gamma</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="EGRAM" no="4">
                    <text>ISGF3 gamma that is able to be translated adequately into vitro of A1 clones (recombinant) bind the DNA with an indistinguishable specificity of ISGF3 gamma purified from HeLa cells.</text>
                    <arg n="0">ISGF3 gamma</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="EGRAM" no="5">
                    <text>ISGF3 gamma that may have been adequately translated into vitro of A1 clones (recombinant) bind the DNA with an indistinguishable specificity of ISGF3 gamma purified from HeLa cells.</text>
                    <arg n="0">ISGF3 gamma</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="EGRAM" no="6">
                    <text>It has been shown that over 100 proteins and polypeptides included in the ArC/XylS family of prokaryotic positive transcriptional regulators have been fully translated from open reading frameworks.</text>
                    <arg n="0">open reading frameworks</arg>
                </example>
                <example src="EGRAM" no="7">
                    <text>It has been shown that translation, as our data showed is translated into a truncated C-terminal protein containing the first, second and third transmembrane domains, while splicing exons 3 and 4 would produce a protein with five membrane domains, but without the third and fourth domains present in ET-AR protein.</text>
                    <arg n="0">a truncated C-terminal protein containing the first, second and third transmembrane domains</arg>
                    <arg n="1">translation, as our data showed</arg>
                </example>
                <example src="EGRAM" no="8">
                    <text>More than 100 proteins and polypeptides included in the ArC/XylS family of positive prokaryotic transcriptional regulators are translated from open leing frames.</text>
                    <arg n="0">open leing frames</arg>
                </example>
                <example src="EGRAM" no="9">
                    <text>More than 100 proteins and polypeptides included in the ArC/XylS family of prokaryotic positive transcriptional regulators can be fully translated from open reading frameworks.</text>
                    <arg n="0">open reading frameworks</arg>
                </example>
                <example src="EGRAM" no="10">
                    <text>More than 100 proteins and polypeptides included in the ArC/XylS family of prokaryotic transcriptional regulators have been fully translated from open reading frameworks.</text>
                    <arg n="0">open reading frameworks</arg>
                </example>
                <example src="EGRAM" no="11">
                    <text>More than 100 proteins and polypeptides that are included in the ArC/XylS family of pro-karyotic positive transcriptional regulators may have been translated completely from open leing frames.</text>
                    <arg n="0">open leing frames</arg>
                </example>
                <example src="EGRAM" no="12">
                    <text>More than 100 proteins and polypeptides that are included in the ArC/XylS family of prokaryotic positive transcriptional regulators are observed to be translated from open led frames.</text>
                    <arg n="0">open led frames</arg>
                </example>
                <example src="EGRAM" no="13">
                    <text>More than 100 proteins and polypeptides that are included in the ArC/XylS family of prokaryotic positive transcriptional regulators are translated from open leing frames.</text>
                    <arg n="0">open leing frames</arg>
                </example>
                <example src="EGRAM" no="14">
                    <text>Stat1 Y701F has been shown to translated into vitro can also be dimerized into the LMP2 gas.</text>
                    <arg n="0">Stat1 Y701F</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="EGRAM" no="15">
                    <text>Stat1 Y701F that is likely to be translated into vitro can also be dimerized into the LMP2 gas.</text>
                    <arg n="0">Stat1 Y701F</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="EGRAM" no="16">
                    <text>Stat1 Y701F that is observed to be probably translated into vitro can also dimerize in the SGL2 of LMP2.</text>
                    <arg n="0">Stat1 Y701F</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="EGRAM" no="17">
                    <text>Stat1 Y701F which has probably translated into vitro can also be dimerised to the LMP2 gas.</text>
                    <arg n="0">Stat1 Y701F</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="EGRAM" no="18">
                    <text>Stat1 Y701F which translated to vitro can also be submerged to SGL2.</text>
                    <arg n="0">Stat1 Y701F</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="EGRAM" no="19">
                    <text>Stat1, Estat1 Y701F, Estat1 N135, Estat1 N200 and Estat5/1, as our data show, can be translated to vitro and partially purified to heparin-acrose.</text>
                    <arg n="0">Stat1, Estat1 Y701F, Estat1 N135, Estat1 N200 and Estat5/1</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="EGRAM" no="20">
                    <text>Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1 , as our data reveal, have been translated into vitro and partially purified into heparin-astrose.</text>
                    <arg n="0">Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="EGRAM" no="21">
                    <text>Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1 , as our data reveal, is observed to translated into vitro and to partially purify into heparin-acrose.</text>
                    <arg n="0">Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="EGRAM" no="22">
                    <text>Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1 are likely to be translated into vitro and partially purified into heparin-acrose.</text>
                    <arg n="0">Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="EGRAM" no="23">
                    <text>Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1 are observed to translated to vitro are partially purified in heparin-astroosa.</text>
                    <arg n="0">Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="EGRAM" no="24">
                    <text>Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1 has been shown to translated into vitro are partially purified in heparin-astroosa.</text>
                    <arg n="0">Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="EGRAM" no="25">
                    <text>Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1 has the ability to be translated into vitro and partially purified into heparin-agarose.</text>
                    <arg n="0">Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="EGRAM" no="26">
                    <text>Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1 have the ability to be translated into vitro and partially purified into heparin-acrose.</text>
                    <arg n="0">Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="EGRAM" no="27">
                    <text>Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1 is observed to be translated into vitro and partially purified into heparin-astroosa.</text>
                    <arg n="0">Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="EGRAM" no="28">
                    <text>Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1 is observed to be translated into vitro and partially purified into heparin-astrose.</text>
                    <arg n="0">Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="EGRAM" no="29">
                    <text>Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1 that have the ability to be translated correctly into vitro are partially purified in heparin-acrose.</text>
                    <arg n="0">Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="EGRAM" no="30">
                    <text>Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1 that have the ability to be translated into vitro are partially purified in heparin-agarose.</text>
                    <arg n="0">Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="EGRAM" no="31">
                    <text>Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1 that have the ability to be translated into vitro are partially purified in heparin-astrous.</text>
                    <arg n="0">Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="EGRAM" no="32">
                    <text>Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1 that may have been translated into vitro are partially purified in heparin-agarose.</text>
                    <arg n="0">Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="EGRAM" no="33">
                    <text>Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1 that translated into vitro are partially purified in heparin-astrous.</text>
                    <arg n="0">Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="EGRAM" no="34">
                    <text>Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1 that will be translated appropriately into vitro are partially purified in heparin-agarose.</text>
                    <arg n="0">Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="EGRAM" no="35">
                    <text>Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1 was translated to vitro and partially purified to heparin-astrous.</text>
                    <arg n="0">Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="EGRAM" no="36">
                    <text>Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1, as our data show, are able to be translated into vitro and partially purified into heparin-agarose.</text>
                    <arg n="0">Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="EGRAM" no="37">
                    <text>Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1, as our data show, are likely to be translated into vitro and partially purified into heparin-agarose.</text>
                    <arg n="0">Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="EGRAM" no="38">
                    <text>Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1, as our data show, was translated to vitro and partially purified in heparin-acrose.</text>
                    <arg n="0">Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="EGRAM" no="39">
                    <text>Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1, as our data show, will be translated into vitro and partially purified into heparin-acrose.</text>
                    <arg n="0">Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="EGRAM" no="40">
                    <text>The A0 snake (ISGF3) is observed to translated into vitro of the A1 clones (recombinant) binds DNA with an indistinguishable specificity of the A0 snake (ISGF3) purified from the HeLa cells.</text>
                    <arg n="2">vitro</arg>
                </example>
                <example src="EGRAM" no="41">
                    <text>The ArC/XylS family of positive prokaryotes transcriptional regulators includes more than 100 proteins and polypeptides that will be translated from open frames.</text>
                    <arg n="0">open frames</arg>
                </example>
                <example src="EGRAM" no="42">
                    <text>The ArC/XylS family of prokaryotic positive transcription regulators includes more than 100 proteins and polypeptides that translated from open leing frameworks.</text>
                    <arg n="0">open leing frameworks</arg>
                </example>
                <example src="EGRAM" no="43">
                    <text>The ArC/XylS family of prokaryotic positive transcriptional regulators includes more than 100 proteins and polypeptides that are translated from aber reading tables.</text>
                    <arg n="0">aber reading tables</arg>
                </example>
                <example src="EGRAM" no="44">
                    <text>The ArC/XylS family of prokaryotic transcriptional regulators includes more than 100 proteins and polypeptides that can be translated from open reading frameworks.</text>
                    <arg n="0">open reading frameworks</arg>
                </example>
                <example src="EGRAM" no="45">
                    <text>The alternative deposition of exon 4 results in transcribed translated into a C-terminal truncated protein containing the first, second and third transmembrane domains, while the deposition of exons 3 and 4 would produce a protein with five coverage domains, but without the third and fourth domains present in the ET-AR protein.</text>
                    <arg n="0">a C-terminal truncated protein containing the first, second and third transmembrane domains</arg>
                    <arg n="1">transcribed</arg>
                </example>
                <example src="EGRAM" no="46">
                    <text>The deposition of a culler spoon solution translated the ass, the ass, the ass, the ass, the ass, the ass, the ass, the ass, the ass, the ass, the ass, the ass, the ass, the ass, the ass, the ass, the ass, the ass, the ass, the ass, the ass, the ass, the ass, the ass, the ass, the ass, the ass, the ass, the ass, the ass, the ass.</text>
                </example>
                <example src="EGRAM" no="47">
                    <text>This mutant is likely to be translated into the presence of C-terminal SBP, and as shown in Figure 6C, reading the AUGA element is not detectable, indicating that the stimulatory effect is completely 3 UTR dependent.</text>
                    <arg n="0">This mutant</arg>
                </example>
                <example src="EGRAM" no="48">
                    <text>We also report the first definitive incorporation of Sec into a selenoprotein that can be translated into reticulocyte forms.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte forms</arg>
                </example>
                <example src="EGRAM" no="49">
                    <text>We also report the first definitive incorporation of Sec into a selenoprotein that could have been successfully translated into reticulocyte shaking.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte shaking</arg>
                </example>
                <example src="EGRAM" no="50">
                    <text>We also report the first definitive incorporation of Sec into a selenoprotein that may have been translated into lysates reticulocytes.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">lysates reticulocytes</arg>
                </example>
                <example src="EGRAM" no="51">
                    <text>We also report the first definitive incorporation of Sec into a selenoprotein that will be translated into reticulocyte dissertations.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte dissertations</arg>
                </example>
                <example src="EGRAM" no="52">
                    <text>We also report the first definitive incorporation of Sec into a selenoprotein which has been successfully translated into reticulocyt lysates.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyt lysates</arg>
                </example>
                <example src="EGRAM" no="53">
                    <text>We also report the first definitive incorporation of Sec into a selenoprotein which has been translated into reticulocyt lysates.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyt lysates</arg>
                </example>
                <example src="EGRAM" no="54">
                    <text>We also report the first definitive incorporation of Sec into a selenoprotein which is successfully translated into reticulocyte shales.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte shales</arg>
                </example>
                <example src="EGRAM" no="55">
                    <text>We also report the first definitive incorporation of Sec into selenoprotein that is able to be successfully translated into lysates reticulocytes.</text>
                    <arg n="0">selenoprotein</arg>
                    <arg n="2">lysates reticulocytes</arg>
                </example>
                <example src="EGRAM" no="56">
                    <text>We also reported the first definitive incorporation of Sec into a selenoprotein which was shown to be translated into reticulocyte silates.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte silates</arg>
                </example>
                <example src="EGRAM" no="57">
                    <text>a transcript, as our data have shown can be translated into a truncated C-terminal protein containing the first, second, and third transmembrane domains, while splicing of exons 3 and 4 would produce a protein with five membrane domains but without the third and fourth domains present in the ET-AR protein.</text>
                    <arg n="0">a truncated C-terminal protein containing the first, second, and third transmembrane domains</arg>
                    <arg n="1">a transcript, as our data have shown</arg>
                </example>
                <example src="EGRAM" no="58">
                    <text>a transcript, as our data have shown has been translated efficiently into a truncated C-terminal protein containing the first, second, and third transmembrane domains, while splicing of exons 3 and 4 would produce a protein with five membrane domains but without the third and fourth domains present in the ET-AR protein.</text>
                    <arg n="0">a truncated C-terminal protein containing the first, second, and third transmembrane domains</arg>
                    <arg n="1">a transcript, as our data have shown</arg>
                </example>
                <example src="EGRAM" no="59">
                    <text>a transcript, as our data have shown is likely to be translated into a truncated C-terminal protein containing the first, second, and third transmembrane domains, while splicing of exons 3 and 4 would produce a protein with five membrane domains but without the third and fourth domains present in the ET-AR protein.</text>
                    <arg n="0">a truncated C-terminal protein containing the first, second, and third transmembrane domains</arg>
                    <arg n="1">a transcript, as our data have shown</arg>
                </example>
                <example src="EGRAM" no="60">
                    <text>a transcription can be efficiently translated into a truncated C-terminal protein containing the first, second, and third transmembrane domains, while splicing of exons 3 and 4 would produce a protein with five membrane domains but without the third and fourth domains present in the ET-AR protein.</text>
                    <arg n="0">a truncated C-terminal protein containing the first, second, and third transmembrane domains</arg>
                    <arg n="1">a transcription</arg>
                </example>
                <example src="EGRAM" no="61">
                    <text>a transcription is observed to be efficiently translated into a truncated C-terminal protein containing the first, second, and third transmembrane domains, while splicing of exons 3 and 4 would produce a protein with five membrane domains but without the third and fourth domains present in the ET-AR protein.</text>
                    <arg n="0">a truncated C-terminal protein containing the first, second, and third transmembrane domains</arg>
                    <arg n="1">a transcription</arg>
                </example>
                <example src="EGRAM" no="62">
                    <text>a transcription was efficiently translated into a truncated C-terminal protein containing the first, second, and third transmembrane domains, while splicing of exons 3 and 4 would produce a protein with five membrane domains but without the third and fourth domains present in the ET-AR protein.</text>
                    <arg n="0">a truncated C-terminal protein containing the first, second, and third transmembrane domains</arg>
                    <arg n="1">a transcription</arg>
                </example>
                <example src="EGRAM" no="63">
                    <text>a transcription will be efficiently translated into a truncated C-terminal protein containing the first, second, and third transmembrane domains, while splicing of exons 3 and 4 will produce a protein with five membrane domains but without the third and fourth domains present in the ET-AR protein.</text>
                    <arg n="0">a truncated C-terminal protein containing the first, second, and third transmembrane domains</arg>
                    <arg n="1">a transcription</arg>
                </example>
                <example src="EGRAM" no="64">
                    <text>this mutant , as our study reveals, will be translated into the presence of C-terminal SBP2, and as shown in Figure 6C no reader can be detected when the AUGA element is removed, indicating that the stimulatory effect is totally dependent on 3 UTR.</text>
                    <arg n="0">this mutant</arg>
                </example>
                <example src="EGRAM" no="65">
                    <text>this mutant is able to be translated efficiently in the presence of C-terminal SBP2, and as shown in Figure 6C no reader can be detected when the AUGA element is removed, indicating that the stimulatory effect is totally dependent on 3 UTR.</text>
                    <arg n="0">this mutant</arg>
                </example>
                <example src="EGRAM" no="66">
                    <text>this mutant is able to be translated into the presence of C-terminal SBP2, and as shown in Figure 6C no reader can be detected when the AUGA element is removed, indicating that the stimulatory effect is totally dependent on 3 UTR.</text>
                    <arg n="0">this mutant</arg>
                </example>
                <example src="EGRAM" no="67">
                    <text>this mutant is efficiently translated in the presence of terminal C SBP2, and as shown in Figure 6C no reader can be detected when the AUGA element is removed, indicating that the stimulatory effect is totally dependent on 3 UTR.</text>
                    <arg n="0">this mutant</arg>
                </example>
                <example src="EGRAM" no="68">
                    <text>this mutant is efficiently translated into the presence of terminal C PAS2, and as shown in Figure 6C no reader can be detected when the AUGA element is removed, indicating that the stimulatory effect is totally dependent on 3 UTR.</text>
                    <arg n="0">this mutant</arg>
                </example>
                <example src="EGRAM" no="69">
                    <text>this mutant was efficiently translated into the presence of PAS-C-terminal2, and as shown in Figure 6C no reader can be detected when the AUGA element is removed, indicating that the stimulatory effect is completely dependent on 3 UTR.</text>
                    <arg n="0">this mutant</arg>
                </example>
                <example src="EGRAM" no="70">
                    <text>this mutant was shown to be effective in the presence of PAS-C, and as shown in Figure 6C, no reader can be detected when the AUGA element is removed, translated that the stimulatory effect is completely dependent on 3 UTR.</text>
                    <arg n="0">this mutant</arg>
                </example>
                <example src="EGRAM" no="71">
                    <text>this mutant, as revealed by our study, has been shown to translated into the presence of C-terminal SBP2, and as shown in Figure 6C no reader can be detected when the AUGA element is removed, indicating that the stimulatory effect is fully dependent on 3 UTR.</text>
                    <arg n="0">this mutant</arg>
                </example>
                <example src="EGRAM" no="72">
                    <text>transcription, as our data showed, is able to be translated into a C-terminal truncated protein containing the first, second and third transmembrane domains, while the splicing of exons 3 and 4 would produce a protein with five coverage domains, but without the third and fourth domains present in the ET-AR protein.</text>
                    <arg n="0">a C-terminal truncated protein containing the first, second and third transmembrane domains</arg>
                    <arg n="1">transcription, as our data showed</arg>
                </example>
                <example src="EGRAM" no="73">
                    <text>translation was efficiently translated into a truncated C-terminal protein containing the first, second, and third transmembrane domains, while splicing outside exons 3 and 4 would produce a protein with five coverage domains, but without the third and fourth domains present in the ET-AR protein.</text>
                    <arg n="0">a truncated C-terminal protein containing the first, second, and third transmembrane domains</arg>
                    <arg n="1">translation</arg>
                </example>
                <example src="EGRAM" no="74">
                    <text>translation will be translated efficiently into a truncated C-terminal protein containing the first, second, and third transmembrane domains, while splicing outside exons 3 and 4 would produce a protein with five membrane domains, but without the third and fourth domains present in the ET-AR protein.</text>
                    <arg n="0">a truncated C-terminal protein containing the first, second, and third transmembrane domains</arg>
                    <arg n="1">translation</arg>
                </example>
                <example src="PERMUTATE" no="1">
                    <text>ISGF3 blood cells , as our data reveal, has been shown to translated into vitro and to partially purify into heparin-acrose.</text>
                    <arg n="0">ISGF3 blood cells</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="2">
                    <text>ISGF3 blood cells are observed to translated to vitro are partially purified in heparin-astroosa.</text>
                    <arg n="0">ISGF3 blood cells</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="3">
                    <text>ISGF3 blood cells can be translated into vitro and partially purified into heparin-agarose.</text>
                    <arg n="0">ISGF3 blood cells</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="4">
                    <text>ISGF3 blood cells has been shown to translated correctly into vitro from A1 clones (recombinant) bound to DNA with an indistinguishable specificity of ISGF3 gamma purified from HeLa cells.</text>
                    <arg n="0">ISGF3 blood cells</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="5">
                    <text>ISGF3 blood cells that has been shown to probably translated into vitro can also be dimerized into the LMP2 gas.</text>
                    <arg n="0">ISGF3 blood cells</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="6">
                    <text>ISGF3 blood cells that has been translated into vitro of A1 clones (recombinant) binds DNA with an indistinguishable specificity of ISGF3 gum purified from HeLa cells.</text>
                    <arg n="0">ISGF3 blood cells</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="7">
                    <text>ISGF3 blood cells that have been translated adequately into vitro are partially purified in heparin-agarose.</text>
                    <arg n="0">ISGF3 blood cells</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="8">
                    <text>ISGF3 blood cells that have the ability to be translated correctly into vitro are partially purified in heparin-acrose.</text>
                    <arg n="0">ISGF3 blood cells</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="9">
                    <text>ISGF3 blood cells that is likely to be correctly translated to vitro is partially purified into heparin-astrous.</text>
                    <arg n="0">ISGF3 blood cells</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="10">
                    <text>ISGF3 blood cells that is observed to be probably translated into vitro can also dimerize in the SGL2 of LMP2.</text>
                    <arg n="0">ISGF3 blood cells</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="11">
                    <text>ISGF3 blood cells that will be translated into vitro are partially purified in heparin-agarose.</text>
                    <arg n="0">ISGF3 blood cells</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="12">
                    <text>ISGF3 blood cells which translated to vitro can also be submerged to SGL2.</text>
                    <arg n="0">ISGF3 blood cells</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="13">
                    <text>ISGF3 blood cells which will be translated into vitro are partially purified into heparin-acrose.</text>
                    <arg n="0">ISGF3 blood cells</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="14">
                    <text>ISGF3 gamma are likely to be translated into vitro and partially purified into heparin-acrose.</text>
                    <arg n="0">ISGF3 gamma</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="15">
                    <text>ISGF3 gamma can be translated efficiently in the presence of C-terminal SBP2, and as shown in Figure 6C no reader can be detected when the AUGA element is removed, indicating that the stimulatory effect is completely dependent on 3 UTR.</text>
                    <arg n="0">ISGF3 gamma</arg>
                </example>
                <example src="PERMUTATE" no="16">
                    <text>ISGF3 gamma can be translated into vitro and partially purified into heparin-agarose.</text>
                    <arg n="0">ISGF3 gamma</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="17">
                    <text>ISGF3 gamma can be translated into vitro and partially purified into heparin-astroosis.</text>
                    <arg n="0">ISGF3 gamma</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="18">
                    <text>ISGF3 gamma has been shown to translated into the presence of C-terminal SBP2, and as shown in Figure 6C no reader can be detected when the AUGA element is removed, indicating that the stimulatory effect is totally dependent on 3 UTR.</text>
                    <arg n="0">ISGF3 gamma</arg>
                </example>
                <example src="PERMUTATE" no="19">
                    <text>ISGF3 gamma is efficiently translated in the presence of terminal C SBP2, and as shown in Figure 6C no reader can be detected when the AUGA element is removed, indicating that the stimulatory effect is totally dependent on 3 UTR.</text>
                    <arg n="0">ISGF3 gamma</arg>
                </example>
                <example src="PERMUTATE" no="20">
                    <text>ISGF3 gamma is likely to be translated in the presence of C-terminal SBP2, and as shown in Figure 6C no reader can be detected when the AUGA element is removed, indicating that the stimulatory effect is totally dependent on 3 UTR.</text>
                    <arg n="0">ISGF3 gamma</arg>
                </example>
                <example src="PERMUTATE" no="21">
                    <text>ISGF3 gamma may have been translated into vitro and partially purified into heparin-agarose.</text>
                    <arg n="0">ISGF3 gamma</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="22">
                    <text>ISGF3 gamma may have been translated into vitro and partially purified into heparin-astrous.</text>
                    <arg n="0">ISGF3 gamma</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="23">
                    <text>ISGF3 gamma that are able to be translated adequately into vitro are partially purified in heparin-agarose.</text>
                    <arg n="0">ISGF3 gamma</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="24">
                    <text>ISGF3 gamma that are adequately translated into vitro are partially purified in heparin-agarose.</text>
                    <arg n="0">ISGF3 gamma</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="25">
                    <text>ISGF3 gamma that are properly translated into vitro are partially purified in heparin-acrose.</text>
                    <arg n="0">ISGF3 gamma</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="26">
                    <text>ISGF3 gamma that can be translated adequately into vitro are partially purified in heparin-agarose.</text>
                    <arg n="0">ISGF3 gamma</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="27">
                    <text>ISGF3 gamma that can be translated to vitro can also be dimerised to LMP2 gas.</text>
                    <arg n="0">ISGF3 gamma</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="28">
                    <text>ISGF3 gamma that can probably be translated to vitro can also be dimerised into LMP2 gas.</text>
                    <arg n="0">ISGF3 gamma</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="29">
                    <text>ISGF3 gamma that have been translated into vitro are partially purified into heparin-astrous.</text>
                    <arg n="0">ISGF3 gamma</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="30">
                    <text>ISGF3 gamma that is observed to be translated into vitro of A1 clones (recombinant) binds DNA with an indistinguishable specificity of ISGF3 snake purified from HeLa cells.</text>
                    <arg n="0">ISGF3 gamma</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="31">
                    <text>ISGF3 gamma that may have been adequately translated into vitro are partially purified in heparin-agarose.</text>
                    <arg n="0">ISGF3 gamma</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="32">
                    <text>ISGF3 gamma that may have been correctly translated into vitro is partially purified in heparin-acrose.</text>
                    <arg n="0">ISGF3 gamma</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="33">
                    <text>ISGF3 gamma that translated into vitro are partially purified in heparin-astrous.</text>
                    <arg n="0">ISGF3 gamma</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="34">
                    <text>ISGF3 gamma that will probably be translated into vitro can also be submerged into SGL2 LMP2.</text>
                    <arg n="0">ISGF3 gamma</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="35">
                    <text>ISGF3 gamma translated into the presence of C-terminal SBP2, and as shown in Figure 6C no reader can be detected when the AUGA element is removed, indicating that the stimulatory effect is totally dependent on 3 UTR.</text>
                    <arg n="0">ISGF3 gamma</arg>
                </example>
                <example src="PERMUTATE" no="36">
                    <text>ISGF3 gamma was efficiently translated into the presence of PAS-C-terminal2, and as shown in Figure 6C no reader can be detected when the AUGA element is removed, indicating that the stimulatory effect is completely dependent on 3 UTR.</text>
                    <arg n="0">ISGF3 gamma</arg>
                </example>
                <example src="PERMUTATE" no="37">
                    <text>ISGF3 gamma which can be translated into vitro can also be dimerized into the LMP2 gas.</text>
                    <arg n="0">ISGF3 gamma</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="38">
                    <text>ISGF3 gamma which has been translated into vitro can also be dimerized into the LMP2 gas.</text>
                    <arg n="0">ISGF3 gamma</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="39">
                    <text>ISGF3 gamma which is observed to be translated into vitro can also be dimerized into SGL2 of LMP2.</text>
                    <arg n="0">ISGF3 gamma</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="40">
                    <text>ISGF3 gamma will be translated efficiently in the presence of C-terminal SBP2, and as shown in Figure 6C no reader can be detected when the AUGA element is removed, indicating that the stimulatory effect is fully 3 UTR dependent.</text>
                    <arg n="0">ISGF3 gamma</arg>
                </example>
                <example src="PERMUTATE" no="41">
                    <text>ISGF3 gamma, as our data show, has the ability to be translated to vitro and partially purified to heparin-astrose.</text>
                    <arg n="0">ISGF3 gamma</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="42">
                    <text>ISGF3 gamma, as revealed by our study, is able to be translated into the presence of C-terminal SBP2, and as shown in Figure 6C no reader can be detected when the AUGA element is removed, indicating that the stimulatory effect is totally dependent on 3 UTR.</text>
                    <arg n="0">ISGF3 gamma</arg>
                </example>
                <example src="PERMUTATE" no="43">
                    <text>ISGF3 gamma, as revealed in our study, has been shown to be translated into the presence of C-terminal SBP, and as shown in Figure 6C, reading the AUGA element is not detectable, indicating that the stimulatory effect is totally 3 UTR dependent.</text>
                    <arg n="0">ISGF3 gamma</arg>
                </example>
                <example src="PERMUTATE" no="44">
                    <text>ISGF3 gamma, as revealed in our study, is translated into the presence of C-terminal SBP, and as shown in Figure 6C, reading the AUGA element is not detectable, indicating that the stimulatory effect is totally 3 UTR dependent.</text>
                    <arg n="0">ISGF3 gamma</arg>
                </example>
                <example src="PERMUTATE" no="45">
                    <text>ISGF3 gum can be correctly translated into vitro from A1 clones (recombinant) bound to DNA with an indistinguishable specificity of ISGF3 gamma purified from HeLa cells.</text>
                    <arg n="0">ISGF3 gum</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="46">
                    <text>ISGF3 gum can be translated into vitro and partially purified into heparin-astroosis.</text>
                    <arg n="0">ISGF3 gum</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="47">
                    <text>ISGF3 gum that are able to be translated adequately into vitro are partially purified in heparin-agarose.</text>
                    <arg n="0">ISGF3 gum</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="48">
                    <text>ISGF3 gum that are able to be translated into vitro are partially purified in heparin-agarose.</text>
                    <arg n="0">ISGF3 gum</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="49">
                    <text>ISGF3 gum that can be correctly translated into vitro are partially purified in heparin-astrous.</text>
                    <arg n="0">ISGF3 gum</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="50">
                    <text>ISGF3 gum that has been translated into vitro can also dimer in the SGL2 of LMP2.</text>
                    <arg n="0">ISGF3 gum</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="51">
                    <text>ISGF3 gum that has been translated into vitro of A1 clones (recombinant) binds DNA with an indistinguishable specificity of ISGF3 gamma purified from HeLa cells.</text>
                    <arg n="0">ISGF3 gum</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="52">
                    <text>ISGF3 gum that have the ability to be translated into vitro are partially purified in heparin-astrous.</text>
                    <arg n="0">ISGF3 gum</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="53">
                    <text>ISGF3 gum that is observed to be adequately translated into vitro of A1 clones (recombinant) bind the DNA with an indistinguishable specificity of ISGF3 blood cells purified from HeLa cells.</text>
                    <arg n="0">ISGF3 gum</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="54">
                    <text>ISGF3 gum that is observed to be translated into vitro can also dimerize in the SGL2 of LMP2.</text>
                    <arg n="0">ISGF3 gum</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="55">
                    <text>ISGF3 gum that may have been adequately translated into vitro are partially purified in heparin-agarose.</text>
                    <arg n="0">ISGF3 gum</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="56">
                    <text>ISGF3 gum that probably translated into vitro can also be dimerised in the LMP2 gas.</text>
                    <arg n="0">ISGF3 gum</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="57">
                    <text>ISGF3 gum that will be correctly translated into vitro are partially purified in heparin-astrous.</text>
                    <arg n="0">ISGF3 gum</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="58">
                    <text>ISGF3 gum that will be translated into vitro are partially purified in heparin-agarose.</text>
                    <arg n="0">ISGF3 gum</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="59">
                    <text>ISGF3 gum that will probably be translated to vitro can also be dimerised into LMP2 gas.</text>
                    <arg n="0">ISGF3 gum</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="60">
                    <text>ISGF3 gum which has been translated into vitro of A1 clones (recombinant) binds DNA with an indistinguishable specificity of ISGF3 gamma purified from HeLa cells.</text>
                    <arg n="0">ISGF3 gum</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="61">
                    <text>ISGF3 gum which was probably translated into vitro can also be dimerized into the LMP2 gas.</text>
                    <arg n="0">ISGF3 gum</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="62">
                    <text>ISGF3 gum, as our data show, has the ability to be translated into vitro and partially purified into heparin-agarose.</text>
                    <arg n="0">ISGF3 gum</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="63">
                    <text>ISGF3 gum, as our data show, is likely to be translated into vitro and partially purified into heparin-acrose.</text>
                    <arg n="0">ISGF3 gum</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="64">
                    <text>ISGF3 gum, which has been adequately translated into vitro of A1 clones (recombinant), binds DNA with an indistinguishable specificity of ISGF3 swab, purified from HeLa cells.</text>
                    <arg n="0">ISGF3 gum</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="65">
                    <text>ISGF3 gum, which has probably been translated to vitro, can also be dimerised to LMP2 gas.</text>
                    <arg n="0">ISGF3 gum</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="66">
                    <text>ISGF3 snake has been shown to translated correctly into vitro from A1 clones (recombinant) bound to DNA with an indistinguishable specificity of ISGF3 gamma purified from HeLa cells.</text>
                    <arg n="0">ISGF3 snake</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="67">
                    <text>ISGF3 snake has the ability to be translated into vitro and partially purified into heparin-agarose.</text>
                    <arg n="0">ISGF3 snake</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="68">
                    <text>ISGF3 snake have been translated into vitro and purified partially in heparin-astroosa.</text>
                    <arg n="0">ISGF3 snake</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="69">
                    <text>ISGF3 snake may have been translated into vitro and partially purified into heparin-astrous.</text>
                    <arg n="0">ISGF3 snake</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="70">
                    <text>ISGF3 snake that are properly translated into vitro are partially purified in heparin-acrose.</text>
                    <arg n="0">ISGF3 snake</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="71">
                    <text>ISGF3 snake that can be adequately translated into vitro of A1 clones (recombinant) bind the DNA with an indistinguishable specificity of ISGF3 gamma purified HeLa cells.</text>
                    <arg n="0">ISGF3 snake</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="72">
                    <text>ISGF3 snake that can be translated to vitro can also be dimerised to LMP2 gas.</text>
                    <arg n="0">ISGF3 snake</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="73">
                    <text>ISGF3 snake that has been adequately translated into vitro of A1 clones (recombinant) bind the DNA with an indistinguishable specificity of ISGF3 gamma purified HeLa cells.</text>
                    <arg n="0">ISGF3 snake</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="74">
                    <text>ISGF3 snake that has been translated into vitro of A1 clones (recombinant) binds DNA with an indistinguishable specificity of ISGF3 gum purified from HeLa cells.</text>
                    <arg n="0">ISGF3 snake</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="75">
                    <text>ISGF3 snake that has probably been translated to vitro can also be dimerised into LMP2 gas.</text>
                    <arg n="0">ISGF3 snake</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="76">
                    <text>ISGF3 snake that have been properly translated into vitro are partially purified in heparin-astrose.</text>
                    <arg n="0">ISGF3 snake</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="77">
                    <text>ISGF3 snake that have been translated adequately into vitro are partially purified in heparin-agarose.</text>
                    <arg n="0">ISGF3 snake</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="78">
                    <text>ISGF3 snake that is able to be translated adequately into vitro of A1 clones (recombinant) bind the DNA with an indistinguishable specificity of ISGF3 gamma purified from HeLa cells.</text>
                    <arg n="0">ISGF3 snake</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="79">
                    <text>ISGF3 snake that is likely to be translated into vitro can also be dimerized into the LMP2 gas.</text>
                    <arg n="0">ISGF3 snake</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="80">
                    <text>ISGF3 snake that is observed to be adequately translated into vitro of A1 clones (recombinant) bind the DNA with an indistinguishable specificity of ISGF3 blood cells purified from HeLa cells.</text>
                    <arg n="0">ISGF3 snake</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="81">
                    <text>ISGF3 snake that is observed to be translated into vitro can also dimerize in the SGL2 of LMP2.</text>
                    <arg n="0">ISGF3 snake</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="82">
                    <text>ISGF3 snake that translated into vitro are partially purified in heparin-astrous.</text>
                    <arg n="0">ISGF3 snake</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="83">
                    <text>ISGF3 snake that translated into vitro can also be dimerised to the LMP2 gas.</text>
                    <arg n="0">ISGF3 snake</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="84">
                    <text>ISGF3 snake was translated into vitro from A1 clones (recombinants) that bind to DNA with an indistinguishable specificity of ISGF3 gamma purified from HeLa cells.</text>
                    <arg n="0">ISGF3 snake</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="85">
                    <text>ISGF3 snake were translated into vitro and purified in part into heparin-astrous.</text>
                    <arg n="0">ISGF3 snake</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="86">
                    <text>ISGF3 snake which can be translated into vitro can also be dimerized into the LMP2 gas.</text>
                    <arg n="0">ISGF3 snake</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="87">
                    <text>ISGF3 snake which is likely to be translated into vitro of A1 clones (recombinant) bind DNA with an indistinguishable specificity of ISGF3 gamma purified from HeLa cells.</text>
                    <arg n="0">ISGF3 snake</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="88">
                    <text>ISGF3 snake, as our data show, can be translated to vitro and partially purified to heparin-acrose.</text>
                    <arg n="0">ISGF3 snake</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="89">
                    <text>ISGF3 snake, as our data show, has the ability to be translated into vitro and partially purified into heparin-agarose.</text>
                    <arg n="0">ISGF3 snake</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="90">
                    <text>ISGF3 snake, as our data show, will be translated into vitro and partially purified into heparin-acrose.</text>
                    <arg n="0">ISGF3 snake</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="91">
                    <text>ISGF3 swab are observed to translated to vitro are partially purified in heparin-astroosa.</text>
                    <arg n="0">ISGF3 swab</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="92">
                    <text>ISGF3 swab has been shown to be translated to vitro can also be dimerised to LMP2 gas.</text>
                    <arg n="0">ISGF3 swab</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="93">
                    <text>ISGF3 swab have been translated into vitro and purified partially in heparin-astroosa.</text>
                    <arg n="0">ISGF3 swab</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="94">
                    <text>ISGF3 swab may have been translated into vitro and partially purified into heparin-agarose.</text>
                    <arg n="0">ISGF3 swab</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="95">
                    <text>ISGF3 swab that are likely to be translated into vitro are partially purified in heparin-acrose.</text>
                    <arg n="0">ISGF3 swab</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="96">
                    <text>ISGF3 swab that are likely to be translated into vitro are partially purified in heparin-agarose.</text>
                    <arg n="0">ISGF3 swab</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="97">
                    <text>ISGF3 swab that can be translated into vitro are partially purified in heparin-astroosis.</text>
                    <arg n="0">ISGF3 swab</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="98">
                    <text>ISGF3 swab that can be translated into vitro of A1 clones (recombinant) bind the DNA with an indistinguishable specificity of ISGF3 gamma purified from HeLa cells.</text>
                    <arg n="0">ISGF3 swab</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="99">
                    <text>ISGF3 swab that can probably be translated to vitro can also be dimerised into LMP2 gas.</text>
                    <arg n="0">ISGF3 swab</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="100">
                    <text>ISGF3 swab that is likely to be correctly translated to vitro is partially purified into heparin-astrous.</text>
                    <arg n="0">ISGF3 swab</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="101">
                    <text>ISGF3 swab that is observed to be adequately translated into vitro of A1 clones (recombinant) bind the DNA with an indistinguishable specificity of ISGF3 blood cells purified from HeLa cells.</text>
                    <arg n="0">ISGF3 swab</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="102">
                    <text>ISGF3 swab that may have been adequately translated into vitro of A1 clones (recombinant) bind the DNA with an indistinguishable specificity of ISGF3 gamma purified from HeLa cells.</text>
                    <arg n="0">ISGF3 swab</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="103">
                    <text>ISGF3 swab that may have been translated into vitro is partially purified in heparin-astrous.</text>
                    <arg n="0">ISGF3 swab</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="104">
                    <text>ISGF3 swab was translated into vitro from A1 clones (recombinants) that bind to DNA with an indistinguishable specificity of ISGF3 gamma purified from HeLa cells.</text>
                    <arg n="0">ISGF3 swab</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="105">
                    <text>ISGF3 swab which has been translated into vitro can also be dimerized into the LMP2 gas.</text>
                    <arg n="0">ISGF3 swab</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="106">
                    <text>ISGF3 swab which has probably been translated into vitro can also be dimerized into LMP2 gas.</text>
                    <arg n="0">ISGF3 swab</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="107">
                    <text>ISGF3 swab, as our data reveal, is observed to translated into vitro and purify in part into heparin-acrose.</text>
                    <arg n="0">ISGF3 swab</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="108">
                    <text>ISGF3 swab, as our data show, is likely to be translated into vitro and partially purified into heparin-acrose.</text>
                    <arg n="0">ISGF3 swab</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="109">
                    <text>ISGF3 swab, as our data show, may have been translated into vitro and partially purified into heparin-agarose.</text>
                    <arg n="0">ISGF3 swab</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="110">
                    <text>It has been shown that more than 100 proteins and polypeptides included in the ArC/XylS family of prokaryotic positive transcriptional regulators were translated from open frames.</text>
                    <arg n="0">open frames</arg>
                </example>
                <example src="PERMUTATE" no="111">
                    <text>It has been shown that over 100 proteins and polypeptides included in the ArC/XylS family of prokaryotic positive transcriptional regulators have been fully translated from ISGF3 gamma.</text>
                    <arg n="0">ISGF3 gamma</arg>
                </example>
                <example src="PERMUTATE" no="112">
                    <text>It has been shown that over 100 proteins and polypeptides included in the ArC/XylS family of prokaryotic positive transcriptional regulators have been fully translated from open leing frames.</text>
                    <arg n="0">open leing frames</arg>
                </example>
                <example src="PERMUTATE" no="113">
                    <text>More than 100 proteins and polypeptides included in the ArC/XylS family of positive prokaryotic transcriptional regulators have been translated from open lee frameworks.</text>
                    <arg n="0">open lee frameworks</arg>
                </example>
                <example src="PERMUTATE" no="114">
                    <text>More than 100 proteins and polypeptides included in the ArC/XylS family of positive prokaryotic transcriptional regulators will be translated from ISGF3 gamma.</text>
                    <arg n="0">ISGF3 gamma</arg>
                </example>
                <example src="PERMUTATE" no="115">
                    <text>More than 100 proteins and polypeptides included in the ArC/XylS family of positive prokaryotic transcriptional regulators will be translated from this mutant.</text>
                    <arg n="0">this mutant</arg>
                </example>
                <example src="PERMUTATE" no="116">
                    <text>More than 100 proteins and polypeptides included in the ArC/XylS family of prokaryotic positive transcriptional regulators are able to be fully translated from aber reading tables.</text>
                    <arg n="0">aber reading tables</arg>
                </example>
                <example src="PERMUTATE" no="117">
                    <text>More than 100 proteins and polypeptides included in the ArC/XylS family of prokaryotic positive transcriptional regulators are able to be fully translated from open lee frameworks.</text>
                    <arg n="0">open lee frameworks</arg>
                </example>
                <example src="PERMUTATE" no="118">
                    <text>More than 100 proteins and polypeptides included in the ArC/XylS family of prokaryotic positive transcriptional regulators are fully translated from Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1.</text>
                    <arg n="0">Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1</arg>
                </example>
                <example src="PERMUTATE" no="119">
                    <text>More than 100 proteins and polypeptides included in the ArC/XylS family of prokaryotic positive transcriptional regulators are fully translated from open frames.</text>
                    <arg n="0">open frames</arg>
                </example>
                <example src="PERMUTATE" no="120">
                    <text>More than 100 proteins and polypeptides included in the ArC/XylS family of prokaryotic positive transcriptional regulators are fully translated from open lee frameworks.</text>
                    <arg n="0">open lee frameworks</arg>
                </example>
                <example src="PERMUTATE" no="121">
                    <text>More than 100 proteins and polypeptides included in the ArC/XylS family of prokaryotic positive transcriptional regulators are likely to be fully translated from This mutant.</text>
                    <arg n="0">This mutant</arg>
                </example>
                <example src="PERMUTATE" no="122">
                    <text>More than 100 proteins and polypeptides included in the ArC/XylS family of prokaryotic positive transcriptional regulators are likely to be fully translated from open frames.</text>
                    <arg n="0">open frames</arg>
                </example>
                <example src="PERMUTATE" no="123">
                    <text>More than 100 proteins and polypeptides included in the ArC/XylS family of prokaryotic positive transcriptional regulators are likely to be translated from aber reading tables.</text>
                    <arg n="0">aber reading tables</arg>
                </example>
                <example src="PERMUTATE" no="124">
                    <text>More than 100 proteins and polypeptides included in the ArC/XylS family of prokaryotic positive transcriptional regulators are likely to be translated from open leing frameworks.</text>
                    <arg n="0">open leing frameworks</arg>
                </example>
                <example src="PERMUTATE" no="125">
                    <text>More than 100 proteins and polypeptides included in the ArC/XylS family of prokaryotic positive transcriptional regulators are likely to be translated from this mutant.</text>
                    <arg n="0">this mutant</arg>
                </example>
                <example src="PERMUTATE" no="126">
                    <text>More than 100 proteins and polypeptides included in the ArC/XylS family of prokaryotic positive transcriptional regulators are observed to be completely translated from aber reading tables.</text>
                    <arg n="0">aber reading tables</arg>
                </example>
                <example src="PERMUTATE" no="127">
                    <text>More than 100 proteins and polypeptides included in the ArC/XylS family of prokaryotic positive transcriptional regulators are observed to be completely translated from open reading frameworks.</text>
                    <arg n="0">open reading frameworks</arg>
                </example>
                <example src="PERMUTATE" no="128">
                    <text>More than 100 proteins and polypeptides included in the ArC/XylS family of prokaryotic positive transcriptional regulators are observed to be fully translated from aber reading tables.</text>
                    <arg n="0">aber reading tables</arg>
                </example>
                <example src="PERMUTATE" no="129">
                    <text>More than 100 proteins and polypeptides included in the ArC/XylS family of prokaryotic positive transcriptional regulators are observed to be fully translated from this mutant.</text>
                    <arg n="0">this mutant</arg>
                </example>
                <example src="PERMUTATE" no="130">
                    <text>More than 100 proteins and polypeptides included in the ArC/XylS family of prokaryotic positive transcriptional regulators are observed to be translated from open leing frames.</text>
                    <arg n="0">open leing frames</arg>
                </example>
                <example src="PERMUTATE" no="131">
                    <text>More than 100 proteins and polypeptides included in the ArC/XylS family of prokaryotic positive transcriptional regulators are observed to be translated from this mutant.</text>
                    <arg n="0">this mutant</arg>
                </example>
                <example src="PERMUTATE" no="132">
                    <text>More than 100 proteins and polypeptides included in the ArC/XylS family of prokaryotic positive transcriptional regulators can be fully translated from Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1.</text>
                    <arg n="0">Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1</arg>
                </example>
                <example src="PERMUTATE" no="133">
                    <text>More than 100 proteins and polypeptides included in the ArC/XylS family of prokaryotic positive transcriptional regulators can be fully translated from This mutant.</text>
                    <arg n="0">This mutant</arg>
                </example>
                <example src="PERMUTATE" no="134">
                    <text>More than 100 proteins and polypeptides included in the ArC/XylS family of prokaryotic positive transcriptional regulators can be fully translated from this mutant.</text>
                    <arg n="0">this mutant</arg>
                </example>
                <example src="PERMUTATE" no="135">
                    <text>More than 100 proteins and polypeptides included in the ArC/XylS family of prokaryotic positive transcriptional regulators can be translated completely from open frames.</text>
                    <arg n="0">open frames</arg>
                </example>
                <example src="PERMUTATE" no="136">
                    <text>More than 100 proteins and polypeptides included in the ArC/XylS family of prokaryotic positive transcriptional regulators can be translated completely from open leing frames.</text>
                    <arg n="0">open leing frames</arg>
                </example>
                <example src="PERMUTATE" no="137">
                    <text>More than 100 proteins and polypeptides included in the ArC/XylS family of prokaryotic positive transcriptional regulators can be translated from This mutant.</text>
                    <arg n="0">This mutant</arg>
                </example>
                <example src="PERMUTATE" no="138">
                    <text>More than 100 proteins and polypeptides included in the ArC/XylS family of prokaryotic positive transcriptional regulators can be translated from open frames.</text>
                    <arg n="0">open frames</arg>
                </example>
                <example src="PERMUTATE" no="139">
                    <text>More than 100 proteins and polypeptides included in the ArC/XylS family of prokaryotic positive transcriptional regulators can be translated from open leing frames.</text>
                    <arg n="0">open leing frames</arg>
                </example>
                <example src="PERMUTATE" no="140">
                    <text>More than 100 proteins and polypeptides included in the ArC/XylS family of prokaryotic positive transcriptional regulators can be translated from open leing frameworks.</text>
                    <arg n="0">open leing frameworks</arg>
                </example>
                <example src="PERMUTATE" no="141">
                    <text>More than 100 proteins and polypeptides included in the ArC/XylS family of prokaryotic positive transcriptional regulators have the ability to be translated from ISGF3 gamma.</text>
                    <arg n="0">ISGF3 gamma</arg>
                </example>
                <example src="PERMUTATE" no="142">
                    <text>More than 100 proteins and polypeptides included in the ArC/XylS family of prokaryotic positive transcriptional regulators have the ability to be translated from open reading frameworks.</text>
                    <arg n="0">open reading frameworks</arg>
                </example>
                <example src="PERMUTATE" no="143">
                    <text>More than 100 proteins and polypeptides included in the ArC/XylS family of prokaryotic positive transcriptional regulators have the ability to be translated from this mutant.</text>
                    <arg n="0">this mutant</arg>
                </example>
                <example src="PERMUTATE" no="144">
                    <text>More than 100 proteins and polypeptides included in the ArC/XylS family of prokaryotic transcriptional regulators have been fully translated from Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1.</text>
                    <arg n="0">Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1</arg>
                </example>
                <example src="PERMUTATE" no="145">
                    <text>More than 100 proteins and polypeptides included in the ArC/XylS family of prokaryotic transcriptional regulators have the ability to be fully translated from this mutant.</text>
                    <arg n="0">this mutant</arg>
                </example>
                <example src="PERMUTATE" no="146">
                    <text>More than 100 proteins and polypeptides included in the ArC/XylS family of prokaryotic transcriptional regulators may have been fully translated from open lee frameworks.</text>
                    <arg n="0">open lee frameworks</arg>
                </example>
                <example src="PERMUTATE" no="147">
                    <text>More than 100 proteins and polypeptides included in the ArC/XylS family of prokaryotic transcriptional regulators may have been fully translated from open leing frameworks.</text>
                    <arg n="0">open leing frameworks</arg>
                </example>
                <example src="PERMUTATE" no="148">
                    <text>More than 100 proteins and polypeptides included in the ArC/XylS family of prokaryotic transcriptional regulators may have been translated from aber reading tables.</text>
                    <arg n="0">aber reading tables</arg>
                </example>
                <example src="PERMUTATE" no="149">
                    <text>More than 100 proteins and polypeptides included in the ArC/XylS family of prokaryotic transcriptional regulators will be translated completely from open frames.</text>
                    <arg n="0">open frames</arg>
                </example>
                <example src="PERMUTATE" no="150">
                    <text>More than 100 proteins and polypeptides included in the ArC/XylS family of prokaryotic transcriptional regulators will be translated completely from open leing frames.</text>
                    <arg n="0">open leing frames</arg>
                </example>
                <example src="PERMUTATE" no="151">
                    <text>More than 100 proteins and polypeptides included in the ArC/XylS family of prokaryotic transcriptional regulators will be translated completely from this mutant.</text>
                    <arg n="0">this mutant</arg>
                </example>
                <example src="PERMUTATE" no="152">
                    <text>More than 100 proteins and polypeptides that are included in the ArC/XylS family of pro-karyotic positive transcriptional regulators are likely to be translated from Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1.</text>
                    <arg n="0">Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1</arg>
                </example>
                <example src="PERMUTATE" no="153">
                    <text>More than 100 proteins and polypeptides that are included in the ArC/XylS family of pro-karyotic positive transcriptional regulators are likely to be translated from open reading frameworks.</text>
                    <arg n="0">open reading frameworks</arg>
                </example>
                <example src="PERMUTATE" no="154">
                    <text>More than 100 proteins and polypeptides that are included in the ArC/XylS family of pro-karyotic positive transcriptional regulators may have been translated completely from ISGF3 gamma.</text>
                    <arg n="0">ISGF3 gamma</arg>
                </example>
                <example src="PERMUTATE" no="155">
                    <text>More than 100 proteins and polypeptides that are included in the ArC/XylS family of pro-karyotic positive transcriptional regulators may have been translated completely from open frames.</text>
                    <arg n="0">open frames</arg>
                </example>
                <example src="PERMUTATE" no="156">
                    <text>More than 100 proteins and polypeptides that are included in the ArC/XylS family of prokaryotic positive transcriptional regulators are able to be translated completely from ISGF3 gamma.</text>
                    <arg n="0">ISGF3 gamma</arg>
                </example>
                <example src="PERMUTATE" no="157">
                    <text>More than 100 proteins and polypeptides that are included in the ArC/XylS family of prokaryotic positive transcriptional regulators are able to be translated completely from This mutant.</text>
                    <arg n="0">This mutant</arg>
                </example>
                <example src="PERMUTATE" no="158">
                    <text>More than 100 proteins and polypeptides that are included in the ArC/XylS family of prokaryotic positive transcriptional regulators are able to be translated completely from open lee frameworks.</text>
                    <arg n="0">open lee frameworks</arg>
                </example>
                <example src="PERMUTATE" no="159">
                    <text>More than 100 proteins and polypeptides that are included in the ArC/XylS family of prokaryotic positive transcriptional regulators are able to be translated from Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1.</text>
                    <arg n="0">Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1</arg>
                </example>
                <example src="PERMUTATE" no="160">
                    <text>More than 100 proteins and polypeptides that are included in the ArC/XylS family of prokaryotic positive transcriptional regulators are able to be translated from aber reading tables.</text>
                    <arg n="0">aber reading tables</arg>
                </example>
                <example src="PERMUTATE" no="161">
                    <text>More than 100 proteins and polypeptides that are included in the ArC/XylS family of prokaryotic positive transcriptional regulators are completely translated from aber reading tables.</text>
                    <arg n="0">aber reading tables</arg>
                </example>
                <example src="PERMUTATE" no="162">
                    <text>More than 100 proteins and polypeptides that are included in the ArC/XylS family of prokaryotic positive transcriptional regulators are completely translated from open reading frameworks.</text>
                    <arg n="0">open reading frameworks</arg>
                </example>
                <example src="PERMUTATE" no="163">
                    <text>More than 100 proteins and polypeptides that are included in the ArC/XylS family of prokaryotic positive transcriptional regulators are completely translated from this mutant.</text>
                    <arg n="0">this mutant</arg>
                </example>
                <example src="PERMUTATE" no="164">
                    <text>More than 100 proteins and polypeptides that are included in the ArC/XylS family of prokaryotic positive transcriptional regulators are translated from open reading frameworks.</text>
                    <arg n="0">open reading frameworks</arg>
                </example>
                <example src="PERMUTATE" no="165">
                    <text>More than 100 proteins and polypeptides that are included in the ArC/XylS family of prokaryotic positive transcriptional regulators can be translated completely from aber reading tables.</text>
                    <arg n="0">aber reading tables</arg>
                </example>
                <example src="PERMUTATE" no="166">
                    <text>More than 100 proteins and polypeptides that are included in the ArC/XylS family of prokaryotic positive transcriptional regulators have been translated completely from Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1.</text>
                    <arg n="0">Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1</arg>
                </example>
                <example src="PERMUTATE" no="167">
                    <text>More than 100 proteins and polypeptides that are included in the ArC/XylS family of prokaryotic positive transcriptional regulators have been translated completely from open lee frameworks.</text>
                    <arg n="0">open lee frameworks</arg>
                </example>
                <example src="PERMUTATE" no="168">
                    <text>More than 100 proteins and polypeptides that are included in the ArC/XylS family of prokaryotic positive transcriptional regulators have been translated from open frames.</text>
                    <arg n="0">open frames</arg>
                </example>
                <example src="PERMUTATE" no="169">
                    <text>More than 100 proteins and polypeptides that are included in the ArC/XylS family of prokaryotic positive transcriptional regulators have been translated from open reading frameworks.</text>
                    <arg n="0">open reading frameworks</arg>
                </example>
                <example src="PERMUTATE" no="170">
                    <text>More than 100 proteins and polypeptides that are included in the ArC/XylS family of prokaryotic positive transcriptional regulators have the ability to be translated completely from Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1.</text>
                    <arg n="0">Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1</arg>
                </example>
                <example src="PERMUTATE" no="171">
                    <text>More than 100 proteins and polypeptides that are included in the ArC/XylS family of prokaryotic positive transcriptional regulators have the ability to be translated completely from open reading frameworks.</text>
                    <arg n="0">open reading frameworks</arg>
                </example>
                <example src="PERMUTATE" no="172">
                    <text>More than 100 proteins and polypeptides that are included in the ArC/XylS family of prokaryotic positive transcriptional regulators have the ability to be translated completely from this mutant.</text>
                    <arg n="0">this mutant</arg>
                </example>
                <example src="PERMUTATE" no="173">
                    <text>More than 100 proteins and polypeptides that are included in the ArC/XylS family of prokaryotic positive transcriptional regulators will be translated completely from aber reading tables.</text>
                    <arg n="0">aber reading tables</arg>
                </example>
                <example src="PERMUTATE" no="174">
                    <text>More than 100 proteins and polypeptides that are included in the ArC/XylS family of prokaryotic positive transcriptional regulators will be translated from open reading frameworks.</text>
                    <arg n="0">open reading frameworks</arg>
                </example>
                <example src="PERMUTATE" no="175">
                    <text>Stat1 Y701F , as our data reveal, is observed to translated into vitro and to partially purify into heparin-acrose.</text>
                    <arg n="0">Stat1 Y701F</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="176">
                    <text>Stat1 Y701F can be correctly translated into vitro from A1 clones (recombinant) bound to DNA with an indistinguishable specificity of ISGF3 gamma purified from HeLa cells.</text>
                    <arg n="0">Stat1 Y701F</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="177">
                    <text>Stat1 Y701F have the ability to be translated into vitro and partially purified into heparin-acrose.</text>
                    <arg n="0">Stat1 Y701F</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="178">
                    <text>Stat1 Y701F that are likely to be translated into vitro are partially purified in heparin-agarose.</text>
                    <arg n="0">Stat1 Y701F</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="179">
                    <text>Stat1 Y701F that has been shown to be correctly translated into vitro are partially purified in heparin-astroosa.</text>
                    <arg n="0">Stat1 Y701F</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="180">
                    <text>Stat1 Y701F that have been translated into vitro are partially purified into heparin-astrous.</text>
                    <arg n="0">Stat1 Y701F</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="181">
                    <text>Stat1 Y701F that have the ability to be translated adequately into vitro are partially purified in heparin-agarose.</text>
                    <arg n="0">Stat1 Y701F</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="182">
                    <text>Stat1 Y701F that have the ability to be translated into vitro are partially purified in heparin-astrous.</text>
                    <arg n="0">Stat1 Y701F</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="183">
                    <text>Stat1 Y701F that may have been adequately translated into vitro are partially purified in heparin-agarose.</text>
                    <arg n="0">Stat1 Y701F</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="184">
                    <text>Stat1 Y701F that may have been correctly translated into vitro is partially purified in heparin-acrose.</text>
                    <arg n="0">Stat1 Y701F</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="185">
                    <text>Stat1 Y701F was correctly translated into vitro from A1 clones (recombinant) bound to DNA with an indistinguishable specificity of ISGF3 gamma purified from HeLa cells.</text>
                    <arg n="0">Stat1 Y701F</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="186">
                    <text>Stat1 Y701F which has been translated into vitro of A1 clones (recombinant) binds DNA with an indistinguishable specificity of ISGF3 gamma purified from HeLa cells.</text>
                    <arg n="0">Stat1 Y701F</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="187">
                    <text>Stat1 Y701F which is likely to be translated into vitro of A1 clones (recombinant) bind DNA with an indistinguishable specificity of ISGF3 gamma purified from HeLa cells.</text>
                    <arg n="0">Stat1 Y701F</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="188">
                    <text>Stat1 Y701F will be correctly translated into vitro from DNA A1 clones (recombinant) linked to an indistinguishable specificity of ISGF3 gamma purified from HeLa cells.</text>
                    <arg n="0">Stat1 Y701F</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="189">
                    <text>Stat1 Y701F, as our data show, can be translated into vitro and partially purified into heparin-acrose.</text>
                    <arg n="0">Stat1 Y701F</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="190">
                    <text>Stat1 Y701F, which has been properly translated into vitro of A1 clones (recombinant), binds DNA with an indistinguishable specificity of ISGF3 swab, purified from HeLa cells.</text>
                    <arg n="0">Stat1 Y701F</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="191">
                    <text>Stat1, Estat1 Y701F, Estat1 N135, Estat1 N200 and Estat5/1 are likely to be translated into vitro and partially purified into heparin-agarose.</text>
                    <arg n="0">Stat1, Estat1 Y701F, Estat1 N135, Estat1 N200 and Estat5/1</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="192">
                    <text>Stat1, Estat1 Y701F, Estat1 N135, Estat1 N200 and Estat5/1 are translated into vitro and partially purified into heparin-astroosis.</text>
                    <arg n="0">Stat1, Estat1 Y701F, Estat1 N135, Estat1 N200 and Estat5/1</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="193">
                    <text>Stat1, Estat1 Y701F, Estat1 N135, Estat1 N200 and Estat5/1 can be translated into vitro and purified partially in heparin-astroose.</text>
                    <arg n="0">Stat1, Estat1 Y701F, Estat1 N135, Estat1 N200 and Estat5/1</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="194">
                    <text>Stat1, Estat1 Y701F, Estat1 N135, Estat1 N200 and Estat5/1 have been translated into vitro and purified partially in heparin-astroosa.</text>
                    <arg n="0">Stat1, Estat1 Y701F, Estat1 N135, Estat1 N200 and Estat5/1</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="195">
                    <text>Stat1, Estat1 Y701F, Estat1 N135, Estat1 N200 and Estat5/1 that can be correctly translated into vitro are partially purified in heparin-astroosis.</text>
                    <arg n="0">Stat1, Estat1 Y701F, Estat1 N135, Estat1 N200 and Estat5/1</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="196">
                    <text>Stat1, Estat1 Y701F, Estat1 N135, Estat1 N200 and Estat5/1 that can be translated adequately into vitro are partially purified in heparin-agarose.</text>
                    <arg n="0">Stat1, Estat1 Y701F, Estat1 N135, Estat1 N200 and Estat5/1</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="197">
                    <text>Stat1, Estat1 Y701F, Estat1 N135, Estat1 N200 and Estat5/1 that has been translated into vitro of A1 clones (recombinant) binds DNA with an indistinguishable specificity of ISGF3 gamma purified from HeLa cells.</text>
                    <arg n="0">Stat1, Estat1 Y701F, Estat1 N135, Estat1 N200 and Estat5/1</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="198">
                    <text>Stat1, Estat1 Y701F, Estat1 N135, Estat1 N200 and Estat5/1 that have been translated into vitro are partially purified in heparin-agarose.</text>
                    <arg n="0">Stat1, Estat1 Y701F, Estat1 N135, Estat1 N200 and Estat5/1</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="199">
                    <text>Stat1, Estat1 Y701F, Estat1 N135, Estat1 N200 and Estat5/1 that is likely to be translated into vitro can also be dimerized into the LMP2 gas.</text>
                    <arg n="0">Stat1, Estat1 Y701F, Estat1 N135, Estat1 N200 and Estat5/1</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="200">
                    <text>Stat1, Estat1 Y701F, Estat1 N135, Estat1 N200 and Estat5/1 that is observed to be adequately translated into vitro of A1 clones (recombinant) bind the DNA with an indistinguishable specificity of ISGF3 blood cells purified from HeLa cells.</text>
                    <arg n="0">Stat1, Estat1 Y701F, Estat1 N135, Estat1 N200 and Estat5/1</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="201">
                    <text>Stat1, Estat1 Y701F, Estat1 N135, Estat1 N200 and Estat5/1 that is observed to be translated into vitro can also dimerize in the SGL2 of LMP2.</text>
                    <arg n="0">Stat1, Estat1 Y701F, Estat1 N135, Estat1 N200 and Estat5/1</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="202">
                    <text>Stat1, Estat1 Y701F, Estat1 N135, Estat1 N200 and Estat5/1 that may have been adequately translated into vitro are partially purified in heparin-agarose.</text>
                    <arg n="0">Stat1, Estat1 Y701F, Estat1 N135, Estat1 N200 and Estat5/1</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="203">
                    <text>Stat1, Estat1 Y701F, Estat1 N135, Estat1 N200 and Estat5/1 was translated to vitro and partially purified to heparin-astrous.</text>
                    <arg n="0">Stat1, Estat1 Y701F, Estat1 N135, Estat1 N200 and Estat5/1</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="204">
                    <text>Stat1, Estat1 Y701F, Estat1 N135, Estat1 N200 and Estat5/1 which translated to vitro can also be dimerized into the LMP2 gas.</text>
                    <arg n="0">Stat1, Estat1 Y701F, Estat1 N135, Estat1 N200 and Estat5/1</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="205">
                    <text>Stat1, Estat1 Y701F, Estat1 N135, Estat1 N200 and Estat5/1 will be translated into vitro and partially purified into heparin-agarose.</text>
                    <arg n="0">Stat1, Estat1 Y701F, Estat1 N135, Estat1 N200 and Estat5/1</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="206">
                    <text>Stat1, Estat1 Y701F, Estat1 N135, Estat1 N200 and Estat5/1, as our data show, may have been translated into vitro and partially purified into heparin-agarose.</text>
                    <arg n="0">Stat1, Estat1 Y701F, Estat1 N135, Estat1 N200 and Estat5/1</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="207">
                    <text>Stat1, Estat1 Y701F, Estat1 N135, Estat1 N200 and Estat5/1, as our data show, were translated into vitro and partially purified into heparin-agarose.</text>
                    <arg n="0">Stat1, Estat1 Y701F, Estat1 N135, Estat1 N200 and Estat5/1</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="208">
                    <text>Stat1, Estat1 Y701F, Estat1 N135, Estat1 N200 and Estat5/1, which has been adequately translated into vitro of A1 clones (recombinant), binds DNA with an indistinguishable specificity of ISGF3 swab, purified from HeLa cells.</text>
                    <arg n="0">Stat1, Estat1 Y701F, Estat1 N135, Estat1 N200 and Estat5/1</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="209">
                    <text>Stat1, Estat1 Y701F, Estat1 N135, Estat1 N200 and Estat5/1, which has probably been translated to vitro, can also be dimerised to LMP2 gas.</text>
                    <arg n="0">Stat1, Estat1 Y701F, Estat1 N135, Estat1 N200 and Estat5/1</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="210">
                    <text>Stat1, Estat1 Y701F, Estat1 N135, Estat1 N200 and Estat5/1, which will be translated appropriately into vitro of A1 clones (recombinant) bind the DNA with an indistinguishable specificity of ISGF3 gum, purified from HeLa cells.</text>
                    <arg n="0">Stat1, Estat1 Y701F, Estat1 N135, Estat1 N200 and Estat5/1</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="211">
                    <text>Stat1, Estat1 Y701F, Estat1 N135, Estat1 N200 and Stat5/1 , as our data reveal, have been translated into vitro and partially purified into heparin-astrose.</text>
                    <arg n="0">Stat1, Estat1 Y701F, Estat1 N135, Estat1 N200 and Stat5/1</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="212">
                    <text>Stat1, Estat1 Y701F, Estat1 N135, Estat1 N200 and Stat5/1 can be translated into vitro and purified partially in heparin-astroose.</text>
                    <arg n="0">Stat1, Estat1 Y701F, Estat1 N135, Estat1 N200 and Stat5/1</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="213">
                    <text>Stat1, Estat1 Y701F, Estat1 N135, Estat1 N200 and Stat5/1 can be translated into vitro from A1 clones (recombinant) bound to DNA with an indistinguishable specificity of ISGF3 gamma purified from HeLa cells.</text>
                    <arg n="0">Stat1, Estat1 Y701F, Estat1 N135, Estat1 N200 and Stat5/1</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="214">
                    <text>Stat1, Estat1 Y701F, Estat1 N135, Estat1 N200 and Stat5/1 has been shown to translated into vitro and to partially purify into heparin-astroosa.</text>
                    <arg n="0">Stat1, Estat1 Y701F, Estat1 N135, Estat1 N200 and Stat5/1</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="215">
                    <text>Stat1, Estat1 Y701F, Estat1 N135, Estat1 N200 and Stat5/1 have the ability to be translated into vitro and partially purified into heparin-acrose.</text>
                    <arg n="0">Stat1, Estat1 Y701F, Estat1 N135, Estat1 N200 and Stat5/1</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="216">
                    <text>Stat1, Estat1 Y701F, Estat1 N135, Estat1 N200 and Stat5/1 is observed to be translated into vitro and partially purified into heparin-astrose.</text>
                    <arg n="0">Stat1, Estat1 Y701F, Estat1 N135, Estat1 N200 and Stat5/1</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="217">
                    <text>Stat1, Estat1 Y701F, Estat1 N135, Estat1 N200 and Stat5/1 may have been translated into vitro and partially purified into heparin-agarose.</text>
                    <arg n="0">Stat1, Estat1 Y701F, Estat1 N135, Estat1 N200 and Stat5/1</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="218">
                    <text>Stat1, Estat1 Y701F, Estat1 N135, Estat1 N200 and Stat5/1 that are likely to be translated into vitro are partially purified in heparin-agarose.</text>
                    <arg n="0">Stat1, Estat1 Y701F, Estat1 N135, Estat1 N200 and Stat5/1</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="219">
                    <text>Stat1, Estat1 Y701F, Estat1 N135, Estat1 N200 and Stat5/1 that are observed as being adequately translated into vitro are partially purified in heparin-agarose.</text>
                    <arg n="0">Stat1, Estat1 Y701F, Estat1 N135, Estat1 N200 and Stat5/1</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="220">
                    <text>Stat1, Estat1 Y701F, Estat1 N135, Estat1 N200 and Stat5/1 that can be translated into vitro of A1 clones (recombinant) bind the DNA with an indistinguishable specificity of ISGF3 gamma purified from HeLa cells.</text>
                    <arg n="0">Stat1, Estat1 Y701F, Estat1 N135, Estat1 N200 and Stat5/1</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="221">
                    <text>Stat1, Estat1 Y701F, Estat1 N135, Estat1 N200 and Stat5/1 that has been translated into vitro can also dimer in the SGL2 of LMP2.</text>
                    <arg n="0">Stat1, Estat1 Y701F, Estat1 N135, Estat1 N200 and Stat5/1</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="222">
                    <text>Stat1, Estat1 Y701F, Estat1 N135, Estat1 N200 and Stat5/1 that has been translated into vitro of A1 clones (recombinant) binds DNA with an indistinguishable specificity of ISGF3 gamma purified from HeLa cells.</text>
                    <arg n="0">Stat1, Estat1 Y701F, Estat1 N135, Estat1 N200 and Stat5/1</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="223">
                    <text>Stat1, Estat1 Y701F, Estat1 N135, Estat1 N200 and Stat5/1 that have the ability to be translated adequately into vitro are partially purified in heparin-agarose.</text>
                    <arg n="0">Stat1, Estat1 Y701F, Estat1 N135, Estat1 N200 and Stat5/1</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="224">
                    <text>Stat1, Estat1 Y701F, Estat1 N135, Estat1 N200 and Stat5/1 that is able to be translated into vitro of A1 clones (recombinant) bind the DNA with an indistinguishable specificity of ISGF3 gamma purified from HeLa cells.</text>
                    <arg n="0">Stat1, Estat1 Y701F, Estat1 N135, Estat1 N200 and Stat5/1</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="225">
                    <text>Stat1, Estat1 Y701F, Estat1 N135, Estat1 N200 and Stat5/1 that is adequately translated into vitro of A1 clones (recombinant) binds DNA with an indistinguishable specificity of ISGF3 gamma purified from HeLa cells.</text>
                    <arg n="0">Stat1, Estat1 Y701F, Estat1 N135, Estat1 N200 and Stat5/1</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="226">
                    <text>Stat1, Estat1 Y701F, Estat1 N135, Estat1 N200 and Stat5/1 that is likely to be correctly translated to vitro is partially purified into heparin-astrous.</text>
                    <arg n="0">Stat1, Estat1 Y701F, Estat1 N135, Estat1 N200 and Stat5/1</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="227">
                    <text>Stat1, Estat1 Y701F, Estat1 N135, Estat1 N200 and Stat5/1 that is likely to be translated to vitro can also be dimerised to LMP2 gas.</text>
                    <arg n="0">Stat1, Estat1 Y701F, Estat1 N135, Estat1 N200 and Stat5/1</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="228">
                    <text>Stat1, Estat1 Y701F, Estat1 N135, Estat1 N200 and Stat5/1 that may have been translated into vitro are partially purified in heparin-agarose.</text>
                    <arg n="0">Stat1, Estat1 Y701F, Estat1 N135, Estat1 N200 and Stat5/1</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="229">
                    <text>Stat1, Estat1 Y701F, Estat1 N135, Estat1 N200 and Stat5/1 was translated into vitro from A1 clones (recombinants) that bind to DNA with an indistinguishable specificity of ISGF3 gamma purified from HeLa cells.</text>
                    <arg n="0">Stat1, Estat1 Y701F, Estat1 N135, Estat1 N200 and Stat5/1</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="230">
                    <text>Stat1, Estat1 Y701F, Estat1 N135, Estat1 N200 and Stat5/1 was translated to vitro and partially purified to heparin-astrous.</text>
                    <arg n="0">Stat1, Estat1 Y701F, Estat1 N135, Estat1 N200 and Stat5/1</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="231">
                    <text>Stat1, Estat1 Y701F, Estat1 N135, Estat1 N200 and Stat5/1 will be translated into vitro and partially purified into heparin-agarose.</text>
                    <arg n="0">Stat1, Estat1 Y701F, Estat1 N135, Estat1 N200 and Stat5/1</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="232">
                    <text>Stat1, Estat1 Y701F, Estat1 N135, Estat1 N200 and Stat5/1, as our data show, can be translated into vitro and partially purified into heparin-acrose.</text>
                    <arg n="0">Stat1, Estat1 Y701F, Estat1 N135, Estat1 N200 and Stat5/1</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="233">
                    <text>Stat1, Estat1 Y701F, Estat1 N135, Estat1 N200 and Stat5/1, as our data show, can be translated to vitro and partially purified to heparin-acrose.</text>
                    <arg n="0">Stat1, Estat1 Y701F, Estat1 N135, Estat1 N200 and Stat5/1</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="234">
                    <text>Stat1, Estat1 Y701F, Estat1 N135, Estat1 N200 and Stat5/1, as our data show, is likely to be translated into vitro and partially purified into heparin-acrose.</text>
                    <arg n="0">Stat1, Estat1 Y701F, Estat1 N135, Estat1 N200 and Stat5/1</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="235">
                    <text>Stat1, Estat1 Y701F, Estat1 N135, Estat1 N200 and Stat5/1, as our data show, may have been translated into vitro and partially purified into heparin-agarose.</text>
                    <arg n="0">Stat1, Estat1 Y701F, Estat1 N135, Estat1 N200 and Stat5/1</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="236">
                    <text>Stat1, Estat1 Y701F, Estat1 N135, Estat1 N200 and Stat5/1, as our data show, were translated into vitro and partially purified into heparin-agarose.</text>
                    <arg n="0">Stat1, Estat1 Y701F, Estat1 N135, Estat1 N200 and Stat5/1</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="237">
                    <text>Stat1, Estat1 Y701F, Estat1 N135, Estat1 N200 and Stat5/1, which has probably been translated to vitro, can also be dimerised to LMP2 gas.</text>
                    <arg n="0">Stat1, Estat1 Y701F, Estat1 N135, Estat1 N200 and Stat5/1</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="238">
                    <text>Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1 can be translated into the presence of C-terminal SBP2, and as shown in Figure 6C no reader can be detected when the AUGA element is removed, indicating that the stimulatory effect is totally dependent on 3 UTR.</text>
                    <arg n="0">Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1</arg>
                </example>
                <example src="PERMUTATE" no="239">
                    <text>Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1 can be translated into vitro from A1 clones (recombinant) bound to DNA with an indistinguishable specificity of ISGF3 gamma purified from HeLa cells.</text>
                    <arg n="0">Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="240">
                    <text>Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1 has been shown to be translated to vitro can also be dimerised to LMP2 gas.</text>
                    <arg n="0">Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="241">
                    <text>Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1 has been shown to translated efficiently in the presence of C-terminal SBP2, and as shown in Figure 6C no reader can be detected when the AUGA element is removed, indicating that the stimulatory effect is completely dependent on 3 UTR.</text>
                    <arg n="0">Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1</arg>
                </example>
                <example src="PERMUTATE" no="242">
                    <text>Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1 has been translated efficiently in the presence of C-terminal SBP2, and as shown in Figure 6C no reader can be detected when the AUGA element is removed, indicating that the stimulatory effect is completely dependent on 3 UTR.</text>
                    <arg n="0">Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1</arg>
                </example>
                <example src="PERMUTATE" no="243">
                    <text>Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1 is efficiently translated in the presence of terminal C SBP2, and as shown in Figure 6C no reader can be detected when the AUGA element is removed, indicating that the stimulatory effect is totally dependent on 3 UTR.</text>
                    <arg n="0">Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1</arg>
                </example>
                <example src="PERMUTATE" no="244">
                    <text>Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1 is likely to be translated in the presence of C-terminal SBP2, and as shown in Figure 6C no reader can be detected when the AUGA element is removed, indicating that the stimulatory effect is totally dependent on 3 UTR.</text>
                    <arg n="0">Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1</arg>
                </example>
                <example src="PERMUTATE" no="245">
                    <text>Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1 that can be adequately translated into vitro of A1 clones (recombinant) bind the DNA with an indistinguishable specificity of ISGF3 gamma purified HeLa cells.</text>
                    <arg n="0">Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="246">
                    <text>Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1 that is adequately translated into vitro of A1 clones (recombinant) binds DNA with an indistinguishable specificity of ISGF3 gamma purified from HeLa cells.</text>
                    <arg n="0">Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="247">
                    <text>Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1 that is likely to be translated to vitro can also be dimerised to LMP2 gas.</text>
                    <arg n="0">Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="248">
                    <text>Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1 that is observed to be translated into vitro can also dimerize in the SGL2 of LMP2.</text>
                    <arg n="0">Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="249">
                    <text>Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1 that may have been translated into vitro of A1 clones (recombinant) bind DNA with an indistinguishable specificity of ISGF3 gamma purified from HeLa cells.</text>
                    <arg n="0">Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="250">
                    <text>Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1 that will probably be translated into vitro can also be submerged into SGL2 LMP2.</text>
                    <arg n="0">Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="251">
                    <text>Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1 that will probably be translated to vitro can also be dimerised into LMP2 gas.</text>
                    <arg n="0">Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="252">
                    <text>Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1, as our study reveals, can be translated to the presence of C-terminal SBP2, and as shown in Figure 6C no reader can be detected when the AUGA element is removed, indicating that the stimulatory effect is totally dependent on 3 UTR.</text>
                    <arg n="0">Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1</arg>
                </example>
                <example src="PERMUTATE" no="253">
                    <text>Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1, as our study reveals, is likely to be translated in the presence of C-terminal SBP2, and as shown in Figure 6C no reader can be detected when the AUGA element is removed, indicating that the stimulatory effect is fully dependent on 3 UTR.</text>
                    <arg n="0">Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1</arg>
                </example>
                <example src="PERMUTATE" no="254">
                    <text>Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1, as revealed by our study, has been translated in the presence of C-terminal SBP2, and as shown in Figure 6C no reader can be detected when the AUGA element is removed, indicating that the stimulatory effect is fully dependent on 3 UTR.</text>
                    <arg n="0">Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1</arg>
                </example>
                <example src="PERMUTATE" no="255">
                    <text>Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1, which has been adequately translated into vitro of A1 clones (recombinant), binds DNA with an indistinguishable specificity of ISGF3 swab, purified from HeLa cells.</text>
                    <arg n="0">Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="256">
                    <text>Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1, which will be translated appropriately into vitro of A1 clones (recombinant) bind the DNA with an indistinguishable specificity of ISGF3 gum, purified from HeLa cells.</text>
                    <arg n="0">Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="257">
                    <text>The ArC/XylS family of positive prokaryotes transcriptional regulators includes more than 100 proteins and polypeptides that will be translated from Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1.</text>
                    <arg n="0">Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1</arg>
                </example>
                <example src="PERMUTATE" no="258">
                    <text>The ArC/XylS family of positive prokaryotic transcriptional regulators includes more than 100 proteins and polypeptides that are observed to be translated from This mutant.</text>
                    <arg n="0">This mutant</arg>
                </example>
                <example src="PERMUTATE" no="259">
                    <text>The ArC/XylS family of positive prokaryotic transcriptional regulators includes more than 100 proteins and polypeptides that are observed to be translated from open leing frames.</text>
                    <arg n="0">open leing frames</arg>
                </example>
                <example src="PERMUTATE" no="260">
                    <text>The ArC/XylS family of positive prokaryotic transcriptional regulators includes more than 100 proteins and polypeptides that can be translated from Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1.</text>
                    <arg n="0">Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1</arg>
                </example>
                <example src="PERMUTATE" no="261">
                    <text>The ArC/XylS family of prokaryotic positive transcription regulators includes more than 100 proteins and polypeptides observed to be translated from Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1.</text>
                    <arg n="0">Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1</arg>
                </example>
                <example src="PERMUTATE" no="262">
                    <text>The ArC/XylS family of prokaryotic positive transcription regulators includes more than 100 proteins and polypeptides observed to be translated from open leing frames.</text>
                    <arg n="0">open leing frames</arg>
                </example>
                <example src="PERMUTATE" no="263">
                    <text>The ArC/XylS family of prokaryotic positive transcription regulators includes more than 100 proteins and polypeptides that translated from open frames.</text>
                    <arg n="0">open frames</arg>
                </example>
                <example src="PERMUTATE" no="264">
                    <text>The ArC/XylS family of prokaryotic positive transcriptional regulators includes more than 100 proteins and polypeptides that are translated from open reading frameworks.</text>
                    <arg n="0">open reading frameworks</arg>
                </example>
                <example src="PERMUTATE" no="265">
                    <text>The ArC/XylS family of prokaryotic positive transcriptional regulators includes more than 100 proteins and polypeptides that have been shown to be translated from Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1.</text>
                    <arg n="0">Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1</arg>
                </example>
                <example src="PERMUTATE" no="266">
                    <text>The ArC/XylS family of prokaryotic positive transcriptional regulators includes more than 100 proteins and polypeptides that have been translated from This mutant.</text>
                    <arg n="0">This mutant</arg>
                </example>
                <example src="PERMUTATE" no="267">
                    <text>The ArC/XylS family of prokaryotic positive transcriptional regulators includes more than 100 proteins and polypeptides that have been translated from this mutant.</text>
                    <arg n="0">this mutant</arg>
                </example>
                <example src="PERMUTATE" no="268">
                    <text>The ArC/XylS family of prokaryotic transcriptional regulators includes more than 100 proteins and polypeptides that are likely to be translated from aber reading tables.</text>
                    <arg n="0">aber reading tables</arg>
                </example>
                <example src="PERMUTATE" no="269">
                    <text>The ArC/XylS family of prokaryotic transcriptional regulators includes more than 100 proteins and polypeptides that can be translated from aber reading tables.</text>
                    <arg n="0">aber reading tables</arg>
                </example>
                <example src="PERMUTATE" no="270">
                    <text>The ArC/XylS family of prokaryotic transcriptional regulators includes more than 100 proteins and polypeptides that can be translated from this mutant.</text>
                    <arg n="0">this mutant</arg>
                </example>
                <example src="PERMUTATE" no="271">
                    <text>The ArC/XylS family of prokaryotic transcriptional regulators includes more than 100 proteins and polypeptides that may have been translated from ISGF3 gamma.</text>
                    <arg n="0">ISGF3 gamma</arg>
                </example>
                <example src="PERMUTATE" no="272">
                    <text>The ArC/XylS family of prokaryotic transcriptional regulators includes more than 100 proteins and polypeptides that may have been translated from this mutant.</text>
                    <arg n="0">this mutant</arg>
                </example>
                <example src="PERMUTATE" no="273">
                    <text>The ArC/XylS family of prokaryotic transcriptional regulators includes more than 100 proteins and polypeptides that will be translated from This mutant.</text>
                    <arg n="0">This mutant</arg>
                </example>
                <example src="PERMUTATE" no="274">
                    <text>The ArC/XylS family of prokaryotic transcriptional regulators includes more than 100 proteins and polypeptides that will be translated from aber reading tables.</text>
                    <arg n="0">aber reading tables</arg>
                </example>
                <example src="PERMUTATE" no="275">
                    <text>The ArC/XylS family of prokaryotic transcriptional regulators includes more than 100 proteins and polypeptides that will be translated from this mutant.</text>
                    <arg n="0">this mutant</arg>
                </example>
                <example src="PERMUTATE" no="276">
                    <text>The ArC/XylS family of prokaryotic transcriptional regulators includes more than 100 proteins and polypeptides translated from open leing frames.</text>
                    <arg n="0">open leing frames</arg>
                </example>
                <example src="PERMUTATE" no="277">
                    <text>The ISGF3 swab that is likely to be correctly translated into vitro is partially purified in heparin-astroosa.</text>
                    <arg n="0">ISGF3 swab</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="278">
                    <text>The Stat1, Estat1 Y701F, Estat1 N135, Estat1 N200 and Estat5/1, as our data show, may have been translated into vitro and partially purified into heparin-astrose.</text>
                    <arg n="0">Stat1, Estat1 Y701F, Estat1 N135, Estat1 N200 and Estat5/1</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="279">
                    <text>The a selenoprotein that is likely to be correctly translated into reticulocyte shading is partially purified in heparin-astroosa.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte shading</arg>
                </example>
                <example src="PERMUTATE" no="280">
                    <text>The a selenoprotein that is likely to be correctly translated into with shading of reticulocytes is partially purified in heparin-astroosa.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">with shading of reticulocytes</arg>
                </example>
                <example src="PERMUTATE" no="281">
                    <text>The selenoprotein that is likely to be correctly translated into reticulocyte cells is partially purified in heparin-astroosa.</text>
                    <arg n="0">selenoprotein</arg>
                    <arg n="2">reticulocyte cells</arg>
                </example>
                <example src="PERMUTATE" no="282">
                    <text>This mutant can be translated efficiently in the presence of C-terminal SBP2, and as shown in Figure 6C no reader can be detected when the AUGA element is removed, indicating that the stimulatory effect is totally dependent on 3 UTR.</text>
                    <arg n="0">This mutant</arg>
                </example>
                <example src="PERMUTATE" no="283">
                    <text>This mutant has been shown to translated efficiently in the presence of C-terminal SBP2, and as shown in Figure 6C no reader can be detected when the AUGA element is removed, indicating that the stimulatory effect is completely dependent on 3 UTR.</text>
                    <arg n="0">This mutant</arg>
                </example>
                <example src="PERMUTATE" no="284">
                    <text>This mutant is observed to translated efficiently in the presence of C-terminal SBP2, and as shown in Figure 6C no reader can be detected when the AUGA element is removed, indicating that the stimulatory effect is completely dependent on 3 UTR.</text>
                    <arg n="0">This mutant</arg>
                </example>
                <example src="PERMUTATE" no="285">
                    <text>This mutant may have been translated efficiently in the presence of C-terminal SBP, and as shown in Figure 6C no reader can be detected when the AUGA element is removed, indicating that the stimulatory effect is completely dependent on 3 UTR.</text>
                    <arg n="0">This mutant</arg>
                </example>
                <example src="PERMUTATE" no="286">
                    <text>This mutant may have been translated into the presence of C-terminal SAP, and as shown in Figure 6C, no reader can be detected when the AUGA element is removed, indicating that the stimulatory effect is totally dependent on 3 UTR.</text>
                    <arg n="0">This mutant</arg>
                </example>
                <example src="PERMUTATE" no="287">
                    <text>This mutant that can be correctly translated into A2 clones (recombinant) binds DNA to an indistinguishable specificity of ISGF3 gamma purified from HeLa cells.</text>
                    <arg n="0">This mutant</arg>
                </example>
                <example src="PERMUTATE" no="288">
                    <text>This mutant was translated to the presence of C-terminal SBP, and as shown in Figure 6C, no reader can be detected when the AUGA element is removed, indicating that the stimulatory effect is totally dependent on 3 UTR.</text>
                    <arg n="0">This mutant</arg>
                </example>
                <example src="PERMUTATE" no="289">
                    <text>This mutant will be translated into the presence of C-terminal SBP2, and as shown in Figure 6C no reader can be detected when the AUGA element is removed, indicating that the stimulatory effect is totally dependent on 3 UTR.</text>
                    <arg n="0">This mutant</arg>
                </example>
                <example src="PERMUTATE" no="290">
                    <text>This mutant, as revealed by our study, is observed to translated into the presence of C-terminal SBP2, and as shown in Figure 6C no reader can be detected when the AUGA element is removed, indicating that the stimulatory effect is fully dependent on 3 UTR.</text>
                    <arg n="0">This mutant</arg>
                </example>
                <example src="PERMUTATE" no="291">
                    <text>This mutant, as revealed by our study, is observed to translated the presence of C-terminal SBP2, and as shown in Figure 6C no reader can be detected when the AUGA element is removed, indicating that the stimulatory effect is totally dependent on 3 UTR.</text>
                    <arg n="0">This mutant</arg>
                </example>
                <example src="PERMUTATE" no="292">
                    <text>We also report the first definitive incorporation of Sec into ISGF3 blood cells that is observed to be translated into vitro.</text>
                    <arg n="0">ISGF3 blood cells</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="293">
                    <text>We also report the first definitive incorporation of Sec into ISGF3 blood cells which has been shown to be successfully translated into vitro.</text>
                    <arg n="0">ISGF3 blood cells</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="294">
                    <text>We also report the first definitive incorporation of Sec into ISGF3 blood cells which has been successfully translated into vitro.</text>
                    <arg n="0">ISGF3 blood cells</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="295">
                    <text>We also report the first definitive incorporation of Sec into ISGF3 blood cells which translated into vitro.</text>
                    <arg n="0">ISGF3 blood cells</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="296">
                    <text>We also report the first definitive incorporation of Sec into ISGF3 blood cells which will probably be translated into vitro.</text>
                    <arg n="0">ISGF3 blood cells</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="297">
                    <text>We also report the first definitive incorporation of Sec into ISGF3 gamma that can be successfully translated into vitro.</text>
                    <arg n="0">ISGF3 gamma</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="298">
                    <text>We also report the first definitive incorporation of Sec into ISGF3 gamma that is able to be successfully translated into vitro.</text>
                    <arg n="0">ISGF3 gamma</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="299">
                    <text>We also report the first definitive incorporation of Sec into ISGF3 gamma that will probably be successfully translated into vitro.</text>
                    <arg n="0">ISGF3 gamma</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="300">
                    <text>We also report the first definitive incorporation of Sec into ISGF3 gamma which is successfully translated into vitro.</text>
                    <arg n="0">ISGF3 gamma</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="301">
                    <text>We also report the first definitive incorporation of Sec into ISGF3 gamma which translated into vitro.</text>
                    <arg n="0">ISGF3 gamma</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="302">
                    <text>We also report the first definitive incorporation of Sec into ISGF3 gum that translated into vitro.</text>
                    <arg n="0">ISGF3 gum</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="303">
                    <text>We also report the first definitive incorporation of Sec into ISGF3 snake that translated into vitro.</text>
                    <arg n="0">ISGF3 snake</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="304">
                    <text>We also report the first definitive incorporation of Sec into ISGF3 snake which has been shown to be successfully translated into vitro.</text>
                    <arg n="0">ISGF3 snake</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="305">
                    <text>We also report the first definitive incorporation of Sec into ISGF3 snake which translated into vitro.</text>
                    <arg n="0">ISGF3 snake</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="306">
                    <text>We also report the first definitive incorporation of Sec into ISGF3 swab that can be successfully translated into vitro.</text>
                    <arg n="0">ISGF3 swab</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="307">
                    <text>We also report the first definitive incorporation of Sec into ISGF3 swab which has been shown to be successfully translated into vitro.</text>
                    <arg n="0">ISGF3 swab</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="308">
                    <text>We also report the first definitive incorporation of Sec into Stat1 Y701F that could have been successfully translated into vitro.</text>
                    <arg n="0">Stat1 Y701F</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="309">
                    <text>We also report the first definitive incorporation of Sec into Stat1 Y701F that is able to be successfully translated into vitro.</text>
                    <arg n="0">Stat1 Y701F</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="310">
                    <text>We also report the first definitive incorporation of Sec into Stat1 Y701F that will probably be translated into vitro.</text>
                    <arg n="0">Stat1 Y701F</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="311">
                    <text>We also report the first definitive incorporation of Sec into Stat1, Estat1 Y701F, Estat1 N135, Estat1 N200 and Estat5/1 that will be translated into vitro.</text>
                    <arg n="0">Stat1, Estat1 Y701F, Estat1 N135, Estat1 N200 and Estat5/1</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="312">
                    <text>We also report the first definitive incorporation of Sec into Stat1, Estat1 Y701F, Estat1 N135, Estat1 N200 and Estat5/1 that will probably be successfully translated into vitro.</text>
                    <arg n="0">Stat1, Estat1 Y701F, Estat1 N135, Estat1 N200 and Estat5/1</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="313">
                    <text>We also report the first definitive incorporation of Sec into Stat1, Estat1 Y701F, Estat1 N135, Estat1 N200 and Estat5/1 which has been shown to be successfully translated into vitro.</text>
                    <arg n="0">Stat1, Estat1 Y701F, Estat1 N135, Estat1 N200 and Estat5/1</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="314">
                    <text>We also report the first definitive incorporation of Sec into Stat1, Estat1 Y701F, Estat1 N135, Estat1 N200 and Estat5/1 which has been translated into vitro.</text>
                    <arg n="0">Stat1, Estat1 Y701F, Estat1 N135, Estat1 N200 and Estat5/1</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="315">
                    <text>We also report the first definitive incorporation of Sec into Stat1, Estat1 Y701F, Estat1 N135, Estat1 N200 and Estat5/1 which will be successfully translated into vitro.</text>
                    <arg n="0">Stat1, Estat1 Y701F, Estat1 N135, Estat1 N200 and Estat5/1</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="316">
                    <text>We also report the first definitive incorporation of Sec into Stat1, Estat1 Y701F, Estat1 N135, Estat1 N200 and Stat5/1 that can be successfully translated into vitro.</text>
                    <arg n="0">Stat1, Estat1 Y701F, Estat1 N135, Estat1 N200 and Stat5/1</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="317">
                    <text>We also report the first definitive incorporation of Sec into Stat1, Estat1 Y701F, Estat1 N135, Estat1 N200 and Stat5/1 that could have been successfully translated into vitro.</text>
                    <arg n="0">Stat1, Estat1 Y701F, Estat1 N135, Estat1 N200 and Stat5/1</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="318">
                    <text>We also report the first definitive incorporation of Sec into Stat1, Estat1 Y701F, Estat1 N135, Estat1 N200 and Stat5/1 that translated into vitro.</text>
                    <arg n="0">Stat1, Estat1 Y701F, Estat1 N135, Estat1 N200 and Stat5/1</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="319">
                    <text>We also report the first definitive incorporation of Sec into Stat1, Estat1 Y701F, Estat1 N135, Estat1 N200 and Stat5/1 that was translated into vitro.</text>
                    <arg n="0">Stat1, Estat1 Y701F, Estat1 N135, Estat1 N200 and Stat5/1</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="320">
                    <text>We also report the first definitive incorporation of Sec into Stat1, Estat1 Y701F, Estat1 N135, Estat1 N200 and Stat5/1 which is likely to be successfully translated into vitro.</text>
                    <arg n="0">Stat1, Estat1 Y701F, Estat1 N135, Estat1 N200 and Stat5/1</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="321">
                    <text>We also report the first definitive incorporation of Sec into Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1 that was translated into vitro.</text>
                    <arg n="0">Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="322">
                    <text>We also report the first definitive incorporation of Sec into Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1 which is likely to be successfully translated into vitro.</text>
                    <arg n="0">Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="323">
                    <text>We also report the first definitive incorporation of Sec into Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1 which is successfully translated into vitro.</text>
                    <arg n="0">Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="324">
                    <text>We also report the first definitive incorporation of Sec into Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1 which was successfully translated into vitro.</text>
                    <arg n="0">Stat1, Stat1 Y701F, Stat1 N135, Stat1 N200 and Stat5/1</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="325">
                    <text>We also report the first definitive incorporation of Sec into a selenoprotein that can be successfully translated into reticulocyte liabilities.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte liabilities</arg>
                </example>
                <example src="PERMUTATE" no="326">
                    <text>We also report the first definitive incorporation of Sec into a selenoprotein that could have been successfully translated into lysates reticulocytes.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">lysates reticulocytes</arg>
                </example>
                <example src="PERMUTATE" no="327">
                    <text>We also report the first definitive incorporation of Sec into a selenoprotein that could have been successfully translated into reticulocyte dissertations.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte dissertations</arg>
                </example>
                <example src="PERMUTATE" no="328">
                    <text>We also report the first definitive incorporation of Sec into a selenoprotein that could have been successfully translated into with shading of reticulocytes.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">with shading of reticulocytes</arg>
                </example>
                <example src="PERMUTATE" no="329">
                    <text>We also report the first definitive incorporation of Sec into a selenoprotein that could have been translated into reticulocyt lysates.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyt lysates</arg>
                </example>
                <example src="PERMUTATE" no="330">
                    <text>We also report the first definitive incorporation of Sec into a selenoprotein that is able to be successfully translated into reticulocyte liabilities.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte liabilities</arg>
                </example>
                <example src="PERMUTATE" no="331">
                    <text>We also report the first definitive incorporation of Sec into a selenoprotein that is able to be translated into reticulocyte dissertations.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte dissertations</arg>
                </example>
                <example src="PERMUTATE" no="332">
                    <text>We also report the first definitive incorporation of Sec into a selenoprotein that is observed to be translated into reticulocyte shales.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte shales</arg>
                </example>
                <example src="PERMUTATE" no="333">
                    <text>We also report the first definitive incorporation of Sec into a selenoprotein that is observed to be translated into reticulocyte silates.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte silates</arg>
                </example>
                <example src="PERMUTATE" no="334">
                    <text>We also report the first definitive incorporation of Sec into a selenoprotein that may have been translated into reticulocyt lysates.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyt lysates</arg>
                </example>
                <example src="PERMUTATE" no="335">
                    <text>We also report the first definitive incorporation of Sec into a selenoprotein that may have been translated into reticulocyte cells.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte cells</arg>
                </example>
                <example src="PERMUTATE" no="336">
                    <text>We also report the first definitive incorporation of Sec into a selenoprotein that may have been translated into reticulocyte liabilities.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte liabilities</arg>
                </example>
                <example src="PERMUTATE" no="337">
                    <text>We also report the first definitive incorporation of Sec into a selenoprotein that may have been translated into reticulocyte silates.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte silates</arg>
                </example>
                <example src="PERMUTATE" no="338">
                    <text>We also report the first definitive incorporation of Sec into a selenoprotein that may have been translated into with shading of reticulocytes.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">with shading of reticulocytes</arg>
                </example>
                <example src="PERMUTATE" no="339">
                    <text>We also report the first definitive incorporation of Sec into a selenoprotein that proved to be translated into with shading of reticulocytes.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">with shading of reticulocytes</arg>
                </example>
                <example src="PERMUTATE" no="340">
                    <text>We also report the first definitive incorporation of Sec into a selenoprotein that translated into reticulocyt lysates.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyt lysates</arg>
                </example>
                <example src="PERMUTATE" no="341">
                    <text>We also report the first definitive incorporation of Sec into a selenoprotein that translated into reticulocyte dissertations.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte dissertations</arg>
                </example>
                <example src="PERMUTATE" no="342">
                    <text>We also report the first definitive incorporation of Sec into a selenoprotein that was observed to be successfully translated into reticulocyte dissertations.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte dissertations</arg>
                </example>
                <example src="PERMUTATE" no="343">
                    <text>We also report the first definitive incorporation of Sec into a selenoprotein that was observed to be successfully translated into with shading of reticulocytes.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">with shading of reticulocytes</arg>
                </example>
                <example src="PERMUTATE" no="344">
                    <text>We also report the first definitive incorporation of Sec into a selenoprotein that was translated into reticulocyte forms.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte forms</arg>
                </example>
                <example src="PERMUTATE" no="345">
                    <text>We also report the first definitive incorporation of Sec into a selenoprotein that will be translated into reticulocyte shading.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte shading</arg>
                </example>
                <example src="PERMUTATE" no="346">
                    <text>We also report the first definitive incorporation of Sec into a selenoprotein that will be translated into reticulocyte shaking.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte shaking</arg>
                </example>
                <example src="PERMUTATE" no="347">
                    <text>We also report the first definitive incorporation of Sec into a selenoprotein that will probably be translated into reticulocyte shaking.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte shaking</arg>
                </example>
                <example src="PERMUTATE" no="348">
                    <text>We also report the first definitive incorporation of Sec into a selenoprotein that will probably be translated into reticulocyte shales.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte shales</arg>
                </example>
                <example src="PERMUTATE" no="349">
                    <text>We also report the first definitive incorporation of Sec into a selenoprotein which has been shown to be successfully translated into reticulocyt lysates.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyt lysates</arg>
                </example>
                <example src="PERMUTATE" no="350">
                    <text>We also report the first definitive incorporation of Sec into a selenoprotein which has been shown to be successfully translated into reticulocyte dissertations.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte dissertations</arg>
                </example>
                <example src="PERMUTATE" no="351">
                    <text>We also report the first definitive incorporation of Sec into a selenoprotein which has been successfully translated into reticulocyte dissertations.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte dissertations</arg>
                </example>
                <example src="PERMUTATE" no="352">
                    <text>We also report the first definitive incorporation of Sec into a selenoprotein which has been successfully translated into reticulocyte shales.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte shales</arg>
                </example>
                <example src="PERMUTATE" no="353">
                    <text>We also report the first definitive incorporation of Sec into a selenoprotein which has been translated into reticulocyte cells.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte cells</arg>
                </example>
                <example src="PERMUTATE" no="354">
                    <text>We also report the first definitive incorporation of Sec into a selenoprotein which has been translated into reticulocyte shaking.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte shaking</arg>
                </example>
                <example src="PERMUTATE" no="355">
                    <text>We also report the first definitive incorporation of Sec into a selenoprotein which has been translated into with shading of reticulocytes.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">with shading of reticulocytes</arg>
                </example>
                <example src="PERMUTATE" no="356">
                    <text>We also report the first definitive incorporation of Sec into a selenoprotein which is able to be successfully translated into reticulocyte shaking.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte shaking</arg>
                </example>
                <example src="PERMUTATE" no="357">
                    <text>We also report the first definitive incorporation of Sec into a selenoprotein which is likely to be successfully translated into lysates reticulocytes.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">lysates reticulocytes</arg>
                </example>
                <example src="PERMUTATE" no="358">
                    <text>We also report the first definitive incorporation of Sec into a selenoprotein which is likely to be successfully translated into reticulocyt lysates.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyt lysates</arg>
                </example>
                <example src="PERMUTATE" no="359">
                    <text>We also report the first definitive incorporation of Sec into a selenoprotein which is likely to be successfully translated into reticulocyte cells.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte cells</arg>
                </example>
                <example src="PERMUTATE" no="360">
                    <text>We also report the first definitive incorporation of Sec into a selenoprotein which is observed to be successfully translated into reticulocyte liabilities.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte liabilities</arg>
                </example>
                <example src="PERMUTATE" no="361">
                    <text>We also report the first definitive incorporation of Sec into a selenoprotein which is observed to be translated into reticulocyt lysates.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyt lysates</arg>
                </example>
                <example src="PERMUTATE" no="362">
                    <text>We also report the first definitive incorporation of Sec into a selenoprotein which is observed to be translated into reticulocyte shading.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte shading</arg>
                </example>
                <example src="PERMUTATE" no="363">
                    <text>We also report the first definitive incorporation of Sec into a selenoprotein which is observed to be translated into with shading of reticulocytes.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">with shading of reticulocytes</arg>
                </example>
                <example src="PERMUTATE" no="364">
                    <text>We also report the first definitive incorporation of Sec into a selenoprotein which is successfully translated into reticulocyt lysates.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyt lysates</arg>
                </example>
                <example src="PERMUTATE" no="365">
                    <text>We also report the first definitive incorporation of Sec into a selenoprotein which is successfully translated into reticulocyte shaking.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte shaking</arg>
                </example>
                <example src="PERMUTATE" no="366">
                    <text>We also report the first definitive incorporation of Sec into a selenoprotein which is successfully translated into reticulocyte silates.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte silates</arg>
                </example>
                <example src="PERMUTATE" no="367">
                    <text>We also report the first definitive incorporation of Sec into a selenoprotein which is successfully translated into with shading of reticulocytes.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">with shading of reticulocytes</arg>
                </example>
                <example src="PERMUTATE" no="368">
                    <text>We also report the first definitive incorporation of Sec into a selenoprotein which translated into reticulocyte shading.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte shading</arg>
                </example>
                <example src="PERMUTATE" no="369">
                    <text>We also report the first definitive incorporation of Sec into a selenoprotein which was successfully translated into reticulocyte shales.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte shales</arg>
                </example>
                <example src="PERMUTATE" no="370">
                    <text>We also report the first definitive incorporation of Sec into a selenoprotein which will be successfully translated into reticulocyt lysates.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyt lysates</arg>
                </example>
                <example src="PERMUTATE" no="371">
                    <text>We also report the first definitive incorporation of Sec into a selenoprotein which will probably be translated into lysates reticulocytes.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">lysates reticulocytes</arg>
                </example>
                <example src="PERMUTATE" no="372">
                    <text>We also report the first definitive incorporation of Sec into a selenoprotein which will probably be translated into reticulocyte shales.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte shales</arg>
                </example>
                <example src="PERMUTATE" no="373">
                    <text>We also report the first definitive incorporation of Sec into selenoprotein that can be translated into reticulocyte cells.</text>
                    <arg n="0">selenoprotein</arg>
                    <arg n="2">reticulocyte cells</arg>
                </example>
                <example src="PERMUTATE" no="374">
                    <text>We also report the first definitive incorporation of Sec into selenoprotein that can be translated into reticulocyte forms.</text>
                    <arg n="0">selenoprotein</arg>
                    <arg n="2">reticulocyte forms</arg>
                </example>
                <example src="PERMUTATE" no="375">
                    <text>We also report the first definitive incorporation of Sec into selenoprotein that could have been successfully translated into lysed by reticulocytes.</text>
                    <arg n="0">selenoprotein</arg>
                    <arg n="2">lysed by reticulocytes</arg>
                </example>
                <example src="PERMUTATE" no="376">
                    <text>We also report the first definitive incorporation of Sec into selenoprotein that could have been successfully translated into reticulocyte cells.</text>
                    <arg n="0">selenoprotein</arg>
                    <arg n="2">reticulocyte cells</arg>
                </example>
                <example src="PERMUTATE" no="377">
                    <text>We also report the first definitive incorporation of Sec into selenoprotein that is able to be translated into lysates reticulocytes.</text>
                    <arg n="0">selenoprotein</arg>
                    <arg n="2">lysates reticulocytes</arg>
                </example>
                <example src="PERMUTATE" no="378">
                    <text>We also report the first definitive incorporation of Sec into selenoprotein that is able to be translated into lysed by reticulocytes.</text>
                    <arg n="0">selenoprotein</arg>
                    <arg n="2">lysed by reticulocytes</arg>
                </example>
                <example src="PERMUTATE" no="379">
                    <text>We also report the first definitive incorporation of Sec into selenoprotein that was translated into lysed by reticulocytes.</text>
                    <arg n="0">selenoprotein</arg>
                    <arg n="2">lysed by reticulocytes</arg>
                </example>
                <example src="PERMUTATE" no="380">
                    <text>We also report the first definitive incorporation of Sec into selenoprotein that will be successfully translated into lysates reticulocytes.</text>
                    <arg n="0">selenoprotein</arg>
                    <arg n="2">lysates reticulocytes</arg>
                </example>
                <example src="PERMUTATE" no="381">
                    <text>We also report the first definitive incorporation of Sec into selenoprotein that will probably be successfully translated into lysates reticulocytes.</text>
                    <arg n="0">selenoprotein</arg>
                    <arg n="2">lysates reticulocytes</arg>
                </example>
                <example src="PERMUTATE" no="382">
                    <text>We also report the first definitive incorporation of Sec into selenoprotein which has been successfully translated into lysed by reticulocytes.</text>
                    <arg n="0">selenoprotein</arg>
                    <arg n="2">lysed by reticulocytes</arg>
                </example>
                <example src="PERMUTATE" no="383">
                    <text>We also report the first definitive incorporation of Sec into selenoprotein which has been successfully translated into reticulocyte forms.</text>
                    <arg n="0">selenoprotein</arg>
                    <arg n="2">reticulocyte forms</arg>
                </example>
                <example src="PERMUTATE" no="384">
                    <text>We also report the first definitive incorporation of Sec into selenoprotein which has been translated into lysed by reticulocytes.</text>
                    <arg n="0">selenoprotein</arg>
                    <arg n="2">lysed by reticulocytes</arg>
                </example>
                <example src="PERMUTATE" no="385">
                    <text>We also report the first definitive incorporation of Sec into selenoprotein which has been translated into reticulocyte forms.</text>
                    <arg n="0">selenoprotein</arg>
                    <arg n="2">reticulocyte forms</arg>
                </example>
                <example src="PERMUTATE" no="386">
                    <text>We also report the first definitive incorporation of Sec into selenoprotein which is able to be successfully translated into reticulocyte cells.</text>
                    <arg n="0">selenoprotein</arg>
                    <arg n="2">reticulocyte cells</arg>
                </example>
                <example src="PERMUTATE" no="387">
                    <text>We also report the first definitive incorporation of Sec into selenoprotein which is able to be successfully translated into reticulocyte forms.</text>
                    <arg n="0">selenoprotein</arg>
                    <arg n="2">reticulocyte forms</arg>
                </example>
                <example src="PERMUTATE" no="388">
                    <text>We also report the first definitive incorporation of Sec into selenoprotein which is likely to be successfully translated into reticulocyte cells.</text>
                    <arg n="0">selenoprotein</arg>
                    <arg n="2">reticulocyte cells</arg>
                </example>
                <example src="PERMUTATE" no="389">
                    <text>We also report the first definitive incorporation of Sec into selenoprotein which is observed to be translated into lysates reticulocytes.</text>
                    <arg n="0">selenoprotein</arg>
                    <arg n="2">lysates reticulocytes</arg>
                </example>
                <example src="PERMUTATE" no="390">
                    <text>We also report the first definitive incorporation of Sec into selenoprotein which is observed to be translated into reticulocyte forms.</text>
                    <arg n="0">selenoprotein</arg>
                    <arg n="2">reticulocyte forms</arg>
                </example>
                <example src="PERMUTATE" no="391">
                    <text>We also report the first definitive incorporation of Sec into selenoprotein which is successfully translated into lysates reticulocytes.</text>
                    <arg n="0">selenoprotein</arg>
                    <arg n="2">lysates reticulocytes</arg>
                </example>
                <example src="PERMUTATE" no="392">
                    <text>We also report the first definitive incorporation of Sec into selenoprotein which translated into lysates reticulocytes.</text>
                    <arg n="0">selenoprotein</arg>
                    <arg n="2">lysates reticulocytes</arg>
                </example>
                <example src="PERMUTATE" no="393">
                    <text>We also report the first definitive incorporation of Sec into selenoprotein which will probably be translated into lysates reticulocytes.</text>
                    <arg n="0">selenoprotein</arg>
                    <arg n="2">lysates reticulocytes</arg>
                </example>
                <example src="PERMUTATE" no="394">
                    <text>We also reported the first definitive incorporation of Sec into ISGF3 gum which was shown to be translated into vitro.</text>
                    <arg n="0">ISGF3 gum</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="395">
                    <text>We also reported the first definitive incorporation of Sec into ISGF3 snake which was shown to be translated into vitro.</text>
                    <arg n="0">ISGF3 snake</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="396">
                    <text>We also reported the first definitive incorporation of Sec into Stat1 Y701F which was successfully translated into vitro.</text>
                    <arg n="0">Stat1 Y701F</arg>
                    <arg n="2">vitro</arg>
                </example>
                <example src="PERMUTATE" no="397">
                    <text>We also reported the first definitive incorporation of Sec into a selenoprotein which was shown to be translated into reticulocyte forms.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte forms</arg>
                </example>
                <example src="PERMUTATE" no="398">
                    <text>We also reported the first definitive incorporation of Sec into a selenoprotein which was shown to be translated into with shading of reticulocytes.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">with shading of reticulocytes</arg>
                </example>
                <example src="PERMUTATE" no="399">
                    <text>We also reported the first definitive incorporation of Sec into a selenoprotein which was translated into reticulocyt lysates.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyt lysates</arg>
                </example>
                <example src="PERMUTATE" no="400">
                    <text>We also reported the first definitive incorporation of Sec into a selenoprotein which was translated into reticulocyte cells.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte cells</arg>
                </example>
                <example src="PERMUTATE" no="401">
                    <text>We also reported the first definitive incorporation of Sec into selenoprotein which was successfully translated into reticulocyte cells.</text>
                    <arg n="0">selenoprotein</arg>
                    <arg n="2">reticulocyte cells</arg>
                </example>
                <example src="PERMUTATE" no="402">
                    <text>We also reported the first definitive incorporation of Sec into selenoprotein which was translated into lysates reticulocytes.</text>
                    <arg n="0">selenoprotein</arg>
                    <arg n="2">lysates reticulocytes</arg>
                </example>
                <example src="PERMUTATE" no="403">
                    <text>a selenoprotein , as our data reveal, is observed to translated into reticulocyte forms and to partially purify into heparin-acrose.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte forms</arg>
                </example>
                <example src="PERMUTATE" no="404">
                    <text>a selenoprotein , as our data reveal, is observed to translated into reticulocyte silates and to partially purify into heparin-acrose.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte silates</arg>
                </example>
                <example src="PERMUTATE" no="405">
                    <text>a selenoprotein , as our data reveal, is observed to translated into with shading of reticulocytes and to partially purify into heparin-acrose.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">with shading of reticulocytes</arg>
                </example>
                <example src="PERMUTATE" no="406">
                    <text>a selenoprotein are able to be translated into reticulocyt lysates and partially purified into heparin-agarose.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyt lysates</arg>
                </example>
                <example src="PERMUTATE" no="407">
                    <text>a selenoprotein are likely to be translated into lysates reticulocytes and partially purified into heparin-agarose.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">lysates reticulocytes</arg>
                </example>
                <example src="PERMUTATE" no="408">
                    <text>a selenoprotein are likely to be translated into reticulocyte shales and partially purified into heparin-acrose.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte shales</arg>
                </example>
                <example src="PERMUTATE" no="409">
                    <text>a selenoprotein are observed to be properly translated into reticulocyte shading are partially purified in heparin-acrose.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte shading</arg>
                </example>
                <example src="PERMUTATE" no="410">
                    <text>a selenoprotein are observed to translated to reticulocyte shales are partially purified in heparin-astroosa.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte shales</arg>
                </example>
                <example src="PERMUTATE" no="411">
                    <text>a selenoprotein are observed to translated to reticulocyte silates are partially purified in heparin-astroosa.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte silates</arg>
                </example>
                <example src="PERMUTATE" no="412">
                    <text>a selenoprotein are translated into lysates reticulocytes and partially purified into heparin-agarose.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">lysates reticulocytes</arg>
                </example>
                <example src="PERMUTATE" no="413">
                    <text>a selenoprotein can be correctly translated into reticulocyte dissertations from A1 clones (recombinant) bound to DNA with an indistinguishable specificity of ISGF3 gamma purified from HeLa cells.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte dissertations</arg>
                </example>
                <example src="PERMUTATE" no="414">
                    <text>a selenoprotein can be correctly translated into reticulocyte forms from A1 clones (recombinant) bound to DNA with an indistinguishable specificity of ISGF3 gamma purified from HeLa cells.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte forms</arg>
                </example>
                <example src="PERMUTATE" no="415">
                    <text>a selenoprotein can be correctly translated into reticulocyte liabilities from A1 clones (recombinant) bound to DNA with an indistinguishable specificity of ISGF3 gamma purified from HeLa cells.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte liabilities</arg>
                </example>
                <example src="PERMUTATE" no="416">
                    <text>a selenoprotein can be translated into lysates reticulocytes from A1 clones (recombinant) bound to DNA with an indistinguishable specificity of ISGF3 gamma purified from HeLa cells.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">lysates reticulocytes</arg>
                </example>
                <example src="PERMUTATE" no="417">
                    <text>a selenoprotein can be translated into reticulocyte dissertations and partially purified into heparin-astroosis.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte dissertations</arg>
                </example>
                <example src="PERMUTATE" no="418">
                    <text>a selenoprotein can be translated into reticulocyte dissertations and purified partially in heparin-astroose.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte dissertations</arg>
                </example>
                <example src="PERMUTATE" no="419">
                    <text>a selenoprotein can be translated into reticulocyte forms and partially purified into heparin-agarose.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte forms</arg>
                </example>
                <example src="PERMUTATE" no="420">
                    <text>a selenoprotein can be translated into reticulocyte forms and purified partially in heparin-astroose.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte forms</arg>
                </example>
                <example src="PERMUTATE" no="421">
                    <text>a selenoprotein can be translated into reticulocyte shading from A1 clones (recombinant) bound to DNA with an indistinguishable specificity of ISGF3 gamma purified from HeLa cells.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte shading</arg>
                </example>
                <example src="PERMUTATE" no="422">
                    <text>a selenoprotein can be translated into reticulocyte shales and partially purified into heparin-astroosis.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte shales</arg>
                </example>
                <example src="PERMUTATE" no="423">
                    <text>a selenoprotein can be translated into reticulocyte shales from A1 clones (recombinant) bound to DNA with an indistinguishable specificity of ISGF3 gamma purified from HeLa cells.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte shales</arg>
                </example>
                <example src="PERMUTATE" no="424">
                    <text>a selenoprotein can be translated into reticulocyte silates and partially purified into heparin-agarose.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte silates</arg>
                </example>
                <example src="PERMUTATE" no="425">
                    <text>a selenoprotein can be translated into reticulocyte silates and purified partially in heparin-astroose.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte silates</arg>
                </example>
                <example src="PERMUTATE" no="426">
                    <text>a selenoprotein can be translated into with shading of reticulocytes and partially purified into heparin-agarose.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">with shading of reticulocytes</arg>
                </example>
                <example src="PERMUTATE" no="427">
                    <text>a selenoprotein has been shown to be translated to lysates reticulocytes can also be dimerised to LMP2 gas.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">lysates reticulocytes</arg>
                </example>
                <example src="PERMUTATE" no="428">
                    <text>a selenoprotein has been shown to translated correctly into reticulocyt lysates from A1 clones (recombinant) bound to DNA with an indistinguishable specificity of ISGF3 gamma purified from HeLa cells.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyt lysates</arg>
                </example>
                <example src="PERMUTATE" no="429">
                    <text>a selenoprotein has been shown to translated correctly into reticulocyte cells from A1 clones (recombinant) bound to DNA with an indistinguishable specificity of ISGF3 gamma purified from HeLa cells.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte cells</arg>
                </example>
                <example src="PERMUTATE" no="430">
                    <text>a selenoprotein has been shown to translated correctly into reticulocyte forms from A1 clones (recombinant) bound to DNA with an indistinguishable specificity of ISGF3 gamma purified from HeLa cells.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte forms</arg>
                </example>
                <example src="PERMUTATE" no="431">
                    <text>a selenoprotein has been shown to translated correctly into reticulocyte shading from A1 clones (recombinant) bound to DNA with an indistinguishable specificity of ISGF3 gamma purified from HeLa cells.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte shading</arg>
                </example>
                <example src="PERMUTATE" no="432">
                    <text>a selenoprotein has been shown to translated correctly into reticulocyte shales from A1 clones (recombinant) bound to DNA with an indistinguishable specificity of ISGF3 gamma purified from HeLa cells.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte shales</arg>
                </example>
                <example src="PERMUTATE" no="433">
                    <text>a selenoprotein has been shown to translated into reticulocyt lysates and to partially purify into heparin-astroosa.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyt lysates</arg>
                </example>
                <example src="PERMUTATE" no="434">
                    <text>a selenoprotein has been shown to translated into reticulocyt lysates can also be dimerized into the LMP2 gas.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyt lysates</arg>
                </example>
                <example src="PERMUTATE" no="435">
                    <text>a selenoprotein has been shown to translated into reticulocyte liabilities are partially purified in heparin-astroosa.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte liabilities</arg>
                </example>
                <example src="PERMUTATE" no="436">
                    <text>a selenoprotein has been shown to translated into reticulocyte shaking and to partially purify into heparin-astroosa.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte shaking</arg>
                </example>
                <example src="PERMUTATE" no="437">
                    <text>a selenoprotein has been shown to translated into reticulocyte shaking are partially purified in heparin-astroosa.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte shaking</arg>
                </example>
                <example src="PERMUTATE" no="438">
                    <text>a selenoprotein has been shown to translated into reticulocyte shaking can also be dimerized into the LMP2 gas.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte shaking</arg>
                </example>
                <example src="PERMUTATE" no="439">
                    <text>a selenoprotein has been shown to translated into reticulocyte shales can also be dimerized into the LMP2 gas.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte shales</arg>
                </example>
                <example src="PERMUTATE" no="440">
                    <text>a selenoprotein has been shown to translated into reticulocyte silates are partially purified in heparin-astroosa.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte silates</arg>
                </example>
                <example src="PERMUTATE" no="441">
                    <text>a selenoprotein has the ability to be translated into reticulocyte forms and partially purified into heparin-agarose.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte forms</arg>
                </example>
                <example src="PERMUTATE" no="442">
                    <text>a selenoprotein have been translated into reticulocyt lysates and purified partially in heparin-astroosa.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyt lysates</arg>
                </example>
                <example src="PERMUTATE" no="443">
                    <text>a selenoprotein have been translated into reticulocyte liabilities and purified partially in heparin-astroosa.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte liabilities</arg>
                </example>
                <example src="PERMUTATE" no="444">
                    <text>a selenoprotein have the ability to be translated into reticulocyte shading and partially purified into heparin-acrose.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte shading</arg>
                </example>
                <example src="PERMUTATE" no="445">
                    <text>a selenoprotein have the ability to be translated into reticulocyte shales and partially purified into heparin-acrose.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte shales</arg>
                </example>
                <example src="PERMUTATE" no="446">
                    <text>a selenoprotein is likely to be correctly translated into reticulocyte dissertations from A1 clones (recombinant) bound to DNA with an indistinguishable specificity of ISGF3 gamma purified from HeLa cells.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte dissertations</arg>
                </example>
                <example src="PERMUTATE" no="447">
                    <text>a selenoprotein is likely to be correctly translated into reticulocyte liabilities from A1 clones (recombinant) bound to DNA with an indistinguishable specificity of ISGF3 gamma purified from HeLa cells.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte liabilities</arg>
                </example>
                <example src="PERMUTATE" no="448">
                    <text>a selenoprotein is likely to be correctly translated into reticulocyte shales from A1 clones (recombinant) bound to DNA with an indistinguishable specificity of ISGF3 gamma purified from HeLa cells.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte shales</arg>
                </example>
                <example src="PERMUTATE" no="449">
                    <text>a selenoprotein is likely to be correctly translated into reticulocyte silates from A1 clones (recombinant) bound to DNA with an indistinguishable specificity of ISGF3 gamma purified from HeLa cells.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte silates</arg>
                </example>
                <example src="PERMUTATE" no="450">
                    <text>a selenoprotein is observed to be translated into reticulocyte liabilities and partially purified into heparin-astrose.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte liabilities</arg>
                </example>
                <example src="PERMUTATE" no="451">
                    <text>a selenoprotein is observed to be translated into with shading of reticulocytes and partially purified into heparin-astroosa.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">with shading of reticulocytes</arg>
                </example>
                <example src="PERMUTATE" no="452">
                    <text>a selenoprotein may have been translated into reticulocyte shaking and partially purified into heparin-agarose.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte shaking</arg>
                </example>
                <example src="PERMUTATE" no="453">
                    <text>a selenoprotein may have been translated into with shading of reticulocytes and partially purified into heparin-astrous.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">with shading of reticulocytes</arg>
                </example>
                <example src="PERMUTATE" no="454">
                    <text>a selenoprotein that are able to be translated adequately into lysates reticulocytes are partially purified in heparin-agarose.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">lysates reticulocytes</arg>
                </example>
                <example src="PERMUTATE" no="455">
                    <text>a selenoprotein that are able to be translated adequately into reticulocyte dissertations are partially purified in heparin-agarose.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte dissertations</arg>
                </example>
                <example src="PERMUTATE" no="456">
                    <text>a selenoprotein that are adequately translated into reticulocyte dissertations are partially purified in heparin-agarose.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte dissertations</arg>
                </example>
                <example src="PERMUTATE" no="457">
                    <text>a selenoprotein that are likely to be translated into reticulocyte dissertations are partially purified in heparin-acrose.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte dissertations</arg>
                </example>
                <example src="PERMUTATE" no="458">
                    <text>a selenoprotein that are likely to be translated into reticulocyte liabilities are partially purified in heparin-agarose.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte liabilities</arg>
                </example>
                <example src="PERMUTATE" no="459">
                    <text>a selenoprotein that are likely to be translated into reticulocyte shading are partially purified in heparin-acrose.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte shading</arg>
                </example>
                <example src="PERMUTATE" no="460">
                    <text>a selenoprotein that are likely to be translated into reticulocyte shading are partially purified in heparin-agarose.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte shading</arg>
                </example>
                <example src="PERMUTATE" no="461">
                    <text>a selenoprotein that are likely to be translated into reticulocyte shaking are partially purified in heparin-agarose.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte shaking</arg>
                </example>
                <example src="PERMUTATE" no="462">
                    <text>a selenoprotein that are likely to be translated into reticulocyte shales are partially purified in heparin-agarose.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte shales</arg>
                </example>
                <example src="PERMUTATE" no="463">
                    <text>a selenoprotein that are observed as being adequately translated into reticulocyte liabilities are partially purified in heparin-agarose.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte liabilities</arg>
                </example>
                <example src="PERMUTATE" no="464">
                    <text>a selenoprotein that are translated into reticulocyt lysates are partially purified in heparin-agarose.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyt lysates</arg>
                </example>
                <example src="PERMUTATE" no="465">
                    <text>a selenoprotein that are translated into reticulocyte cells are partially purified in heparin-agarose.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte cells</arg>
                </example>
                <example src="PERMUTATE" no="466">
                    <text>a selenoprotein that are translated into reticulocyte forms are partially purified in heparin-agarose.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte forms</arg>
                </example>
                <example src="PERMUTATE" no="467">
                    <text>a selenoprotein that are translated into reticulocyte shales are partially purified in heparin-agarose.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte shales</arg>
                </example>
                <example src="PERMUTATE" no="468">
                    <text>a selenoprotein that are translated into reticulocyte silates are partially purified in heparin-agarose.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte silates</arg>
                </example>
                <example src="PERMUTATE" no="469">
                    <text>a selenoprotein that can be adequately translated into reticulocyte shading of A1 clones (recombinant) bind the DNA with an indistinguishable specificity of ISGF3 gamma purified HeLa cells.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte shading</arg>
                </example>
                <example src="PERMUTATE" no="470">
                    <text>a selenoprotein that can be adequately translated into with shading of reticulocytes of A1 clones (recombinant) bind the DNA with an indistinguishable specificity of ISGF3 gamma purified HeLa cells.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">with shading of reticulocytes</arg>
                </example>
                <example src="PERMUTATE" no="471">
                    <text>a selenoprotein that can be correctly translated into lysates reticulocytes are partially purified in heparin-astrous.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">lysates reticulocytes</arg>
                </example>
                <example src="PERMUTATE" no="472">
                    <text>a selenoprotein that can be correctly translated into reticulocyte dissertations are partially purified in heparin-astroosis.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte dissertations</arg>
                </example>
                <example src="PERMUTATE" no="473">
                    <text>a selenoprotein that can be correctly translated into reticulocyte forms are partially purified in heparin-astroosis.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte forms</arg>
                </example>
                <example src="PERMUTATE" no="474">
                    <text>a selenoprotein that can be correctly translated into reticulocyte shading are partially purified in heparin-astrous.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte shading</arg>
                </example>
                <example src="PERMUTATE" no="475">
                    <text>a selenoprotein that can be correctly translated into reticulocyte silates are partially purified in heparin-astroosis.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte silates</arg>
                </example>
                <example src="PERMUTATE" no="476">
                    <text>a selenoprotein that can be translated adequately into reticulocyte shaking are partially purified in heparin-agarose.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte shaking</arg>
                </example>
                <example src="PERMUTATE" no="477">
                    <text>a selenoprotein that can be translated adequately into reticulocyte shales are partially purified in heparin-agarose.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte shales</arg>
                </example>
                <example src="PERMUTATE" no="478">
                    <text>a selenoprotein that can be translated into reticulocyte cells are partially purified in heparin-agarose.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte cells</arg>
                </example>
                <example src="PERMUTATE" no="479">
                    <text>a selenoprotein that can be translated into reticulocyte liabilities are partially purified in heparin-astroosis.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte liabilities</arg>
                </example>
                <example src="PERMUTATE" no="480">
                    <text>a selenoprotein that can be translated into reticulocyte shaking are partially purified in heparin-agarose.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte shaking</arg>
                </example>
                <example src="PERMUTATE" no="481">
                    <text>a selenoprotein that can be translated into reticulocyte shales of A1 clones (recombinant) bind the DNA with an indistinguishable specificity of ISGF3 gamma purified from HeLa cells.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte shales</arg>
                </example>
                <example src="PERMUTATE" no="482">
                    <text>a selenoprotein that can be translated into with shading of reticulocytes of A1 clones (recombinant) bind the DNA with an indistinguishable specificity of ISGF3 gamma purified from HeLa cells.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">with shading of reticulocytes</arg>
                </example>
                <example src="PERMUTATE" no="483">
                    <text>a selenoprotein that can be translated to reticulocyte shading can also be dimerised to LMP2 gas.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte shading</arg>
                </example>
                <example src="PERMUTATE" no="484">
                    <text>a selenoprotein that can probably be translated to reticulocyt lysates can also be dimerised into LMP2 gas.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyt lysates</arg>
                </example>
                <example src="PERMUTATE" no="485">
                    <text>a selenoprotein that can probably be translated to reticulocyte dissertations can also be dimerised into LMP2 gas.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte dissertations</arg>
                </example>
                <example src="PERMUTATE" no="486">
                    <text>a selenoprotein that can probably be translated to reticulocyte liabilities can also be dimerised into LMP2 gas.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte liabilities</arg>
                </example>
                <example src="PERMUTATE" no="487">
                    <text>a selenoprotein that has been adequately translated into reticulocyte dissertations of A1 clones (recombinant) bind the DNA with an indistinguishable specificity of ISGF3 gamma purified HeLa cells.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte dissertations</arg>
                </example>
                <example src="PERMUTATE" no="488">
                    <text>a selenoprotein that has been proven to be correctly translated to reticulocyte dissertations are partially purified in heparin-astrous.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte dissertations</arg>
                </example>
                <example src="PERMUTATE" no="489">
                    <text>a selenoprotein that has been shown to be correctly translated into reticulocyte shaking are partially purified in heparin-astroosa.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte shaking</arg>
                </example>
                <example src="PERMUTATE" no="490">
                    <text>a selenoprotein that has been shown to be correctly translated into reticulocyte shales are partially purified in heparin-astroosa.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte shales</arg>
                </example>
                <example src="PERMUTATE" no="491">
                    <text>a selenoprotein that has been shown to probably translated into lysates reticulocytes can also be dimerized into the LMP2 gas.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">lysates reticulocytes</arg>
                </example>
                <example src="PERMUTATE" no="492">
                    <text>a selenoprotein that has been shown to probably translated into reticulocyte shales can also be dimerized into the LMP2 gas.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte shales</arg>
                </example>
                <example src="PERMUTATE" no="493">
                    <text>a selenoprotein that has been translated into reticulocyt lysates of A1 clones (recombinant) binds DNA with an indistinguishable specificity of ISGF3 gum purified from HeLa cells.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyt lysates</arg>
                </example>
                <example src="PERMUTATE" no="494">
                    <text>a selenoprotein that has been translated into reticulocyte shales of A1 clones (recombinant) binds DNA with an indistinguishable specificity of ISGF3 gum purified from HeLa cells.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte shales</arg>
                </example>
                <example src="PERMUTATE" no="495">
                    <text>a selenoprotein that has been translated into reticulocyte silates of A1 clones (recombinant) binds DNA with an indistinguishable specificity of ISGF3 gum purified from HeLa cells.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte silates</arg>
                </example>
                <example src="PERMUTATE" no="496">
                    <text>a selenoprotein that has been translated into with shading of reticulocytes of A1 clones (recombinant) binds DNA with an indistinguishable specificity of ISGF3 gamma purified from HeLa cells.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">with shading of reticulocytes</arg>
                </example>
                <example src="PERMUTATE" no="497">
                    <text>a selenoprotein that has been translated to reticulocyte cells can also be dimerised to LMP2 gas.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte cells</arg>
                </example>
                <example src="PERMUTATE" no="498">
                    <text>a selenoprotein that has probably been translated to reticulocyte shading can also be dimerised into LMP2 gas.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte shading</arg>
                </example>
                <example src="PERMUTATE" no="499">
                    <text>a selenoprotein that have been properly translated into lysates reticulocytes are partially purified in heparin-astrose.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">lysates reticulocytes</arg>
                </example>
                <example src="PERMUTATE" no="500">
                    <text>a selenoprotein that have been properly translated into reticulocyte liabilities are partially purified in heparin-astrose.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte liabilities</arg>
                </example>
                <example src="PERMUTATE" no="501">
                    <text>a selenoprotein that have been properly translated into reticulocyte shales are partially purified in heparin-astrose.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte shales</arg>
                </example>
                <example src="PERMUTATE" no="502">
                    <text>a selenoprotein that have been properly translated into reticulocyte silates are partially purified in heparin-astrose.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte silates</arg>
                </example>
                <example src="PERMUTATE" no="503">
                    <text>a selenoprotein that have been translated adequately into reticulocyte shales are partially purified in heparin-agarose.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte shales</arg>
                </example>
                <example src="PERMUTATE" no="504">
                    <text>a selenoprotein that have been translated adequately into with shading of reticulocytes are partially purified in heparin-agarose.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">with shading of reticulocytes</arg>
                </example>
                <example src="PERMUTATE" no="505">
                    <text>a selenoprotein that have been translated into lysates reticulocytes are partially purified in heparin-agarose.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">lysates reticulocytes</arg>
                </example>
                <example src="PERMUTATE" no="506">
                    <text>a selenoprotein that have been translated into reticulocyte shading are partially purified in heparin-agarose.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte shading</arg>
                </example>
                <example src="PERMUTATE" no="507">
                    <text>a selenoprotein that have been translated into reticulocyte shaking are partially purified in heparin-agarose.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte shaking</arg>
                </example>
                <example src="PERMUTATE" no="508">
                    <text>a selenoprotein that have been translated into reticulocyte shales are partially purified in heparin-agarose.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte shales</arg>
                </example>
                <example src="PERMUTATE" no="509">
                    <text>a selenoprotein that have the ability to be translated adequately into reticulocyt lysates are partially purified in heparin-agarose.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyt lysates</arg>
                </example>
                <example src="PERMUTATE" no="510">
                    <text>a selenoprotein that have the ability to be translated adequately into reticulocyte cells are partially purified in heparin-agarose.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte cells</arg>
                </example>
                <example src="PERMUTATE" no="511">
                    <text>a selenoprotein that have the ability to be translated adequately into reticulocyte shading are partially purified in heparin-agarose.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte shading</arg>
                </example>
                <example src="PERMUTATE" no="512">
                    <text>a selenoprotein that have the ability to be translated adequately into reticulocyte shales are partially purified in heparin-agarose.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte shales</arg>
                </example>
                <example src="PERMUTATE" no="513">
                    <text>a selenoprotein that have the ability to be translated correctly into reticulocyt lysates are partially purified in heparin-acrose.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyt lysates</arg>
                </example>
                <example src="PERMUTATE" no="514">
                    <text>a selenoprotein that have the ability to be translated correctly into reticulocyte dissertations are partially purified in heparin-acrose.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte dissertations</arg>
                </example>
                <example src="PERMUTATE" no="515">
                    <text>a selenoprotein that have the ability to be translated correctly into reticulocyte liabilities are partially purified in heparin-acrose.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte liabilities</arg>
                </example>
                <example src="PERMUTATE" no="516">
                    <text>a selenoprotein that is able to be translated adequately into reticulocyt lysates of A1 clones (recombinant) bind the DNA with an indistinguishable specificity of ISGF3 gamma purified from HeLa cells.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyt lysates</arg>
                </example>
                <example src="PERMUTATE" no="517">
                    <text>a selenoprotein that is able to be translated adequately into reticulocyte forms of A1 clones (recombinant) bind the DNA with an indistinguishable specificity of ISGF3 gamma purified from HeLa cells.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte forms</arg>
                </example>
                <example src="PERMUTATE" no="518">
                    <text>a selenoprotein that is able to be translated into reticulocyte liabilities of A1 clones (recombinant) bind the DNA with an indistinguishable specificity of ISGF3 gamma purified from HeLa cells.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte liabilities</arg>
                </example>
                <example src="PERMUTATE" no="519">
                    <text>a selenoprotein that is able to be translated into reticulocyte silates of A1 clones (recombinant) bind the DNA with an indistinguishable specificity of ISGF3 gamma purified from HeLa cells.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte silates</arg>
                </example>
                <example src="PERMUTATE" no="520">
                    <text>a selenoprotein that is adequately translated into lysates reticulocytes of A1 clones (recombinant) binds DNA with an indistinguishable specificity of ISGF3 gamma purified from HeLa cells.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">lysates reticulocytes</arg>
                </example>
                <example src="PERMUTATE" no="521">
                    <text>a selenoprotein that is adequately translated into reticulocyte cells of A1 clones (recombinant) binds DNA with an indistinguishable specificity of ISGF3 gamma purified from HeLa cells.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte cells</arg>
                </example>
                <example src="PERMUTATE" no="522">
                    <text>a selenoprotein that is adequately translated into reticulocyte forms of A1 clones (recombinant) binds DNA with an indistinguishable specificity of ISGF3 gamma purified from HeLa cells.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte forms</arg>
                </example>
                <example src="PERMUTATE" no="523">
                    <text>a selenoprotein that is adequately translated into with shading of reticulocytes of A1 clones (recombinant) binds DNA with an indistinguishable specificity of ISGF3 gamma purified from HeLa cells.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">with shading of reticulocytes</arg>
                </example>
                <example src="PERMUTATE" no="524">
                    <text>a selenoprotein that is likely to be correctly translated to reticulocyt lysates is partially purified into heparin-astrous.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyt lysates</arg>
                </example>
                <example src="PERMUTATE" no="525">
                    <text>a selenoprotein that is likely to be translated into reticulocyte dissertations of A1 clones (recombinant) bind the DNA with an indistinguishable specificity of ISGF3 gamma purified from HeLa cells.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte dissertations</arg>
                </example>
                <example src="PERMUTATE" no="526">
                    <text>a selenoprotein that is likely to be translated into reticulocyte silates can also be dimerized into the LMP2 gas.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte silates</arg>
                </example>
                <example src="PERMUTATE" no="527">
                    <text>a selenoprotein that is likely to be translated to reticulocyt lysates can also be dimerised to LMP2 gas.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyt lysates</arg>
                </example>
                <example src="PERMUTATE" no="528">
                    <text>a selenoprotein that is likely to be translated to reticulocyte shaking can also be dimerised to LMP2 gas.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte shaking</arg>
                </example>
                <example src="PERMUTATE" no="529">
                    <text>a selenoprotein that is likely to be translated to with shading of reticulocytes can also be dimerised to LMP2 gas.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">with shading of reticulocytes</arg>
                </example>
                <example src="PERMUTATE" no="530">
                    <text>a selenoprotein that is observed to be adequately translated into reticulocyte forms of A1 clones (recombinant) bind the DNA with an indistinguishable specificity of ISGF3 blood cells purified from HeLa cells.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte forms</arg>
                </example>
                <example src="PERMUTATE" no="531">
                    <text>a selenoprotein that is observed to be adequately translated into with shading of reticulocytes of A1 clones (recombinant) bind the DNA with an indistinguishable specificity of ISGF3 blood cells purified from HeLa cells.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">with shading of reticulocytes</arg>
                </example>
                <example src="PERMUTATE" no="532">
                    <text>a selenoprotein that is observed to be translated into with shading of reticulocytes of A1 clones (recombinant) binds DNA with an indistinguishable specificity of ISGF3 snake purified from HeLa cells.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">with shading of reticulocytes</arg>
                </example>
                <example src="PERMUTATE" no="533">
                    <text>a selenoprotein that may have been adequately translated into lysates reticulocytes of A1 clones (recombinant) bind the DNA with an indistinguishable specificity of ISGF3 gamma purified from HeLa cells.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">lysates reticulocytes</arg>
                </example>
                <example src="PERMUTATE" no="534">
                    <text>a selenoprotein that may have been adequately translated into reticulocyte dissertations of A1 clones (recombinant) bind the DNA with an indistinguishable specificity of ISGF3 gamma purified from HeLa cells.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte dissertations</arg>
                </example>
                <example src="PERMUTATE" no="535">
                    <text>a selenoprotein that may have been correctly translated into reticulocyte liabilities is partially purified in heparin-acrose.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte liabilities</arg>
                </example>
                <example src="PERMUTATE" no="536">
                    <text>a selenoprotein that may have been correctly translated into reticulocyte shaking is partially purified in heparin-acrose.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte shaking</arg>
                </example>
                <example src="PERMUTATE" no="537">
                    <text>a selenoprotein that may have been translated into reticulocyte cells of A1 clones (recombinant) bind the DNA with an indistinguishable specificity of ISGF3 gamma purified from HeLa cells.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte cells</arg>
                </example>
                <example src="PERMUTATE" no="538">
                    <text>a selenoprotein that may have been translated into reticulocyte dissertations of A1 clones (recombinant) bind the DNA with an indistinguishable specificity of ISGF3 gamma purified from HeLa cells.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte dissertations</arg>
                </example>
                <example src="PERMUTATE" no="539">
                    <text>a selenoprotein that may have been translated into reticulocyte shaking is partially purified in heparin-astrous.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte shaking</arg>
                </example>
                <example src="PERMUTATE" no="540">
                    <text>a selenoprotein that may have been translated into reticulocyte shales are partially purified in heparin-agarose.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte shales</arg>
                </example>
                <example src="PERMUTATE" no="541">
                    <text>a selenoprotein that may have been translated into reticulocyte shales of A1 clones (recombinant) bind DNA with an indistinguishable specificity of ISGF3 gamma purified from HeLa cells.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte shales</arg>
                </example>
                <example src="PERMUTATE" no="542">
                    <text>a selenoprotein that probably translated into reticulocyte dissertations can also be dimerised in the LMP2 gas.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte dissertations</arg>
                </example>
                <example src="PERMUTATE" no="543">
                    <text>a selenoprotein that probably translated into reticulocyte shales can also be dimerised in the LMP2 gas.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte shales</arg>
                </example>
                <example src="PERMUTATE" no="544">
                    <text>a selenoprotein that translated into lysates reticulocytes are partially purified in heparin-astrous.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">lysates reticulocytes</arg>
                </example>
                <example src="PERMUTATE" no="545">
                    <text>a selenoprotein that translated into reticulocyt lysates are partially purified in heparin-astrous.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyt lysates</arg>
                </example>
                <example src="PERMUTATE" no="546">
                    <text>a selenoprotein that translated into reticulocyte cells are partially purified in heparin-astrous.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte cells</arg>
                </example>
                <example src="PERMUTATE" no="547">
                    <text>a selenoprotein that translated into reticulocyte dissertations are partially purified in heparin-astrous.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte dissertations</arg>
                </example>
                <example src="PERMUTATE" no="548">
                    <text>a selenoprotein that translated into reticulocyte shaking are partially purified in heparin-astrous.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte shaking</arg>
                </example>
                <example src="PERMUTATE" no="549">
                    <text>a selenoprotein that will be correctly translated into reticulocyte dissertations are partially purified in heparin-astrous.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte dissertations</arg>
                </example>
                <example src="PERMUTATE" no="550">
                    <text>a selenoprotein that will be correctly translated into reticulocyte shaking are partially purified in heparin-astrous.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte shaking</arg>
                </example>
                <example src="PERMUTATE" no="551">
                    <text>a selenoprotein that will be translated appropriately into reticulocyte forms are partially purified in heparin-agarose.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte forms</arg>
                </example>
                <example src="PERMUTATE" no="552">
                    <text>a selenoprotein that will be translated into reticulocyte dissertations are partially purified in heparin-agarose.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte dissertations</arg>
                </example>
                <example src="PERMUTATE" no="553">
                    <text>a selenoprotein that will be translated into reticulocyte liabilities are partially purified in heparin-agarose.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte liabilities</arg>
                </example>
                <example src="PERMUTATE" no="554">
                    <text>a selenoprotein that will be translated into reticulocyte shading of A1 clones (recombinant) bind the DNA with an indistinguishable specificity of ISGF3 gamma purified from HeLa cells.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte shading</arg>
                </example>
                <example src="PERMUTATE" no="555">
                    <text>a selenoprotein that will be translated into reticulocyte silates of A1 clones (recombinant) bind the DNA with an indistinguishable specificity of ISGF3 gamma purified from HeLa cells.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte silates</arg>
                </example>
                <example src="PERMUTATE" no="556">
                    <text>a selenoprotein that will probably be translated into reticulocyt lysates can also be submerged into SGL2 LMP2.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyt lysates</arg>
                </example>
                <example src="PERMUTATE" no="557">
                    <text>a selenoprotein that will probably be translated to reticulocyte forms can also be dimerised into LMP2 gas.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte forms</arg>
                </example>
                <example src="PERMUTATE" no="558">
                    <text>a selenoprotein that will probably be translated to reticulocyte shales can also be dimerised into LMP2 gas.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte shales</arg>
                </example>
                <example src="PERMUTATE" no="559">
                    <text>a selenoprotein was correctly translated into reticulocyte shaking from A1 clones (recombinant) bound to DNA with an indistinguishable specificity of ISGF3 gamma purified from HeLa cells.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte shaking</arg>
                </example>
                <example src="PERMUTATE" no="560">
                    <text>a selenoprotein was correctly translated into reticulocyte shales from A1 clones (recombinant) bound to DNA with an indistinguishable specificity of ISGF3 gamma purified from HeLa cells.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte shales</arg>
                </example>
                <example src="PERMUTATE" no="561">
                    <text>a selenoprotein was translated into reticulocyte silates from A1 clones (recombinants) that bind to DNA with an indistinguishable specificity of ISGF3 gamma purified from HeLa cells.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte silates</arg>
                </example>
                <example src="PERMUTATE" no="562">
                    <text>a selenoprotein were translated into lysates reticulocytes and purified in part into heparin-astrous.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">lysates reticulocytes</arg>
                </example>
                <example src="PERMUTATE" no="563">
                    <text>a selenoprotein which can be translated into lysates reticulocytes can also be dimerized into the LMP2 gas.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">lysates reticulocytes</arg>
                </example>
                <example src="PERMUTATE" no="564">
                    <text>a selenoprotein which can be translated into reticulocyte forms can also be dimerized into the LMP2 gas.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte forms</arg>
                </example>
                <example src="PERMUTATE" no="565">
                    <text>a selenoprotein which has been shown to have been translated into reticulocyte shading from A1 clones (recombinant) bind the DNA with an indistinguishable specificity of ISGF3 swab purified from HeLa cells.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte shading</arg>
                </example>
                <example src="PERMUTATE" no="566">
                    <text>a selenoprotein which has been shown to have been translated into reticulocyte shales from A1 clones (recombinant) bind the DNA with an indistinguishable specificity of ISGF3 swab purified from HeLa cells.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte shales</arg>
                </example>
                <example src="PERMUTATE" no="567">
                    <text>a selenoprotein which has been translated into reticulocyt lysates of A1 clones (recombinant) binds DNA with an indistinguishable specificity of ISGF3 gamma purified from HeLa cells.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyt lysates</arg>
                </example>
                <example src="PERMUTATE" no="568">
                    <text>a selenoprotein which has been translated into reticulocyte forms can also be dimerized into the LMP2 gas.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte forms</arg>
                </example>
                <example src="PERMUTATE" no="569">
                    <text>a selenoprotein which has been translated into reticulocyte shading can also be dimerized into the LMP2 gas.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte shading</arg>
                </example>
                <example src="PERMUTATE" no="570">
                    <text>a selenoprotein which has been translated into reticulocyte shales of A1 clones (recombinant) binds DNA with an indistinguishable specificity of ISGF3 gamma purified from HeLa cells.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte shales</arg>
                </example>
                <example src="PERMUTATE" no="571">
                    <text>a selenoprotein which has probably been translated into reticulocyte dissertations can also be dimerized into LMP2 gas.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte dissertations</arg>
                </example>
                <example src="PERMUTATE" no="572">
                    <text>a selenoprotein which has probably been translated into with shading of reticulocytes can also be dimerized into LMP2 gas.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">with shading of reticulocytes</arg>
                </example>
                <example src="PERMUTATE" no="573">
                    <text>a selenoprotein which has probably translated into lysates reticulocytes can also be dimerised to the LMP2 gas.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">lysates reticulocytes</arg>
                </example>
                <example src="PERMUTATE" no="574">
                    <text>a selenoprotein which is observed to be translated into lysates reticulocytes can also be dimerized into SGL2 of LMP2.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">lysates reticulocytes</arg>
                </example>
                <example src="PERMUTATE" no="575">
                    <text>a selenoprotein which is observed to be translated into reticulocyte liabilities can also be dimerized into SGL2 of LMP2.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte liabilities</arg>
                </example>
                <example src="PERMUTATE" no="576">
                    <text>a selenoprotein which is translated into reticulocyte dissertations of A1 clones (recombinant) binds DNA with an indistinguishable specificity of ISGF3 gamma purified from HeLa cells.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte dissertations</arg>
                </example>
                <example src="PERMUTATE" no="577">
                    <text>a selenoprotein which is translated into reticulocyte liabilities of A1 clones (recombinant) binds DNA with an indistinguishable specificity of ISGF3 gamma purified from HeLa cells.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte liabilities</arg>
                </example>
                <example src="PERMUTATE" no="578">
                    <text>a selenoprotein which probably translated into reticulocyt lysates can also be dimerized into the LMP2 gas.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyt lysates</arg>
                </example>
                <example src="PERMUTATE" no="579">
                    <text>a selenoprotein which probably translated into reticulocyte cells can also be dimerized into the LMP2 gas.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte cells</arg>
                </example>
                <example src="PERMUTATE" no="580">
                    <text>a selenoprotein which probably translated into reticulocyte dissertations can also be dimerized into the LMP2 gas.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte dissertations</arg>
                </example>
                <example src="PERMUTATE" no="581">
                    <text>a selenoprotein which probably translated into reticulocyte forms can also be dimerized into the LMP2 gas.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte forms</arg>
                </example>
                <example src="PERMUTATE" no="582">
                    <text>a selenoprotein which probably translated into reticulocyte silates can also be dimerized into the LMP2 gas.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte silates</arg>
                </example>
                <example src="PERMUTATE" no="583">
                    <text>a selenoprotein which probably translated into with shading of reticulocytes can also be dimerized into the LMP2 gas.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">with shading of reticulocytes</arg>
                </example>
                <example src="PERMUTATE" no="584">
                    <text>a selenoprotein which translated to reticulocyte cells can also be dimerized into LMP2 gas.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte cells</arg>
                </example>
                <example src="PERMUTATE" no="585">
                    <text>a selenoprotein which translated to reticulocyte cells can also be dimerized into the LMP2 gas.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte cells</arg>
                </example>
                <example src="PERMUTATE" no="586">
                    <text>a selenoprotein which translated to reticulocyte shading can also be dimerized into the LMP2 gas.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte shading</arg>
                </example>
                <example src="PERMUTATE" no="587">
                    <text>a selenoprotein which translated to reticulocyte shading can also be submerged to SGL2.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte shading</arg>
                </example>
                <example src="PERMUTATE" no="588">
                    <text>a selenoprotein which translated to reticulocyte shales can also be dimerized into LMP2 gas.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte shales</arg>
                </example>
                <example src="PERMUTATE" no="589">
                    <text>a selenoprotein which translated to reticulocyte silates can also be dimerized into LMP2 gas.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte silates</arg>
                </example>
                <example src="PERMUTATE" no="590">
                    <text>a selenoprotein which was probably translated into reticulocyt lysates can also be dimerized into the LMP2 gas.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyt lysates</arg>
                </example>
                <example src="PERMUTATE" no="591">
                    <text>a selenoprotein which was probably translated into reticulocyte cells can also be dimerized into the LMP2 gas.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte cells</arg>
                </example>
                <example src="PERMUTATE" no="592">
                    <text>a selenoprotein which was translated into reticulocyte forms can also be dimerized into the LMP2 gas.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte forms</arg>
                </example>
                <example src="PERMUTATE" no="593">
                    <text>a selenoprotein which was translated into reticulocyte shales can also be dimerized into the LMP2 gas.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte shales</arg>
                </example>
                <example src="PERMUTATE" no="594">
                    <text>a selenoprotein which will be translated into lysates reticulocytes are partially purified into heparin-acrose.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">lysates reticulocytes</arg>
                </example>
                <example src="PERMUTATE" no="595">
                    <text>a selenoprotein which will be translated into reticulocyte shading are partially purified into heparin-acrose.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte shading</arg>
                </example>
                <example src="PERMUTATE" no="596">
                    <text>a selenoprotein will be correctly translated into lysates reticulocytes from DNA A1 clones (recombinant) linked to an indistinguishable specificity of ISGF3 gamma purified from HeLa cells.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">lysates reticulocytes</arg>
                </example>
                <example src="PERMUTATE" no="597">
                    <text>a selenoprotein will be correctly translated into reticulocyt lysates from DNA A1 clones (recombinant) linked to an indistinguishable specificity of ISGF3 gamma purified from HeLa cells.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyt lysates</arg>
                </example>
                <example src="PERMUTATE" no="598">
                    <text>a selenoprotein will be correctly translated into reticulocyte liabilities from DNA A1 clones (recombinant) linked to an indistinguishable specificity of ISGF3 gamma purified from HeLa cells.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte liabilities</arg>
                </example>
                <example src="PERMUTATE" no="599">
                    <text>a selenoprotein will be correctly translated into reticulocyte shales from DNA A1 clones (recombinant) linked to an indistinguishable specificity of ISGF3 gamma purified from HeLa cells.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte shales</arg>
                </example>
                <example src="PERMUTATE" no="600">
                    <text>a selenoprotein will be translated into reticulocyt lysates and partially purified into heparin-acrose.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyt lysates</arg>
                </example>
                <example src="PERMUTATE" no="601">
                    <text>a selenoprotein will be translated into reticulocyte liabilities and partially purified into heparin-acrose.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte liabilities</arg>
                </example>
                <example src="PERMUTATE" no="602">
                    <text>a selenoprotein, as our data reveal, is observed to translated into reticulocyt lysates and purify in part into heparin-acrose.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyt lysates</arg>
                </example>
                <example src="PERMUTATE" no="603">
                    <text>a selenoprotein, as our data show, are likely to be translated into reticulocyte shading and partially purified into heparin-agarose.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte shading</arg>
                </example>
                <example src="PERMUTATE" no="604">
                    <text>a selenoprotein, as our data show, are likely to be translated into reticulocyte shales and partially purified into heparin-agarose.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte shales</arg>
                </example>
                <example src="PERMUTATE" no="605">
                    <text>a selenoprotein, as our data show, are translated into with shading of reticulocytes and partially purified into heparin-aminosis.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">with shading of reticulocytes</arg>
                </example>
                <example src="PERMUTATE" no="606">
                    <text>a selenoprotein, as our data show, can be translated into reticulocyt lysates and partially purified into heparin-amikanosis.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyt lysates</arg>
                </example>
                <example src="PERMUTATE" no="607">
                    <text>a selenoprotein, as our data show, can be translated into reticulocyte shading and partially purified into heparin-amikanosis.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte shading</arg>
                </example>
                <example src="PERMUTATE" no="608">
                    <text>a selenoprotein, as our data show, can be translated into reticulocyte shales and partially purified into heparin-acrose.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte shales</arg>
                </example>
                <example src="PERMUTATE" no="609">
                    <text>a selenoprotein, as our data show, has the ability to be translated into reticulocyte dissertations and partially purified into heparin-agarose.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte dissertations</arg>
                </example>
                <example src="PERMUTATE" no="610">
                    <text>a selenoprotein, as our data show, has the ability to be translated to reticulocyt lysates and partially purified to heparin-astrose.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyt lysates</arg>
                </example>
                <example src="PERMUTATE" no="611">
                    <text>a selenoprotein, as our data show, is likely to be translated into reticulocyte shading and partially purified into heparin-acrose.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte shading</arg>
                </example>
                <example src="PERMUTATE" no="612">
                    <text>a selenoprotein, as our data show, may have been translated into lysates reticulocytes and partially purified into heparin-agarose.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">lysates reticulocytes</arg>
                </example>
                <example src="PERMUTATE" no="613">
                    <text>a selenoprotein, as our data show, was translated to lysates reticulocytes and partially purified in heparin-acrose.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">lysates reticulocytes</arg>
                </example>
                <example src="PERMUTATE" no="614">
                    <text>a selenoprotein, as our data show, was translated to reticulocyte dissertations and partially purified in heparin-acrose.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte dissertations</arg>
                </example>
                <example src="PERMUTATE" no="615">
                    <text>a selenoprotein, as our data show, were translated into reticulocyt lysates and partially purified into heparin-agarose.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyt lysates</arg>
                </example>
                <example src="PERMUTATE" no="616">
                    <text>a selenoprotein, as our data show, were translated into reticulocyte shales and partially purified into heparin-agarose.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte shales</arg>
                </example>
                <example src="PERMUTATE" no="617">
                    <text>a selenoprotein, as our data show, will be translated into reticulocyte cells and partially purified into heparin-acrose.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte cells</arg>
                </example>
                <example src="PERMUTATE" no="618">
                    <text>a selenoprotein, as our data show, will be translated into reticulocyte shading and partially purified into heparin-aminosis.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte shading</arg>
                </example>
                <example src="PERMUTATE" no="619">
                    <text>a selenoprotein, as our data show, will be translated into reticulocyte shales and partially purified into heparin-acrose.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte shales</arg>
                </example>
                <example src="PERMUTATE" no="620">
                    <text>a selenoprotein, which has probably been translated to reticulocyte liabilities, can also be dimerised to LMP2 gas.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyte liabilities</arg>
                </example>
                <example src="PERMUTATE" no="621">
                    <text>a selenoprotein, which has probably been translated to with shading of reticulocytes, can also be dimerised to LMP2 gas.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">with shading of reticulocytes</arg>
                </example>
                <example src="PERMUTATE" no="622">
                    <text>a selenoprotein, which is able to be translated into with shading of reticulocytes, can also dimer into SGL2.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">with shading of reticulocytes</arg>
                </example>
                <example src="PERMUTATE" no="623">
                    <text>a selenoprotein, which will be translated appropriately into reticulocyt lysates of A1 clones (recombinant) bind the DNA with an indistinguishable specificity of ISGF3 gum, purified from HeLa cells.</text>
                    <arg n="0">a selenoprotein</arg>
                    <arg n="2">reticulocyt lysates</arg>
                </example>
                <example src="PERMUTATE" no="624">
                    <text>aber reading tables , as our study reveals, can be translated into the presence of C-terminal SBP2, and as shown in Figure 6C no reader can be detected when the AUGA element is removed, indicating that the stimulatory effect is totally dependent on 3 UTR.</text>
                    <arg n="0">aber reading tables</arg>
                </example>
                <example src="PERMUTATE" no="625">
                    <text>aber reading tables is likely to be translated efficiently in the presence of PAS-C, and as can be seen in Figure 6C, no reader can be detected when the AUGA element is removed, indicating that the stimulatory effect is totally dependent on 3 UTR.</text>
                    <arg n="0">aber reading tables</arg>
                </example>
                <example src="PERMUTATE" no="626">
                    <text>aber reading tables was shown to be effective in the presence of PAS-C, and as shown in Figure 6C, no reader can be detected when the AUGA element is removed, translated that the stimulatory effect is completely dependent on 3 UTR.</text>
                    <arg n="0">aber reading tables</arg>
                </example>
                <example src="PERMUTATE" no="627">
                    <text>aber reading tables will be translated efficiently in the presence of C-terminal SBP, and as shown in Figure 6C no reader can be detected when the AUGA element is removed, indicating that the stimulatory effect is completely 3 UTR dependent.</text>
                    <arg n="0">aber reading tables</arg>
                </example>
                <example src="PERMUTATE" no="628">
                    <text>open frames is able to be translated efficiently in the presence of C-terminal SBP2, and as shown in Figure 6C no reader can be detected when the AUGA element is removed, indicating that the stimulatory effect is totally dependent on 3 UTR.</text>
                    <arg n="0">open frames</arg>
                </example>
                <example src="PERMUTATE" no="629">
                    <text>open frames is observed to translated efficiently in the presence of PAS-C, and as shown in Figure 6C no reader can be detected when the AUGA element is removed, indicating that the stimulatory effect is completely dependent on 3 UTR.</text>
                    <arg n="0">open frames</arg>
                </example>
                <example src="PERMUTATE" no="630">
                    <text>open frames may have been translated efficiently in the presence of C-terminal SBP2, and as shown in Figure 6C no reader can be detected when the AUGA element is removed, indicating that the stimulatory effect is completely dependent on 3 UTR.</text>
                    <arg n="0">open frames</arg>
                </example>
                <example src="PERMUTATE" no="631">
                    <text>open frames may have been translated in the presence of C-terminal SBP2, and as shown in Figure 6C no reader can be detected when the AUGA element is removed, indicating that the stimulatory effect is totally dependent on 3 UTR.</text>
                    <arg n="0">open frames</arg>
                </example>
                <example src="PERMUTATE" no="632">
                    <text>open frames may have been translated into the presence of C-terminal SAP, and as shown in Figure 6C, no reader can be detected when the AUGA element is removed, indicating that the stimulatory effect is totally dependent on 3 UTR.</text>
                    <arg n="0">open frames</arg>
                </example>
                <example src="PERMUTATE" no="633">
                    <text>open frames will be translated efficiently in the presence of C-terminal SBP, and as shown in Figure 6C no reader can be detected when the AUGA element is removed, indicating that the stimulatory effect is completely 3 UTR dependent.</text>
                    <arg n="0">open frames</arg>
                </example>
                <example src="PERMUTATE" no="634">
                    <text>open frames, as revealed by our study, has been shown to translated into the presence of C-terminal SBP2, and as shown in Figure 6C no reader can be detected when the AUGA element is removed, indicating that the stimulatory effect is fully dependent on 3 UTR.</text>
                    <arg n="0">open frames</arg>
                </example>
                <example src="PERMUTATE" no="635">
                    <text>open frames, as revealed by our study, is observed to translated the presence of C-terminal SBP2, and as shown in Figure 6C no reader can be detected when the AUGA element is removed, indicating that the stimulatory effect is totally dependent on 3 UTR.</text>
                    <arg n="0">open frames</arg>
                </example>
                <example src="PERMUTATE" no="636">
                    <text>open frames, as revealed in our study, is able to be translated into the presence of PAS-C-terminal2, and as shown in Figure 6C, reading when the AUGA element is excluded is not detectable, indicating that the stimulating effect is totally 3 UTR dependent.</text>
                    <arg n="0">open frames</arg>
                </example>
                <example src="PERMUTATE" no="637">
                    <text>open frames, as revealed in our study, is likely to be translated into the presence of PAS-C-terminal2, and as shown in Figure 6C no reader can be detected when the AUGA element is removed, indicating that the stimulatory effect is totally dependent on 3 UTR.</text>
                    <arg n="0">open frames</arg>
                </example>
                <example src="PERMUTATE" no="638">
                    <text>open lee frameworks can be efficiently translated into the presence of PAS-C-terminal2, and as shown in Figure 6C no reader can be detected when the AUGA element is removed, indicating that the stimulatory effect is totally dependent on 3 UTR.</text>
                    <arg n="0">open lee frameworks</arg>
                </example>
                <example src="PERMUTATE" no="639">
                    <text>open lee frameworks is efficiently translated in the presence of terminal C SBP2, and as shown in Figure 6C no reader can be detected when the AUGA element is removed, indicating that the stimulatory effect is totally dependent on 3 UTR.</text>
                    <arg n="0">open lee frameworks</arg>
                </example>
                <example src="PERMUTATE" no="640">
                    <text>open lee frameworks is likely to be translated in the presence of C-terminal SBP2, and as shown in Figure 6C no reader can be detected when the AUGA element is removed, indicating that the stimulatory effect is totally dependent on 3 UTR.</text>
                    <arg n="0">open lee frameworks</arg>
                </example>
                <example src="PERMUTATE" no="641">
                    <text>open lee frameworks may have been translated efficiently in the presence of C-terminal SBP, and as shown in Figure 6C no reader can be detected when the AUGA element is removed, indicating that the stimulatory effect is completely dependent on 3 UTR.</text>
                    <arg n="0">open lee frameworks</arg>
                </example>
                <example src="PERMUTATE" no="642">
                    <text>open lee frameworks may have been translated efficiently in the presence of C-terminal SBP2, and as shown in Figure 6C no reader can be detected when the AUGA element is removed, indicating that the stimulatory effect is completely dependent on 3 UTR.</text>
                    <arg n="0">open lee frameworks</arg>
                </example>
                <example src="PERMUTATE" no="643">
                    <text>open lee frameworks may have been translated in the presence of C-terminal SBP2, and as shown in Figure 6C no reader can be detected when the AUGA element is removed, indicating that the stimulatory effect is totally dependent on 3 UTR.</text>
                    <arg n="0">open lee frameworks</arg>
                </example>
                <example src="PERMUTATE" no="644">
                    <text>open lee frameworks may have been translated into the presence of C-terminal SAP, and as shown in Figure 6C, no reader can be detected when the AUGA element is removed, indicating that the stimulatory effect is totally dependent on 3 UTR.</text>
                    <arg n="0">open lee frameworks</arg>
                </example>
                <example src="PERMUTATE" no="645">
                    <text>open lee frameworks that can be correctly translated into A2 clones (recombinant) binds DNA to an indistinguishable specificity of ISGF3 gamma purified from HeLa cells.</text>
                    <arg n="0">open lee frameworks</arg>
                </example>
                <example src="PERMUTATE" no="646">
                    <text>open lee frameworks, as revealed by our study, has been translated in the presence of C-terminal SBP2, and as shown in Figure 6C no reader can be detected when the AUGA element is removed, indicating that the stimulatory effect is fully dependent on 3 UTR.</text>
                    <arg n="0">open lee frameworks</arg>
                </example>
                <example src="PERMUTATE" no="647">
                    <text>open lee frameworks, as revealed by our study, translated into the presence of C-terminal SBP, and as shown in Figure 6C no reader can be detected when the AUGA element is removed, indicating that the stimulating effect is totally dependent on 3 UTR.</text>
                    <arg n="0">open lee frameworks</arg>
                </example>
                <example src="PERMUTATE" no="648">
                    <text>open lee frameworks, as revealed in our study, has been shown to be translated into the presence of C-terminal SBP, and as shown in Figure 6C, reading the AUGA element is not detectable, indicating that the stimulatory effect is totally 3 UTR dependent.</text>
                    <arg n="0">open lee frameworks</arg>
                </example>
                <example src="PERMUTATE" no="649">
                    <text>open lee frameworks, as revealed in our study, is able to be translated into the presence of PAS-C-terminal2, and as shown in Figure 6C, reading when the AUGA element is excluded is not detectable, indicating that the stimulating effect is totally 3 UTR dependent.</text>
                    <arg n="0">open lee frameworks</arg>
                </example>
                <example src="PERMUTATE" no="650">
                    <text>open leing frames , as our study reveals, can be translated into the presence of C-terminal SBP2, and as shown in Figure 6C no reader can be detected when the AUGA element is removed, indicating that the stimulatory effect is totally dependent on 3 UTR.</text>
                    <arg n="0">open leing frames</arg>
                </example>
                <example src="PERMUTATE" no="651">
                    <text>open leing frames may have been translated efficiently in the presence of C-terminal SBP, and as shown in Figure 6C no reader can be detected when the AUGA element is removed, indicating that the stimulatory effect is completely dependent on 3 UTR.</text>
                    <arg n="0">open leing frames</arg>
                </example>
                <example src="PERMUTATE" no="652">
                    <text>open leing frames, as revealed by our study, has been translated in the presence of C-terminal SBP2, and as shown in Figure 6C no reader can be detected when the AUGA element is removed, indicating that the stimulatory effect is fully dependent on 3 UTR.</text>
                    <arg n="0">open leing frames</arg>
                </example>
                <example src="PERMUTATE" no="653">
                    <text>open leing frames, as revealed by our study, is able to be translated into the presence of C-terminal SBP2, and as shown in Figure 6C no reader can be detected when the AUGA element is removed, indicating that the stimulatory effect is totally dependent on 3 UTR.</text>
                    <arg n="0">open leing frames</arg>
                </example>
                <example src="PERMUTATE" no="654">
                    <text>open leing frames, as revealed by our study, was translated into the presence of PAS-C-terminal2, and as shown in Figure 6C no reader can be detected when the AUGA element is removed, indicating that the stimulatory effect is totally dependent on 3 UTR.</text>
                    <arg n="0">open leing frames</arg>
                </example>
                <example src="PERMUTATE" no="655">
                    <text>open leing frameworks , as our study reveals, may have been translated in the presence of C-terminal SBP2, and as shown in Figure 6C no reader can be detected when the AUGA element is removed, indicating that the stimulatory effect is totally dependent on 3 UTR.</text>
                    <arg n="0">open leing frameworks</arg>
                </example>
                <example src="PERMUTATE" no="656">
                    <text>open leing frameworks can be translated efficiently in the presence of C-terminal SBP, and as shown in Figure 6C no reader can be detected when the AUGA element is removed, indicating that the stimulatory effect is completely dependent on 3 UTR.</text>
                    <arg n="0">open leing frameworks</arg>
                </example>
                <example src="PERMUTATE" no="657">
                    <text>open leing frameworks can be translated efficiently in the presence of C-terminal SBP2, and as shown in Figure 6C no reader can be detected when the AUGA element is removed, indicating that the stimulatory effect is totally dependent on 3 UTR.</text>
                    <arg n="0">open leing frameworks</arg>
                </example>
                <example src="PERMUTATE" no="658">
                    <text>open leing frameworks has been shown to translated efficiently in the presence of C-terminal SBP2, and as shown in Figure 6C no reader can be detected when the AUGA element is removed, indicating that the stimulatory effect is completely dependent on 3 UTR.</text>
                    <arg n="0">open leing frameworks</arg>
                </example>
                <example src="PERMUTATE" no="659">
                    <text>open leing frameworks has been shown to translated into the presence of C-terminal SBP2, and as shown in Figure 6C no reader can be detected when the AUGA element is removed, indicating that the stimulatory effect is totally dependent on 3 UTR.</text>
                    <arg n="0">open leing frameworks</arg>
                </example>
                <example src="PERMUTATE" no="660">
                    <text>open leing frameworks is able to be translated into the presence of C-terminal SBP, and as shown in Figure 6C, reading when the AUGA element is excluded is not detectable, indicating that the stimulating effect is completely 3 UTR dependent.</text>
                    <arg n="0">open leing frameworks</arg>
                </example>
                <example src="PERMUTATE" no="661">
                    <text>open leing frameworks is likely to be translated into the presence of C-terminal SBP, and as shown in Figure 6C, reading the AUGA element is not detectable, indicating that the stimulatory effect is completely 3 UTR dependent.</text>
                    <arg n="0">open leing frameworks</arg>
                </example>
                <example src="PERMUTATE" no="662">
                    <text>open leing frameworks may have been translated efficiently in the presence of C-terminal SBP2, and as shown in Figure 6C no reader can be detected when the AUGA element is removed, indicating that the stimulatory effect is completely dependent on 3 UTR.</text>
                    <arg n="0">open leing frameworks</arg>
                </example>
                <example src="PERMUTATE" no="663">
                    <text>open leing frameworks was translated to the presence of C-terminal SBP, and as shown in Figure 6C, no reader can be detected when the AUGA element is removed, indicating that the stimulatory effect is totally dependent on 3 UTR.</text>
                    <arg n="0">open leing frameworks</arg>
                </example>
                <example src="PERMUTATE" no="664">
                    <text>open leing frameworks, as our study reveals, is likely to be translated in the presence of C-terminal SBP2, and as shown in Figure 6C no reader can be detected when the AUGA element is removed, indicating that the stimulatory effect is fully dependent on 3 UTR.</text>
                    <arg n="0">open leing frameworks</arg>
                </example>
                <example src="PERMUTATE" no="665">
                    <text>open leing frameworks, as revealed by our study, has been shown to translated into the presence of C-terminal SBP2, and as shown in Figure 6C no reader can be detected when the AUGA element is removed, indicating that the stimulatory effect is fully dependent on 3 UTR.</text>
                    <arg n="0">open leing frameworks</arg>
                </example>
                <example src="PERMUTATE" no="666">
                    <text>open leing frameworks, as revealed in our study, will be translated into the presence of C-terminal SBP, and as shown in Figure 6C, reading the AUGA element is not detectable, indicating that the stimulatory effect is totally 3 UTR dependent.</text>
                    <arg n="0">open leing frameworks</arg>
                </example>
                <example src="PERMUTATE" no="667">
                    <text>open reading frameworks has been translated efficiently in the presence of C-terminal SBP2, and as shown in Figure 6C no reader can be detected when the AUGA element is removed, indicating that the stimulatory effect is completely dependent on 3 UTR.</text>
                    <arg n="0">open reading frameworks</arg>
                </example>
                <example src="PERMUTATE" no="668">
                    <text>open reading frameworks has been translated in the presence of C-terminal SBP2, and as shown in Figure 6C no reader can be detected when the AUGA element is removed, indicating that the stimulatory effect is totally dependent on 3 UTR.</text>
                    <arg n="0">open reading frameworks</arg>
                </example>
                <example src="PERMUTATE" no="669">
                    <text>open reading frameworks is likely to be translated in the presence of C-terminal SBP2, and as shown in Figure 6C no reader can be detected when the AUGA element is removed, indicating that the stimulatory effect is totally dependent on 3 UTR.</text>
                    <arg n="0">open reading frameworks</arg>
                </example>
                <example src="PERMUTATE" no="670">
                    <text>open reading frameworks is observed to be translated into the presence of C-terminal SBP, and as shown in Figure 6C, reading when the AUGA element is excluded is not detectable, indicating that the stimulatory effect is completely 3 UTR dependent.</text>
                    <arg n="0">open reading frameworks</arg>
                </example>
                <example src="PERMUTATE" no="671">
                    <text>open reading frameworks was efficiently translated into the presence of PAS-C-terminal2, and as shown in Figure 6C no reader can be detected when the AUGA element is removed, indicating that the stimulatory effect is completely dependent on 3 UTR.</text>
                    <arg n="0">open reading frameworks</arg>
                </example>
                <example src="PERMUTATE" no="672">
                    <text>open reading frameworks will be translated efficiently in the presence of C-terminal SBP2, and as shown in Figure 6C no reader can be detected when the AUGA element is removed, indicating that the stimulatory effect is fully 3 UTR dependent.</text>
                    <arg n="0">open reading frameworks</arg>
                </example>
                <example src="PERMUTATE" no="673">
                    <text>open reading frameworks will be translated to the presence of C-terminal SBP2, and as shown in Figure 6C no reader can be detected when the AUGA element is removed, indicating that the stimulatory effect is totally dependent on 3 UTR.</text>
                    <arg n="0">open reading frameworks</arg>
                </example>
                <example src="PERMUTATE" no="674">
                    <text>open reading frameworks, as revealed in our study, can be translated into the presence of C-terminal SBP, and as shown in Figure 6C, reading the AUGA element is not detectable, indicating that the stimulatory effect is completely 3 UTR dependent.</text>
                    <arg n="0">open reading frameworks</arg>
                </example>
                <example src="PERMUTATE" no="675">
                    <text>open reading frameworks, as revealed in our study, is likely to be translated into the presence of PAS-C-terminal2, and as shown in Figure 6C no reader can be detected when the AUGA element is removed, indicating that the stimulatory effect is totally dependent on 3 UTR.</text>
                    <arg n="0">open reading frameworks</arg>
                </example>
                <example src="PERMUTATE" no="676">
                    <text>selenoprotein , as our data reveal, has been shown to translated into lysed by reticulocytes and to partially purify into heparin-acrose.</text>
                    <arg n="0">selenoprotein</arg>
                    <arg n="2">lysed by reticulocytes</arg>
                </example>
                <example src="PERMUTATE" no="677">
                    <text>selenoprotein , as our data reveal, has been shown to translated into reticulocyte cells and to partially purify into heparin-acrose.</text>
                    <arg n="0">selenoprotein</arg>
                    <arg n="2">reticulocyte cells</arg>
                </example>
                <example src="PERMUTATE" no="678">
                    <text>selenoprotein , as our data reveal, have been translated into lysed by reticulocytes and partially purified into heparin-astrose.</text>
                    <arg n="0">selenoprotein</arg>
                    <arg n="2">lysed by reticulocytes</arg>
                </example>
                <example src="PERMUTATE" no="679">
                    <text>selenoprotein are likely to be translated into reticulocyte cells and partially purified into heparin-acrose.</text>
                    <arg n="0">selenoprotein</arg>
                    <arg n="2">reticulocyte cells</arg>
                </example>
                <example src="PERMUTATE" no="680">
                    <text>selenoprotein can be translated into lysates reticulocytes and purified partially in heparin-astroose.</text>
                    <arg n="0">selenoprotein</arg>
                    <arg n="2">lysates reticulocytes</arg>
                </example>
                <example src="PERMUTATE" no="681">
                    <text>selenoprotein can be translated into reticulocyte forms and partially purified into heparin-agarose.</text>
                    <arg n="0">selenoprotein</arg>
                    <arg n="2">reticulocyte forms</arg>
                </example>
                <example src="PERMUTATE" no="682">
                    <text>selenoprotein has been shown to be translated to lysates reticulocytes can also be dimerised to LMP2 gas.</text>
                    <arg n="0">selenoprotein</arg>
                    <arg n="2">lysates reticulocytes</arg>
                </example>
                <example src="PERMUTATE" no="683">
                    <text>selenoprotein has been shown to translated into lysates reticulocytes are partially purified in heparin-astroosa.</text>
                    <arg n="0">selenoprotein</arg>
                    <arg n="2">lysates reticulocytes</arg>
                </example>
                <example src="PERMUTATE" no="684">
                    <text>selenoprotein has been shown to translated into reticulocyte forms and to partially purify into heparin-astroosa.</text>
                    <arg n="0">selenoprotein</arg>
                    <arg n="2">reticulocyte forms</arg>
                </example>
                <example src="PERMUTATE" no="685">
                    <text>selenoprotein have been translated into lysates reticulocytes and purified partially in heparin-astroosa.</text>
                    <arg n="0">selenoprotein</arg>
                    <arg n="2">lysates reticulocytes</arg>
                </example>
                <example src="PERMUTATE" no="686">
                    <text>selenoprotein have been translated into reticulocyte forms and purified partially in heparin-astroosa.</text>
                    <arg n="0">selenoprotein</arg>
                    <arg n="2">reticulocyte forms</arg>
                </example>
                <example src="PERMUTATE" no="687">
                    <text>selenoprotein have the ability to be translated into lysed by reticulocytes and partially purified into heparin-acrose.</text>
                    <arg n="0">selenoprotein</arg>
                    <arg n="2">lysed by reticulocytes</arg>
                </example>
                <example src="PERMUTATE" no="688">
                    <text>selenoprotein is observed to be translated into reticulocyte forms and partially purified into heparin-astrose.</text>
                    <arg n="0">selenoprotein</arg>
                    <arg n="2">reticulocyte forms</arg>
                </example>
                <example src="PERMUTATE" no="689">
                    <text>selenoprotein may have been translated into lysates reticulocytes and partially purified into heparin-astrous.</text>
                    <arg n="0">selenoprotein</arg>
                    <arg n="2">lysates reticulocytes</arg>
                </example>
                <example src="PERMUTATE" no="690">
                    <text>selenoprotein that are observed as being adequately translated into lysates reticulocytes are partially purified in heparin-agarose.</text>
                    <arg n="0">selenoprotein</arg>
                    <arg n="2">lysates reticulocytes</arg>
                </example>
                <example src="PERMUTATE" no="691">
                    <text>selenoprotein that are observed as being adequately translated into lysed by reticulocytes are partially purified in heparin-agarose.</text>
                    <arg n="0">selenoprotein</arg>
                    <arg n="2">lysed by reticulocytes</arg>
                </example>
                <example src="PERMUTATE" no="692">
                    <text>selenoprotein that are observed as being adequately translated into reticulocyte forms are partially purified in heparin-agarose.</text>
                    <arg n="0">selenoprotein</arg>
                    <arg n="2">reticulocyte forms</arg>
                </example>
                <example src="PERMUTATE" no="693">
                    <text>selenoprotein that can be correctly translated into lysed by reticulocytes are partially purified in heparin-astrous.</text>
                    <arg n="0">selenoprotein</arg>
                    <arg n="2">lysed by reticulocytes</arg>
                </example>
                <example src="PERMUTATE" no="694">
                    <text>selenoprotein that can be translated into lysates reticulocytes are partially purified in heparin-astroosis.</text>
                    <arg n="0">selenoprotein</arg>
                    <arg n="2">lysates reticulocytes</arg>
                </example>
                <example src="PERMUTATE" no="695">
                    <text>selenoprotein that can be translated into lysed by reticulocytes of A1 clones (recombinant) bind the DNA with an indistinguishable specificity of ISGF3 gamma purified from HeLa cells.</text>
                    <arg n="0">selenoprotein</arg>
                    <arg n="2">lysed by reticulocytes</arg>
                </example>
                <example src="PERMUTATE" no="696">
                    <text>selenoprotein that can be translated into reticulocyte cells of A1 clones (recombinant) bind the DNA with an indistinguishable specificity of ISGF3 gamma purified from HeLa cells.</text>
                    <arg n="0">selenoprotein</arg>
                    <arg n="2">reticulocyte cells</arg>
                </example>
                <example src="PERMUTATE" no="697">
                    <text>selenoprotein that can probably be translated to lysed by reticulocytes can also be dimerised into LMP2 gas.</text>
                    <arg n="0">selenoprotein</arg>
                    <arg n="2">lysed by reticulocytes</arg>
                </example>
                <example src="PERMUTATE" no="698">
                    <text>selenoprotein that has been shown to be correctly translated into lysates reticulocytes are partially purified in heparin-astroosa.</text>
                    <arg n="0">selenoprotein</arg>
                    <arg n="2">lysates reticulocytes</arg>
                </example>
                <example src="PERMUTATE" no="699">
                    <text>selenoprotein that has been shown to probably translated into lysates reticulocytes can also be dimerized into the LMP2 gas.</text>
                    <arg n="0">selenoprotein</arg>
                    <arg n="2">lysates reticulocytes</arg>
                </example>
                <example src="PERMUTATE" no="700">
                    <text>selenoprotein that have been properly translated into reticulocyte forms are partially purified in heparin-astrose.</text>
                    <arg n="0">selenoprotein</arg>
                    <arg n="2">reticulocyte forms</arg>
                </example>
                <example src="PERMUTATE" no="701">
                    <text>selenoprotein that have the ability to be translated correctly into reticulocyte forms are partially purified in heparin-acrose.</text>
                    <arg n="0">selenoprotein</arg>
                    <arg n="2">reticulocyte forms</arg>
                </example>
                <example src="PERMUTATE" no="702">
                    <text>selenoprotein that is adequately translated into reticulocyte cells of A1 clones (recombinant) binds DNA with an indistinguishable specificity of ISGF3 gamma purified from HeLa cells.</text>
                    <arg n="0">selenoprotein</arg>
                    <arg n="2">reticulocyte cells</arg>
                </example>
                <example src="PERMUTATE" no="703">
                    <text>selenoprotein that is likely to be correctly translated to reticulocyte cells is partially purified into heparin-astrous.</text>
                    <arg n="0">selenoprotein</arg>
                    <arg n="2">reticulocyte cells</arg>
                </example>
                <example src="PERMUTATE" no="704">
                    <text>selenoprotein that is likely to be correctly translated to reticulocyte forms is partially purified into heparin-astrous.</text>
                    <arg n="0">selenoprotein</arg>
                    <arg n="2">reticulocyte forms</arg>
                </example>
                <example src="PERMUTATE" no="705">
                    <text>selenoprotein that is observed to be probably translated into lysates reticulocytes can also dimerize in the SGL2 of LMP2.</text>
                    <arg n="0">selenoprotein</arg>
                    <arg n="2">lysates reticulocytes</arg>
                </example>
                <example src="PERMUTATE" no="706">
                    <text>selenoprotein that is observed to be translated into reticulocyte forms of A1 clones (recombinant) binds DNA with an indistinguishable specificity of ISGF3 snake purified from HeLa cells.</text>
                    <arg n="0">selenoprotein</arg>
                    <arg n="2">reticulocyte forms</arg>
                </example>
                <example src="PERMUTATE" no="707">
                    <text>selenoprotein that may have been correctly translated into lysates reticulocytes is partially purified in heparin-acrose.</text>
                    <arg n="0">selenoprotein</arg>
                    <arg n="2">lysates reticulocytes</arg>
                </example>
                <example src="PERMUTATE" no="708">
                    <text>selenoprotein that may have been correctly translated into reticulocyte forms is partially purified in heparin-acrose.</text>
                    <arg n="0">selenoprotein</arg>
                    <arg n="2">reticulocyte forms</arg>
                </example>
                <example src="PERMUTATE" no="709">
                    <text>selenoprotein that may have been translated into lysates reticulocytes are partially purified in heparin-agarose.</text>
                    <arg n="0">selenoprotein</arg>
                    <arg n="2">lysates reticulocytes</arg>
                </example>
                <example src="PERMUTATE" no="710">
                    <text>selenoprotein that may have been translated into lysed by reticulocytes of A1 clones (recombinant) bind DNA with an indistinguishable specificity of ISGF3 gamma purified from HeLa cells.</text>
                    <arg n="0">selenoprotein</arg>
                    <arg n="2">lysed by reticulocytes</arg>
                </example>
                <example src="PERMUTATE" no="711">
                    <text>selenoprotein that may have been translated into lysed by reticulocytes of A1 clones (recombinant) bind the DNA with an indistinguishable specificity of ISGF3 gamma purified from HeLa cells.</text>
                    <arg n="0">selenoprotein</arg>
                    <arg n="2">lysed by reticulocytes</arg>
                </example>
                <example src="PERMUTATE" no="712">
                    <text>selenoprotein that may have been translated into reticulocyte forms of A1 clones (recombinant) bind the DNA with an indistinguishable specificity of ISGF3 gamma purified from HeLa cells.</text>
                    <arg n="0">selenoprotein</arg>
                    <arg n="2">reticulocyte forms</arg>
                </example>
                <example src="PERMUTATE" no="713">
                    <text>selenoprotein that translated into reticulocyte cells can also be dimerised to the LMP2 gas.</text>
                    <arg n="0">selenoprotein</arg>
                    <arg n="2">reticulocyte cells</arg>
                </example>
                <example src="PERMUTATE" no="714">
                    <text>selenoprotein that translated into reticulocyte forms can also be dimerised to the LMP2 gas.</text>
                    <arg n="0">selenoprotein</arg>
                    <arg n="2">reticulocyte forms</arg>
                </example>
                <example src="PERMUTATE" no="715">
                    <text>selenoprotein that will be translated appropriately into lysed by reticulocytes are partially purified in heparin-agarose.</text>
                    <arg n="0">selenoprotein</arg>
                    <arg n="2">lysed by reticulocytes</arg>
                </example>
                <example src="PERMUTATE" no="716">
                    <text>selenoprotein that will be translated appropriately into reticulocyte forms are partially purified in heparin-agarose.</text>
                    <arg n="0">selenoprotein</arg>
                    <arg n="2">reticulocyte forms</arg>
                </example>
                <example src="PERMUTATE" no="717">
                    <text>selenoprotein that will be translated into lysed by reticulocytes are partially purified in heparin-agarose.</text>
                    <arg n="0">selenoprotein</arg>
                    <arg n="2">lysed by reticulocytes</arg>
                </example>
                <example src="PERMUTATE" no="718">
                    <text>selenoprotein that will be translated into reticulocyte forms of A1 clones (recombinant) bind the DNA with an indistinguishable specificity of ISGF3 gamma purified from HeLa cells.</text>
                    <arg n="0">selenoprotein</arg>
                    <arg n="2">reticulocyte forms</arg>
                </example>
                <example src="PERMUTATE" no="719">
                    <text>selenoprotein that will probably be translated into lysates reticulocytes can also be submerged into SGL2 LMP2.</text>
                    <arg n="0">selenoprotein</arg>
                    <arg n="2">lysates reticulocytes</arg>
                </example>
                <example src="PERMUTATE" no="720">
                    <text>selenoprotein that will probably be translated to lysed by reticulocytes can also be dimerised into LMP2 gas.</text>
                    <arg n="0">selenoprotein</arg>
                    <arg n="2">lysed by reticulocytes</arg>
                </example>
                <example src="PERMUTATE" no="721">
                    <text>selenoprotein was correctly translated into lysates reticulocytes from A1 clones (recombinant) bound to DNA with an indistinguishable specificity of ISGF3 gamma purified from HeLa cells.</text>
                    <arg n="0">selenoprotein</arg>
                    <arg n="2">lysates reticulocytes</arg>
                </example>
                <example src="PERMUTATE" no="722">
                    <text>selenoprotein was correctly translated into reticulocyte cells from A1 clones (recombinant) bound to DNA with an indistinguishable specificity of ISGF3 gamma purified from HeLa cells.</text>
                    <arg n="0">selenoprotein</arg>
                    <arg n="2">reticulocyte cells</arg>
                </example>
                <example src="PERMUTATE" no="723">
                    <text>selenoprotein was translated into lysates reticulocytes from A1 clones (recombinants) that bind to DNA with an indistinguishable specificity of ISGF3 gamma purified from HeLa cells.</text>
                    <arg n="0">selenoprotein</arg>
                    <arg n="2">lysates reticulocytes</arg>
                </example>
                <example src="PERMUTATE" no="724">
                    <text>selenoprotein was translated into lysed by reticulocytes from A1 clones (recombinants) that bind to DNA with an indistinguishable specificity of ISGF3 gamma purified from HeLa cells.</text>
                    <arg n="0">selenoprotein</arg>
                    <arg n="2">lysed by reticulocytes</arg>
                </example>
                <example src="PERMUTATE" no="725">
                    <text>selenoprotein which can be translated into lysates reticulocytes can also be dimerized into the LMP2 gas.</text>
                    <arg n="0">selenoprotein</arg>
                    <arg n="2">lysates reticulocytes</arg>
                </example>
                <example src="PERMUTATE" no="726">
                    <text>selenoprotein which can be translated into lysed by reticulocytes can also be dimerized into the LMP2 gas.</text>
                    <arg n="0">selenoprotein</arg>
                    <arg n="2">lysed by reticulocytes</arg>
                </example>
                <example src="PERMUTATE" no="727">
                    <text>selenoprotein which has probably translated into reticulocyte cells can also be dimerised to the LMP2 gas.</text>
                    <arg n="0">selenoprotein</arg>
                    <arg n="2">reticulocyte cells</arg>
                </example>
                <example src="PERMUTATE" no="728">
                    <text>selenoprotein which translated to reticulocyte cells can also be dimerized into LMP2 gas.</text>
                    <arg n="0">selenoprotein</arg>
                    <arg n="2">reticulocyte cells</arg>
                </example>
                <example src="PERMUTATE" no="729">
                    <text>selenoprotein which translated to reticulocyte forms can also be dimerized into LMP2 gas.</text>
                    <arg n="0">selenoprotein</arg>
                    <arg n="2">reticulocyte forms</arg>
                </example>
                <example src="PERMUTATE" no="730">
                    <text>selenoprotein which was probably translated into lysates reticulocytes can also be dimerized into the LMP2 gas.</text>
                    <arg n="0">selenoprotein</arg>
                    <arg n="2">lysates reticulocytes</arg>
                </example>
                <example src="PERMUTATE" no="731">
                    <text>selenoprotein which was translated into lysates reticulocytes can also be dimerized into the LMP2 gas.</text>
                    <arg n="0">selenoprotein</arg>
                    <arg n="2">lysates reticulocytes</arg>
                </example>
                <example src="PERMUTATE" no="732">
                    <text>selenoprotein which was translated into reticulocyte forms can also be dimerized into the LMP2 gas.</text>
                    <arg n="0">selenoprotein</arg>
                    <arg n="2">reticulocyte forms</arg>
                </example>
                <example src="PERMUTATE" no="733">
                    <text>selenoprotein will be translated into lysed by reticulocytes and partially purified into heparin-acrose.</text>
                    <arg n="0">selenoprotein</arg>
                    <arg n="2">lysed by reticulocytes</arg>
                </example>
                <example src="PERMUTATE" no="734">
                    <text>selenoprotein, as our data show, are translated into reticulocyte cells and partially purified into heparin-aminosis.</text>
                    <arg n="0">selenoprotein</arg>
                    <arg n="2">reticulocyte cells</arg>
                </example>
                <example src="PERMUTATE" no="735">
                    <text>selenoprotein, as our data show, are translated into reticulocyte forms and partially purified into heparin-acrose.</text>
                    <arg n="0">selenoprotein</arg>
                    <arg n="2">reticulocyte forms</arg>
                </example>
                <example src="PERMUTATE" no="736">
                    <text>selenoprotein, as our data show, can be translated into reticulocyte cells and partially purified into heparin-amikanosis.</text>
                    <arg n="0">selenoprotein</arg>
                    <arg n="2">reticulocyte cells</arg>
                </example>
                <example src="PERMUTATE" no="737">
                    <text>selenoprotein, as our data show, can be translated into reticulocyte forms and partially purified into heparin-amikanosis.</text>
                    <arg n="0">selenoprotein</arg>
                    <arg n="2">reticulocyte forms</arg>
                </example>
                <example src="PERMUTATE" no="738">
                    <text>selenoprotein, as our data show, has the ability to be translated into lysates reticulocytes and partially purified into heparin-agarose.</text>
                    <arg n="0">selenoprotein</arg>
                    <arg n="2">lysates reticulocytes</arg>
                </example>
                <example src="PERMUTATE" no="739">
                    <text>selenoprotein, as our data show, has the ability to be translated to lysed by reticulocytes and partially purified to heparin-astrose.</text>
                    <arg n="0">selenoprotein</arg>
                    <arg n="2">lysed by reticulocytes</arg>
                </example>
                <example src="PERMUTATE" no="740">
                    <text>selenoprotein, as our data show, may have been translated into lysed by reticulocytes and partially purified into heparin-agarose.</text>
                    <arg n="0">selenoprotein</arg>
                    <arg n="2">lysed by reticulocytes</arg>
                </example>
                <example src="PERMUTATE" no="741">
                    <text>selenoprotein, as our data show, was translated to reticulocyte cells and partially purified in heparin-acrose.</text>
                    <arg n="0">selenoprotein</arg>
                    <arg n="2">reticulocyte cells</arg>
                </example>
                <example src="PERMUTATE" no="742">
                    <text>selenoprotein, as our data show, will be translated into lysates reticulocytes and partially purified into heparin-acrose.</text>
                    <arg n="0">selenoprotein</arg>
                    <arg n="2">lysates reticulocytes</arg>
                </example>
                <example src="PERMUTATE" no="743">
                    <text>selenoprotein, as our data show, will be translated into lysed by reticulocytes and partially purified into heparin-aminosis.</text>
                    <arg n="0">selenoprotein</arg>
                    <arg n="2">lysed by reticulocytes</arg>
                </example>
                <example src="PERMUTATE" no="744">
                    <text>selenoprotein, which has been adequately translated into reticulocyte forms of A1 clones (recombinant), binds DNA with an indistinguishable specificity of ISGF3 swab, purified from HeLa cells.</text>
                    <arg n="0">selenoprotein</arg>
                    <arg n="2">reticulocyte forms</arg>
                </example>
                <example src="PERMUTATE" no="745">
                    <text>selenoprotein, which is able to be translated into reticulocyte cells, can also dimer into SGL2.</text>
                    <arg n="0">selenoprotein</arg>
                    <arg n="2">reticulocyte cells</arg>
                </example>
                <example src="PERMUTATE" no="746">
                    <text>this mutant was partially translated in heparin-astrous.</text>
                    <arg n="0">this mutant</arg>
                </example>
                <example src="REPLACE" no="1">
                    <text>It has been shown that over 100 proteins and polypeptides included in the ArC/XylS family of prokaryotic positive transcriptional regulators have been fully translated from open led frames.</text>
                    <arg n="0">open led frames</arg>
                </example>
                <example src="REPLACE" no="2">
                    <text>More than 100 proteins and polypeptides included in the ArC/XylS family of prokaryotic positive transcriptional regulators are fully translated from a truncated C-terminal protein containing the first, second, and third transmembrane domains.</text>
                    <arg n="0">a truncated C-terminal protein containing the first, second, and third transmembrane domains</arg>
                </example>
                <example src="REPLACE" no="3">
                    <text>More than 100 proteins and polypeptides included in the ArC/XylS family of prokaryotic positive transcriptional regulators are likely to be translated from a C-terminal truncated protein containing the first, second and third transmembrane domains.</text>
                    <arg n="0">a C-terminal truncated protein containing the first, second and third transmembrane domains</arg>
                </example>
                <example src="REPLACE" no="4">
                    <text>More than 100 proteins and polypeptides included in the ArC/XylS family of prokaryotic positive transcriptional regulators are observed to be completely translated from a C-terminal truncated protein containing the first, second and third transmembrane domains.</text>
                    <arg n="0">a C-terminal truncated protein containing the first, second and third transmembrane domains</arg>
                </example>
                <example src="REPLACE" no="5">
                    <text>More than 100 proteins and polypeptides included in the ArC/XylS family of prokaryotic positive transcriptional regulators are observed to be completely translated from a truncated C-terminal protein containing the first, second and third transmembranous domains.</text>
                    <arg n="0">a truncated C-terminal protein containing the first, second and third transmembranous domains</arg>
                </example>
                <example src="REPLACE" no="6">
                    <text>More than 100 proteins and polypeptides included in the ArC/XylS family of prokaryotic positive transcriptional regulators are observed to be translated from a truncated C-terminal protein containing the first, second, and third transmembrane domains.</text>
                    <arg n="0">a truncated C-terminal protein containing the first, second, and third transmembrane domains</arg>
                </example>
                <example src="REPLACE" no="7">
                    <text>More than 100 proteins and polypeptides included in the ArC/XylS family of prokaryotic positive transcriptional regulators have the ability to be translated from a C-terminal truncated protein containing the first, second and third transmembrane domains.</text>
                    <arg n="0">a C-terminal truncated protein containing the first, second and third transmembrane domains</arg>
                </example>
                <example src="REPLACE" no="8">
                    <text>More than 100 proteins and polypeptides included in the ArC/XylS family of prokaryotic positive transcriptional regulators have the ability to be translated from a truncated C-terminal protein containing the first, second and third transmembranous domains.</text>
                    <arg n="0">a truncated C-terminal protein containing the first, second and third transmembranous domains</arg>
                </example>
                <example src="REPLACE" no="9">
                    <text>More than 100 proteins and polypeptides included in the ArC/XylS family of prokaryotic transcriptional regulators have the ability to be fully translated from a C-terminal truncated protein containing the first, second and third transmembrane domains.</text>
                    <arg n="0">a C-terminal truncated protein containing the first, second and third transmembrane domains</arg>
                </example>
                <example src="REPLACE" no="10">
                    <text>More than 100 proteins and polypeptides included in the ArC/XylS family of prokaryotic transcriptional regulators may have been fully translated from open led frames.</text>
                    <arg n="0">open led frames</arg>
                </example>
                <example src="REPLACE" no="11">
                    <text>More than 100 proteins and polypeptides included in the ArC/XylS family of prokaryotic transcriptional regulators will be translated completely from a truncated C-terminal protein containing the first, second, and third transmembrane domains.</text>
                    <arg n="0">a truncated C-terminal protein containing the first, second, and third transmembrane domains</arg>
                </example>
                <example src="REPLACE" no="12">
                    <text>More than 100 proteins and polypeptides included in the ArC/XylS family of prokaryotic transcriptional regulators will be translated completely from open led frames.</text>
                    <arg n="0">open led frames</arg>
                </example>
                <example src="REPLACE" no="13">
                    <text>More than 100 proteins and polypeptides that are included in the ArC/XylS family of pro-karyotic positive transcriptional regulators are likely to be translated from open led frames.</text>
                    <arg n="0">open led frames</arg>
                </example>
                <example src="REPLACE" no="14">
                    <text>More than 100 proteins and polypeptides that are included in the ArC/XylS family of pro-karyotic positive transcriptional regulators have been translated completely from a truncated C-terminal protein containing the first, second, and third transmembrane domains.</text>
                    <arg n="0">a truncated C-terminal protein containing the first, second, and third transmembrane domains</arg>
                </example>
                <example src="REPLACE" no="15">
                    <text>More than 100 proteins and polypeptides that are included in the ArC/XylS family of prokaryotic positive transcriptional regulators are able to be translated completely from a truncated C-terminal protein containing the first, second and third transmembrane domains.</text>
                    <arg n="0">a truncated C-terminal protein containing the first, second and third transmembrane domains</arg>
                </example>
                <example src="REPLACE" no="16">
                    <text>More than 100 proteins and polypeptides that are included in the ArC/XylS family of prokaryotic positive transcriptional regulators are able to be translated completely from open led frames.</text>
                    <arg n="0">open led frames</arg>
                </example>
                <example src="REPLACE" no="17">
                    <text>More than 100 proteins and polypeptides that are included in the ArC/XylS family of prokaryotic positive transcriptional regulators are completely translated from a truncated C-terminal protein containing the first, second and third transmembrane domains.</text>
                    <arg n="0">a truncated C-terminal protein containing the first, second and third transmembrane domains</arg>
                </example>
                <example src="REPLACE" no="18">
                    <text>More than 100 proteins and polypeptides that are included in the ArC/XylS family of prokaryotic positive transcriptional regulators are completely translated from a truncated C-terminal protein containing the first, second and third transmembranous domains.</text>
                    <arg n="0">a truncated C-terminal protein containing the first, second and third transmembranous domains</arg>
                </example>
                <example src="REPLACE" no="19">
                    <text>More than 100 proteins and polypeptides that are included in the ArC/XylS family of prokaryotic positive transcriptional regulators are translated from a truncated C-terminal protein containing the first, second and third transmembranous domains.</text>
                    <arg n="0">a truncated C-terminal protein containing the first, second and third transmembranous domains</arg>
                </example>
                <example src="REPLACE" no="20">
                    <text>More than 100 proteins and polypeptides that are included in the ArC/XylS family of prokaryotic positive transcriptional regulators can be translated completely from a truncated C-terminal protein containing the first, second, and third transmembrane domains.</text>
                    <arg n="0">a truncated C-terminal protein containing the first, second, and third transmembrane domains</arg>
                </example>
                <example src="REPLACE" no="21">
                    <text>More than 100 proteins and polypeptides that are included in the ArC/XylS family of prokaryotic positive transcriptional regulators have the ability to be translated from a truncated C-terminal protein containing the first, second and third transmembranous domains.</text>
                    <arg n="0">a truncated C-terminal protein containing the first, second and third transmembranous domains</arg>
                </example>
                <example src="REPLACE" no="22">
                    <text>More than 100 proteins and polypeptides that are included in the ArC/XylS family of prokaryotic positive transcriptional regulators may have been translated from a truncated C-terminal protein containing the first, second and third transmembrane domains.</text>
                    <arg n="0">a truncated C-terminal protein containing the first, second and third transmembrane domains</arg>
                </example>
                <example src="REPLACE" no="23">
                    <text>More than 100 proteins and polypeptides that are included in the ArC/XylS family of prokaryotic positive transcriptional regulators will be translated completely from a truncated C-terminal protein containing the first, second and third transmembrane domains.</text>
                    <arg n="0">a truncated C-terminal protein containing the first, second and third transmembrane domains</arg>
                </example>
                <example src="REPLACE" no="24">
                    <text>More than 100 proteins and polypeptides that are included in the ArC/XylS family of prokaryotic positive transcriptional regulators will be translated from a C-terminal truncated protein containing the first, second and third transmembrane domains.</text>
                    <arg n="0">a C-terminal truncated protein containing the first, second and third transmembrane domains</arg>
                </example>
                <example src="REPLACE" no="25">
                    <text>The ArC/XylS family of positive prokaryotes transcriptional regulators includes more than 100 proteins and polypeptides that will be translated from a truncated C-terminal protein containing the first, second and third transmembranous domains.</text>
                    <arg n="0">a truncated C-terminal protein containing the first, second and third transmembranous domains</arg>
                </example>
                <example src="REPLACE" no="26">
                    <text>The ArC/XylS family of positive prokaryotic transcriptional regulators includes more than 100 proteins and polypeptides that are likely to be translated from a truncated C-terminal protein containing the first, second and third transmembrane domains.</text>
                    <arg n="0">a truncated C-terminal protein containing the first, second and third transmembrane domains</arg>
                </example>
                <example src="REPLACE" no="27">
                    <text>The ArC/XylS family of prokaryotic positive transcription regulators includes more than 100 proteins and polypeptides observed to be translated from a truncated C-terminal protein containing the first, second and third transmembrane domains.</text>
                    <arg n="0">a truncated C-terminal protein containing the first, second and third transmembrane domains</arg>
                </example>
                <example src="REPLACE" no="28">
                    <text>The ArC/XylS family of prokaryotic positive transcription regulators includes more than 100 proteins and polypeptides observed to be translated from open led frames.</text>
                    <arg n="0">open led frames</arg>
                </example>
                <example src="REPLACE" no="29">
                    <text>The ArC/XylS family of prokaryotic positive transcription regulators includes more than 100 proteins and polypeptides that translated from a C-terminal truncated protein containing the first, second and third transmembrane domains.</text>
                    <arg n="0">a C-terminal truncated protein containing the first, second and third transmembrane domains</arg>
                </example>
                <example src="REPLACE" no="30">
                    <text>The ArC/XylS family of prokaryotic positive transcription regulators includes more than 100 proteins and polypeptides that translated from a truncated C-terminal protein containing the first, second, and third transmembrane domains.</text>
                    <arg n="0">a truncated C-terminal protein containing the first, second, and third transmembrane domains</arg>
                </example>
                <example src="REPLACE" no="31">
                    <text>The ArC/XylS family of prokaryotic positive transcriptional regulators includes more than 100 proteins and polypeptides that are translated from a C-terminal truncated protein containing the first, second and third transmembrane domains.</text>
                    <arg n="0">a C-terminal truncated protein containing the first, second and third transmembrane domains</arg>
                </example>
                <example src="REPLACE" no="32">
                    <text>The ArC/XylS family of prokaryotic positive transcriptional regulators includes more than 100 proteins and polypeptides that have been shown to be translated from a C-terminal truncated protein containing the first, second and third transmembrane domains.</text>
                    <arg n="0">a C-terminal truncated protein containing the first, second and third transmembrane domains</arg>
                </example>
                <example src="REPLACE" no="33">
                    <text>The ArC/XylS family of prokaryotic transcriptional regulators includes more than 100 proteins and polypeptides that are likely to be translated from a truncated C-terminal protein containing the first, second, and third transmembrane domains.</text>
                    <arg n="0">a truncated C-terminal protein containing the first, second, and third transmembrane domains</arg>
                </example>
                <example src="REPLACE" no="34">
                    <text>The ArC/XylS family of prokaryotic transcriptional regulators includes more than 100 proteins and polypeptides that are translated from open led frames.</text>
                    <arg n="0">open led frames</arg>
                </example>
                <example src="REPLACE" no="35">
                    <text>The ArC/XylS family of prokaryotic transcriptional regulators includes more than 100 proteins and polypeptides that can be translated from a truncated C-terminal protein containing the first, second and third transmembranous domains.</text>
                    <arg n="0">a truncated C-terminal protein containing the first, second and third transmembranous domains</arg>
                </example>
                <example src="REPLACE" no="36">
                    <text>The ArC/XylS family of prokaryotic transcriptional regulators includes more than 100 proteins and polypeptides that can be translated from a truncated C-terminal protein containing the first, second, and third transmembrane domains.</text>
                    <arg n="0">a truncated C-terminal protein containing the first, second, and third transmembrane domains</arg>
                </example>
                <example src="REPLACE" no="37">
                    <text>The ArC/XylS family of prokaryotic transcriptional regulators includes more than 100 proteins and polypeptides that may have been translated from a truncated C-terminal protein containing the first, second, and third transmembrane domains.</text>
                    <arg n="0">a truncated C-terminal protein containing the first, second, and third transmembrane domains</arg>
                </example>
                <example src="REPLACE" no="38">
                    <text>The ArC/XylS family of prokaryotic transcriptional regulators includes more than 100 proteins and polypeptides that will be translated from a C-terminal truncated protein containing the first, second and third transmembrane domains.</text>
                    <arg n="0">a C-terminal truncated protein containing the first, second and third transmembrane domains</arg>
                </example>
                <example src="REPLACE" no="39">
                    <text>a C-terminal truncated protein containing the first, second and third transmembrane domains is able to be translated efficiently in the presence of C-terminal SBP2, and as shown in Figure 6C no reader can be detected when the AUGA element is removed, indicating that the stimulatory effect is totally dependent on 3 UTR.</text>
                    <arg n="0">a C-terminal truncated protein containing the first, second and third transmembrane domains</arg>
                </example>
                <example src="REPLACE" no="40">
                    <text>a C-terminal truncated protein containing the first, second and third transmembrane domains that can be correctly translated into A2 clones (recombinant) binds DNA to an indistinguishable specificity of ISGF3 gamma purified from HeLa cells.</text>
                    <arg n="0">a C-terminal truncated protein containing the first, second and third transmembrane domains</arg>
                </example>
                <example src="REPLACE" no="41">
                    <text>a C-terminal truncated protein containing the first, second and third transmembrane domains was translated into the presence of C-terminal SAP, and as shown in Figure 6C, no reader can be detected when the AUGA element is removed, indicating that the stimulatory effect is totally dependent on 3 UTR.</text>
                    <arg n="0">a C-terminal truncated protein containing the first, second and third transmembrane domains</arg>
                </example>
                <example src="REPLACE" no="42">
                    <text>a C-terminal truncated protein containing the first, second and third transmembrane domains will be translated efficiently in the presence of C-terminal SBP2, and as shown in Figure 6C no reader can be detected when the AUGA element is removed, indicating that the stimulatory effect is fully 3 UTR dependent.</text>
                    <arg n="0">a C-terminal truncated protein containing the first, second and third transmembrane domains</arg>
                </example>
                <example src="REPLACE" no="43">
                    <text>a C-terminal truncated protein containing the first, second and third transmembrane domains, as revealed in our study, is translated into the presence of C-terminal SBP, and as shown in Figure 6C, reading the AUGA element is not detectable, indicating that the stimulatory effect is totally 3 UTR dependent.</text>
                    <arg n="0">a C-terminal truncated protein containing the first, second and third transmembrane domains</arg>
                </example>
                <example src="REPLACE" no="44">
                    <text>a C-terminal truncated protein containing the first, second and third transmembrane domains, as revealed in our study, will be translated into the presence of C-terminal SBP, and as shown in Figure 6C, reading the AUGA element is not detectable, indicating that the stimulatory effect is totally 3 UTR dependent.</text>
                    <arg n="0">a C-terminal truncated protein containing the first, second and third transmembrane domains</arg>
                </example>
                <example src="REPLACE" no="45">
                    <text>a truncated C-terminal protein containing the first, second and third transmembrane domains , as our study reveals, may have been translated in the presence of C-terminal SBP2, and as shown in Figure 6C no reader can be detected when the AUGA element is removed, indicating that the stimulatory effect is totally dependent on 3 UTR.</text>
                    <arg n="0">a truncated C-terminal protein containing the first, second and third transmembrane domains</arg>
                </example>
                <example src="REPLACE" no="46">
                    <text>a truncated C-terminal protein containing the first, second and third transmembrane domains may have been translated into the presence of C-terminal SAP, and as shown in Figure 6C, no reader can be detected when the AUGA element is removed, indicating that the stimulatory effect is totally dependent on 3 UTR.</text>
                    <arg n="0">a truncated C-terminal protein containing the first, second and third transmembrane domains</arg>
                </example>
                <example src="REPLACE" no="47">
                    <text>a truncated C-terminal protein containing the first, second and third transmembrane domains that can be correctly translated into A2 clones (recombinant) binds DNA to an indistinguishable specificity of ISGF3 gamma purified from HeLa cells.</text>
                    <arg n="0">a truncated C-terminal protein containing the first, second and third transmembrane domains</arg>
                </example>
                <example src="REPLACE" no="48">
                    <text>a truncated C-terminal protein containing the first, second and third transmembrane domains, as our study reveals, can be translated to the presence of C-terminal SBP2, and as shown in Figure 6C no reader can be detected when the AUGA element is removed, indicating that the stimulatory effect is totally dependent on 3 UTR.</text>
                    <arg n="0">a truncated C-terminal protein containing the first, second and third transmembrane domains</arg>
                </example>
                <example src="REPLACE" no="49">
                    <text>a truncated C-terminal protein containing the first, second and third transmembrane domains, as our study reveals, is likely to be translated in the presence of C-terminal SBP2, and as shown in Figure 6C no reader can be detected when the AUGA element is removed, indicating that the stimulatory effect is fully dependent on 3 UTR.</text>
                    <arg n="0">a truncated C-terminal protein containing the first, second and third transmembrane domains</arg>
                </example>
                <example src="REPLACE" no="50">
                    <text>a truncated C-terminal protein containing the first, second and third transmembranous domains may have been translated in the presence of C-terminal SBP2, and as shown in Figure 6C no reader can be detected when the AUGA element is removed, indicating that the stimulatory effect is totally dependent on 3 UTR.</text>
                    <arg n="0">a truncated C-terminal protein containing the first, second and third transmembranous domains</arg>
                </example>
                <example src="REPLACE" no="51">
                    <text>a truncated C-terminal protein containing the first, second and third transmembranous domains translated into the presence of C-terminal SBP2, and as shown in Figure 6C no reader can be detected when the AUGA element is removed, indicating that the stimulatory effect is totally dependent on 3 UTR.</text>
                    <arg n="0">a truncated C-terminal protein containing the first, second and third transmembranous domains</arg>
                </example>
                <example src="REPLACE" no="52">
                    <text>a truncated C-terminal protein containing the first, second and third transmembranous domains was efficiently translated into the presence of PAS-C-terminal2, and as shown in Figure 6C no reader can be detected when the AUGA element is removed, indicating that the stimulatory effect is completely dependent on 3 UTR.</text>
                    <arg n="0">a truncated C-terminal protein containing the first, second and third transmembranous domains</arg>
                </example>
                <example src="REPLACE" no="53">
                    <text>a truncated C-terminal protein containing the first, second and third transmembranous domains, as revealed in our study, can be translated into the presence of C-terminal SBP, and as shown in Figure 6C, reading the AUGA element is not detectable, indicating that the stimulatory effect is completely 3 UTR dependent.</text>
                    <arg n="0">a truncated C-terminal protein containing the first, second and third transmembranous domains</arg>
                </example>
                <example src="REPLACE" no="54">
                    <text>a truncated C-terminal protein containing the first, second and third transmembranous domains, as revealed in our study, is able to be translated into the presence of PAS-C-terminal2, and as shown in Figure 6C, reading when the AUGA element is excluded is not detectable, indicating that the stimulating effect is totally 3 UTR dependent.</text>
                    <arg n="0">a truncated C-terminal protein containing the first, second and third transmembranous domains</arg>
                </example>
                <example src="REPLACE" no="55">
                    <text>a truncated C-terminal protein containing the first, second, and third transmembrane domains , as our study reveals, can be translated into the presence of C-terminal SBP2, and as shown in Figure 6C no reader can be detected when the AUGA element is removed, indicating that the stimulatory effect is totally dependent on 3 UTR.</text>
                    <arg n="0">a truncated C-terminal protein containing the first, second, and third transmembrane domains</arg>
                </example>
                <example src="REPLACE" no="56">
                    <text>a truncated C-terminal protein containing the first, second, and third transmembrane domains is likely to be translated efficiently in the presence of PAS-C, and as can be seen in Figure 6C, no reader can be detected when the AUGA element is removed, indicating that the stimulatory effect is totally dependent on 3 UTR.</text>
                    <arg n="0">a truncated C-terminal protein containing the first, second, and third transmembrane domains</arg>
                </example>
                <example src="REPLACE" no="57">
                    <text>a truncated C-terminal protein containing the first, second, and third transmembrane domains may have been translated into the presence of C-terminal SAP, and as shown in Figure 6C, no reader can be detected when the AUGA element is removed, indicating that the stimulatory effect is totally dependent on 3 UTR.</text>
                    <arg n="0">a truncated C-terminal protein containing the first, second, and third transmembrane domains</arg>
                </example>
                <example src="REPLACE" no="58">
                    <text>a truncated C-terminal protein containing the first, second, and third transmembrane domains that can be correctly translated into A2 clones (recombinant) binds DNA to an indistinguishable specificity of ISGF3 gamma purified from HeLa cells.</text>
                    <arg n="0">a truncated C-terminal protein containing the first, second, and third transmembrane domains</arg>
                </example>
                <example src="REPLACE" no="59">
                    <text>a truncated C-terminal protein containing the first, second, and third transmembrane domains translated into the presence of C-terminal SBP2, and as shown in Figure 6C no reader can be detected when the AUGA element is removed, indicating that the stimulatory effect is totally dependent on 3 UTR.</text>
                    <arg n="0">a truncated C-terminal protein containing the first, second, and third transmembrane domains</arg>
                </example>
                <example src="REPLACE" no="60">
                    <text>a truncated C-terminal protein containing the first, second, and third transmembrane domains was shown to be effective in the presence of PAS-C, and as shown in Figure 6C, no reader can be detected when the AUGA element is removed, translated that the stimulatory effect is completely dependent on 3 UTR.</text>
                    <arg n="0">a truncated C-terminal protein containing the first, second, and third transmembrane domains</arg>
                </example>
                <example src="REPLACE" no="61">
                    <text>a truncated C-terminal protein containing the first, second, and third transmembrane domains was translated into the presence of C-terminal SAP, and as shown in Figure 6C, no reader can be detected when the AUGA element is removed, indicating that the stimulatory effect is totally dependent on 3 UTR.</text>
                    <arg n="0">a truncated C-terminal protein containing the first, second, and third transmembrane domains</arg>
                </example>
                <example src="REPLACE" no="62">
                    <text>a truncated C-terminal protein containing the first, second, and third transmembrane domains, as our study reveals, is likely to be translated in the presence of C-terminal SBP2, and as shown in Figure 6C no reader can be detected when the AUGA element is removed, indicating that the stimulatory effect is fully dependent on 3 UTR.</text>
                    <arg n="0">a truncated C-terminal protein containing the first, second, and third transmembrane domains</arg>
                </example>
                <example src="REPLACE" no="63">
                    <text>a truncated C-terminal protein containing the first, second, and third transmembrane domains, as revealed in our study, is able to be translated into the presence of PAS-C-terminal2, and as shown in Figure 6C, reading when the AUGA element is excluded is not detectable, indicating that the stimulating effect is totally 3 UTR dependent.</text>
                    <arg n="0">a truncated C-terminal protein containing the first, second, and third transmembrane domains</arg>
                </example>
                <example src="REPLACE" no="64">
                    <text>open led frames has been shown to translated efficiently in the presence of C-terminal SBP2, and as shown in Figure 6C no reader can be detected when the AUGA element is removed, indicating that the stimulatory effect is completely dependent on 3 UTR.</text>
                    <arg n="0">open led frames</arg>
                </example>
                <example src="REPLACE" no="65">
                    <text>open led frames is able to be translated efficiently in the presence of C-terminal SBP2, and as shown in Figure 6C no reader can be detected when the AUGA element is removed, indicating that the stimulatory effect is totally dependent on 3 UTR.</text>
                    <arg n="0">open led frames</arg>
                </example>
                <example src="REPLACE" no="66">
                    <text>open led frames is likely to be translated efficiently in the presence of PAS-C, and as can be seen in Figure 6C, no reader can be detected when the AUGA element is removed, indicating that the stimulatory effect is totally dependent on 3 UTR.</text>
                    <arg n="0">open led frames</arg>
                </example>
                <example src="REPLACE" no="67">
                    <text>open led frames is likely to be translated into the presence of C-terminal SBP, and as shown in Figure 6C, reading the AUGA element is not detectable, indicating that the stimulatory effect is completely 3 UTR dependent.</text>
                    <arg n="0">open led frames</arg>
                </example>
                <example src="REPLACE" no="68">
                    <text>open led frames may have been translated efficiently in the presence of C-terminal SBP2, and as shown in Figure 6C no reader can be detected when the AUGA element is removed, indicating that the stimulatory effect is completely dependent on 3 UTR.</text>
                    <arg n="0">open led frames</arg>
                </example>
                <example src="REPLACE" no="69">
                    <text>open led frames, as revealed in our study, has been shown to be translated into the presence of C-terminal SBP, and as shown in Figure 6C, reading the AUGA element is not detectable, indicating that the stimulatory effect is totally 3 UTR dependent.</text>
                    <arg n="0">open led frames</arg>
                </example>
            </roleset>
        </predicate>
    </framesest>
</PASBIO>
